Stem definition | Drug id | CAS RN |
---|---|---|
3317 | 191732-72-6 |
Dose | Unit | Route |
---|---|---|
10 | mg | O |
Property | Value | Reference |
---|---|---|
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 4 | Benet LZ, Broccatelli F, Oprea TI |
S (Water solubility) | 0.00 mg/mL | Benet LZ, Broccatelli F, Oprea TI |
EoM (Fraction excreted unchanged in urine) | 66 % | Benet LZ, Broccatelli F, Oprea TI |
MRTD (Maximum Recommended Therapeutic Daily Dose) | 1.38 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
Date | Agency | Company | Orphan |
---|---|---|---|
June 14, 2007 | EMA | CELEGENE EUROPE BV | |
Dec. 27, 2005 | FDA | CELGENE | |
June 25, 2010 | PMDA | Celgene K.K. |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Full blood count decreased | 6109.20 | 15.46 | 2788 | 269559 | 19558 | 50313219 |
Diarrhoea | 6075.29 | 15.46 | 11076 | 261271 | 577400 | 49755377 |
Death | 4821.77 | 15.46 | 7225 | 265122 | 318154 | 50014623 |
White blood cell count decreased | 4076.49 | 15.46 | 4012 | 268335 | 112710 | 50220067 |
Neuropathy peripheral | 3589.28 | 15.46 | 3439 | 268908 | 93318 | 50239459 |
Thrombosis | 3281.78 | 15.46 | 2582 | 269765 | 53251 | 50279526 |
Laboratory test abnormal | 2678.52 | 15.46 | 1627 | 270720 | 21581 | 50311196 |
Platelet count decreased | 2631.19 | 15.46 | 2968 | 269379 | 97758 | 50235019 |
Pneumonia | 2483.49 | 15.46 | 5940 | 266407 | 372461 | 49960316 |
Fatigue | 1661.25 | 15.46 | 7842 | 264505 | 699759 | 49633018 |
Unevaluable event | 1543.89 | 15.46 | 1551 | 270796 | 44515 | 50288262 |
Plasma cell myeloma | 1516.31 | 15.46 | 1295 | 271052 | 30027 | 50302750 |
Constipation | 1491.43 | 15.46 | 3165 | 269182 | 182543 | 50150234 |
Drug ineffective | 1457.57 | 15.46 | 1368 | 270979 | 817965 | 49514812 |
Muscle spasms | 1439.45 | 15.46 | 2490 | 269857 | 123063 | 50209714 |
Adverse drug reaction | 1333.35 | 15.46 | 1564 | 270783 | 53658 | 50279119 |
Rash | 1330.20 | 15.46 | 5250 | 267097 | 432221 | 49900556 |
Off label use | 1314.70 | 15.46 | 459 | 271888 | 473967 | 49858810 |
Human chorionic gonadotropin increased | 1051.66 | 15.46 | 353 | 271994 | 898 | 50331879 |
Condition aggravated | 1051.48 | 15.46 | 170 | 272177 | 296888 | 50035889 |
COVID-19 | 994.70 | 15.46 | 1241 | 271106 | 45421 | 50287356 |
Neutropenia | 937.89 | 15.46 | 2298 | 270049 | 145667 | 50187110 |
Plasma cell myeloma recurrent | 917.04 | 15.46 | 391 | 271956 | 2267 | 50330510 |
Rheumatoid arthritis | 913.34 | 15.46 | 42 | 272305 | 202508 | 50130269 |
Blood potassium decreased | 887.47 | 15.46 | 1044 | 271303 | 35901 | 50296876 |
Product dose omission issue | 836.34 | 15.46 | 2527 | 269820 | 181311 | 50151466 |
Maternal exposure during pregnancy | 830.50 | 15.46 | 5 | 272342 | 159773 | 50173004 |
Deep vein thrombosis | 822.27 | 15.46 | 1441 | 270906 | 71863 | 50260914 |
Haemoglobin decreased | 758.74 | 15.46 | 1931 | 270416 | 125285 | 50207492 |
Drug interaction | 745.82 | 15.46 | 97 | 272250 | 199524 | 50133253 |
Neutrophil count decreased | 721.21 | 15.46 | 1054 | 271293 | 44972 | 50287805 |
Systemic lupus erythematosus | 687.96 | 15.46 | 14 | 272333 | 140608 | 50192169 |
Completed suicide | 666.82 | 15.46 | 8 | 272339 | 131881 | 50200896 |
Pancytopenia | 657.59 | 15.46 | 1419 | 270928 | 82611 | 50250166 |
Ageusia | 652.16 | 15.46 | 523 | 271824 | 11060 | 50321717 |
Synovitis | 637.96 | 15.46 | 5 | 272342 | 123860 | 50208917 |
Tooth disorder | 598.98 | 15.46 | 695 | 271652 | 23533 | 50309244 |
Red blood cell count decreased | 583.25 | 15.46 | 811 | 271536 | 33024 | 50299753 |
Exposure during pregnancy | 558.89 | 15.46 | 21 | 272326 | 120994 | 50211783 |
Skin discolouration | 555.45 | 15.46 | 779 | 271568 | 31978 | 50300799 |
Drug hypersensitivity | 531.39 | 15.46 | 349 | 271998 | 250661 | 50082116 |
Product use issue | 520.45 | 15.46 | 89 | 272258 | 149386 | 50183391 |
Asthenia | 517.06 | 15.46 | 3206 | 269141 | 315836 | 50016941 |
Injection site pain | 513.61 | 15.46 | 19 | 272328 | 111005 | 50221772 |
Renal disorder | 503.82 | 15.46 | 679 | 271668 | 26826 | 50305951 |
Thrombocytopenia | 488.68 | 15.46 | 1655 | 270692 | 126018 | 50206759 |
Infusion related reaction | 480.26 | 15.46 | 157 | 272190 | 169400 | 50163377 |
Peripheral swelling | 458.93 | 15.46 | 2257 | 270090 | 203679 | 50129098 |
Pulmonary thrombosis | 455.67 | 15.46 | 355 | 271992 | 7186 | 50325591 |
Rash pruritic | 440.10 | 15.46 | 864 | 271483 | 46982 | 50285795 |
Treatment failure | 427.45 | 15.46 | 107 | 272240 | 137530 | 50195247 |
Taste disorder | 424.81 | 15.46 | 355 | 271992 | 7969 | 50324808 |
Multiple allergies | 421.73 | 15.46 | 356 | 271991 | 8107 | 50324670 |
Cytopenia | 412.54 | 15.46 | 357 | 271990 | 8418 | 50324359 |
Plasmacytoma | 412.35 | 15.46 | 218 | 272129 | 2167 | 50330610 |
Cardiac disorder | 404.87 | 15.46 | 784 | 271563 | 42195 | 50290582 |
Dehydration | 402.27 | 15.46 | 1756 | 270591 | 150693 | 50182084 |
Glossodynia | 401.82 | 15.46 | 69 | 272278 | 115500 | 50217277 |
Arthralgia | 398.19 | 15.46 | 1134 | 271213 | 437568 | 49895209 |
Seasonal allergy | 384.67 | 15.46 | 434 | 271913 | 14242 | 50318535 |
Urinary tract infection | 374.76 | 15.46 | 2271 | 270076 | 221749 | 50111028 |
Pain | 367.83 | 15.46 | 1736 | 270611 | 577167 | 49755610 |
Dry skin | 367.38 | 15.46 | 755 | 271592 | 42436 | 50290341 |
Hip fracture | 352.44 | 15.46 | 556 | 271791 | 25375 | 50307402 |
Product use in unapproved indication | 346.37 | 15.46 | 97 | 272250 | 115722 | 50217055 |
Overdose | 343.48 | 15.46 | 61 | 272286 | 99666 | 50233111 |
Therapeutic product effect decreased | 343.42 | 15.46 | 151 | 272196 | 135899 | 50196878 |
Headache | 341.25 | 15.46 | 1486 | 270861 | 505049 | 49827728 |
Full blood count abnormal | 338.15 | 15.46 | 516 | 271831 | 22872 | 50309905 |
Therapeutic product effect incomplete | 335.46 | 15.46 | 47 | 272300 | 91468 | 50241309 |
Discomfort | 327.41 | 15.46 | 89 | 272258 | 108291 | 50224486 |
Cataract | 327.40 | 15.46 | 761 | 271586 | 46539 | 50286238 |
Intentional product use issue | 316.28 | 15.46 | 26 | 272321 | 76892 | 50255885 |
Monoclonal immunoglobulin present | 299.51 | 15.46 | 122 | 272225 | 618 | 50332159 |
Anaemia | 299.18 | 15.46 | 2352 | 269995 | 250104 | 50082673 |
Injection site erythema | 293.01 | 15.46 | 31 | 272316 | 74905 | 50257872 |
Pericarditis | 289.37 | 15.46 | 40 | 272307 | 78649 | 50254128 |
Blood test abnormal | 283.56 | 15.46 | 327 | 272020 | 10992 | 50321785 |
Full blood count increased | 283.49 | 15.46 | 124 | 272223 | 772 | 50332005 |
Renal failure | 279.31 | 15.46 | 1226 | 271121 | 105407 | 50227370 |
Spinal fracture | 266.37 | 15.46 | 372 | 271975 | 15201 | 50317576 |
Wound | 266.03 | 15.46 | 118 | 272229 | 105676 | 50227101 |
Protein total increased | 254.84 | 15.46 | 162 | 272185 | 2334 | 50330443 |
Pulmonary embolism | 252.56 | 15.46 | 1151 | 271196 | 100553 | 50232224 |
Hospitalisation | 248.71 | 15.46 | 35 | 272312 | 67902 | 50264875 |
Suicide attempt | 242.15 | 15.46 | 8 | 272339 | 51724 | 50281053 |
Pruritus | 241.26 | 15.46 | 2458 | 269889 | 281110 | 50051667 |
Wrong technique in product usage process | 230.32 | 15.46 | 18 | 272329 | 55492 | 50277285 |
Mobility decreased | 229.78 | 15.46 | 72 | 272275 | 79876 | 50252901 |
Fall | 225.71 | 15.46 | 2773 | 269574 | 332159 | 50000618 |
Psoriasis | 225.33 | 15.46 | 48 | 272299 | 68952 | 50263825 |
Light chain analysis increased | 223.43 | 15.46 | 112 | 272235 | 986 | 50331791 |
Intentional product misuse | 219.55 | 15.46 | 7 | 272340 | 46727 | 50286050 |
Aspartate aminotransferase increased | 219.30 | 15.46 | 73 | 272274 | 77925 | 50254852 |
Body height decreased | 217.53 | 15.46 | 254 | 272093 | 8654 | 50324123 |
Gastric disorder | 215.05 | 15.46 | 485 | 271862 | 29063 | 50303714 |
Hepatic enzyme increased | 212.27 | 15.46 | 256 | 272091 | 137124 | 50195653 |
Alanine aminotransferase increased | 212.18 | 15.46 | 105 | 272242 | 88254 | 50244523 |
Tachycardia | 211.72 | 15.46 | 138 | 272209 | 99625 | 50233152 |
Abortion spontaneous | 208.95 | 15.46 | 3 | 272344 | 41769 | 50291008 |
Plasma cell leukaemia | 207.91 | 15.46 | 104 | 272243 | 911 | 50331866 |
Hypoaesthesia | 206.64 | 15.46 | 1281 | 271066 | 125976 | 50206801 |
Acute myeloid leukaemia | 203.13 | 15.46 | 322 | 272025 | 14752 | 50318025 |
Helicobacter infection | 201.02 | 15.46 | 18 | 272329 | 49684 | 50283093 |
Suicidal ideation | 199.32 | 15.46 | 30 | 272317 | 55355 | 50277422 |
Hordeolum | 197.18 | 15.46 | 135 | 272212 | 2218 | 50330559 |
Oxygen saturation decreased | 194.94 | 15.46 | 75 | 272272 | 73173 | 50259604 |
Anaphylactic reaction | 192.88 | 15.46 | 30 | 272317 | 54025 | 50278752 |
Lactose intolerance | 191.01 | 15.46 | 137 | 272210 | 2433 | 50330344 |
Back disorder | 187.81 | 15.46 | 241 | 272106 | 9064 | 50323713 |
Folliculitis | 187.47 | 15.46 | 5 | 272342 | 39220 | 50293557 |
Influenza | 186.75 | 15.46 | 964 | 271383 | 88574 | 50244203 |
Lower respiratory tract infection | 184.57 | 15.46 | 145 | 272202 | 95056 | 50237721 |
Decreased appetite | 183.95 | 15.46 | 1769 | 270578 | 199154 | 50133623 |
Injection site pruritus | 183.14 | 15.46 | 8 | 272339 | 40403 | 50292374 |
Myelodysplastic syndrome | 181.92 | 15.46 | 307 | 272040 | 14825 | 50317952 |
Inappropriate schedule of product administration | 180.73 | 15.46 | 80 | 272267 | 71751 | 50261026 |
SARS-CoV-2 test positive | 180.49 | 15.46 | 170 | 272177 | 4489 | 50328288 |
Muscle injury | 180.15 | 15.46 | 4 | 272343 | 37107 | 50295670 |
Injection site reaction | 177.99 | 15.46 | 28 | 272319 | 50004 | 50282773 |
Sepsis | 177.19 | 15.46 | 1274 | 271073 | 131651 | 50201126 |
Injection site swelling | 174.84 | 15.46 | 13 | 272334 | 41760 | 50291017 |
Injection site bruising | 174.56 | 15.46 | 5 | 272342 | 36763 | 50296014 |
Depressed level of consciousness | 169.92 | 15.46 | 36 | 272311 | 51917 | 50280860 |
Knee arthroplasty | 169.72 | 15.46 | 5 | 272342 | 35841 | 50296936 |
Hyponatraemia | 168.68 | 15.46 | 161 | 272186 | 95978 | 50236799 |
Myelodysplastic syndrome transformation | 168.68 | 15.46 | 69 | 272278 | 354 | 50332423 |
Loss of personal independence in daily activities | 168.54 | 15.46 | 83 | 272264 | 69967 | 50262810 |
Impaired healing | 162.96 | 15.46 | 86 | 272261 | 69700 | 50263077 |
Coma | 160.29 | 15.46 | 53 | 272294 | 56826 | 50275951 |
Hypertension | 156.41 | 15.46 | 596 | 271751 | 210607 | 50122170 |
Migraine | 154.52 | 15.46 | 108 | 272239 | 75172 | 50257605 |
Fibromyalgia | 153.75 | 15.46 | 28 | 272319 | 44950 | 50287827 |
Swelling | 153.21 | 15.46 | 560 | 271787 | 200312 | 50132465 |
Depression | 148.47 | 15.46 | 429 | 271918 | 164994 | 50167783 |
Atrial fibrillation | 144.22 | 15.46 | 990 | 271357 | 100755 | 50232022 |
Clostridium difficile infection | 140.88 | 15.46 | 376 | 271971 | 25063 | 50307714 |
Hypoglycaemia | 140.69 | 15.46 | 56 | 272291 | 53525 | 50279252 |
Blood pressure systolic increased | 140.27 | 15.46 | 14 | 272333 | 35435 | 50297342 |
Cerebrovascular accident | 137.61 | 15.46 | 927 | 271420 | 93753 | 50239024 |
Musculoskeletal stiffness | 137.09 | 15.46 | 305 | 272042 | 128176 | 50204601 |
Rhabdomyolysis | 136.23 | 15.46 | 23 | 272324 | 39004 | 50293773 |
Skin exfoliation | 135.70 | 15.46 | 444 | 271903 | 33168 | 50299609 |
Dysgeusia | 135.22 | 15.46 | 489 | 271858 | 38427 | 50294350 |
Blood magnesium decreased | 134.93 | 15.46 | 227 | 272120 | 10933 | 50321844 |
Alopecia | 133.95 | 15.46 | 772 | 271575 | 244275 | 50088502 |
Squamous cell carcinoma of skin | 133.75 | 15.46 | 152 | 272195 | 5026 | 50327751 |
C-reactive protein increased | 131.69 | 15.46 | 99 | 272248 | 66375 | 50266402 |
Hip arthroplasty | 131.66 | 15.46 | 8 | 272339 | 30421 | 50302356 |
Product quality issue | 130.88 | 15.46 | 9 | 272338 | 30849 | 50301928 |
Sinus disorder | 129.89 | 15.46 | 299 | 272048 | 18159 | 50314618 |
Sedation | 129.62 | 15.46 | 9 | 272338 | 30601 | 50302176 |
Osteoarthritis | 128.59 | 15.46 | 108 | 272239 | 68498 | 50264279 |
Upper limb fracture | 128.51 | 15.46 | 272 | 272075 | 15601 | 50317176 |
Illness | 128.18 | 15.46 | 355 | 271992 | 24185 | 50308592 |
Bradycardia | 127.56 | 15.46 | 96 | 272251 | 64330 | 50268447 |
Flatulence | 126.99 | 15.46 | 398 | 271949 | 29060 | 50303717 |
Bone pain | 122.75 | 15.46 | 542 | 271805 | 46687 | 50286090 |
Immune system disorder | 122.59 | 15.46 | 184 | 272163 | 8033 | 50324744 |
Electrocardiogram QT prolonged | 122.52 | 15.46 | 63 | 272284 | 51823 | 50280954 |
Hypersensitivity | 121.82 | 15.46 | 670 | 271677 | 214491 | 50118286 |
Agitation | 121.40 | 15.46 | 68 | 272279 | 53316 | 50279461 |
Type 2 diabetes mellitus | 120.56 | 15.46 | 20 | 272327 | 34355 | 50298422 |
Medication error | 120.17 | 15.46 | 24 | 272323 | 36080 | 50296697 |
Wheezing | 119.61 | 15.46 | 95 | 272252 | 61952 | 50270825 |
Tumour flare | 117.51 | 15.46 | 47 | 272300 | 225 | 50332552 |
Injury | 116.13 | 15.46 | 59 | 272288 | 48866 | 50283911 |
Abdominal pain | 114.69 | 15.46 | 772 | 271575 | 235456 | 50097321 |
Drug withdrawal syndrome | 113.53 | 15.46 | 5 | 272342 | 25076 | 50307701 |
Gallbladder disorder | 113.20 | 15.46 | 267 | 272080 | 16475 | 50316302 |
Bronchitis | 111.46 | 15.46 | 949 | 271398 | 103210 | 50229567 |
Dementia | 111.31 | 15.46 | 258 | 272089 | 15739 | 50317038 |
Blood pressure increased | 110.34 | 15.46 | 358 | 271989 | 132774 | 50200003 |
Renal impairment | 109.45 | 15.46 | 740 | 271607 | 74921 | 50257856 |
Gout | 108.88 | 15.46 | 210 | 272137 | 11260 | 50321517 |
Ill-defined disorder | 108.76 | 15.46 | 81 | 272266 | 54573 | 50278204 |
Blood creatine phosphokinase increased | 108.11 | 15.46 | 9 | 272338 | 26358 | 50306419 |
Interstitial lung disease | 106.87 | 15.46 | 78 | 272269 | 53098 | 50279679 |
Incorrect dose administered | 106.77 | 15.46 | 64 | 272283 | 48350 | 50284427 |
General physical health deterioration | 105.33 | 15.46 | 402 | 271945 | 142032 | 50190745 |
Disease progression | 104.45 | 15.46 | 877 | 271470 | 94989 | 50237788 |
Papule | 102.94 | 15.46 | 122 | 272225 | 4223 | 50328554 |
Gamma-glutamyltransferase increased | 102.20 | 15.46 | 18 | 272329 | 29605 | 50303172 |
Surgery | 98.62 | 15.46 | 21 | 272326 | 30184 | 50302593 |
Emotional distress | 97.62 | 15.46 | 18 | 272329 | 28645 | 50304132 |
Paraesthesia | 94.72 | 15.46 | 1027 | 271320 | 119216 | 50213561 |
Injection site haemorrhage | 94.23 | 15.46 | 5 | 272342 | 21341 | 50311436 |
Somnolence | 93.03 | 15.46 | 473 | 271874 | 154512 | 50178265 |
Anxiety | 93.01 | 15.46 | 567 | 271780 | 177039 | 50155738 |
Herpes zoster | 92.81 | 15.46 | 676 | 271671 | 70110 | 50262667 |
COVID-19 pneumonia | 91.35 | 15.46 | 163 | 272184 | 8232 | 50324545 |
Acute lymphocytic leukaemia | 91.10 | 15.46 | 84 | 272263 | 2157 | 50330620 |
Drug level increased | 90.09 | 15.46 | 3 | 272344 | 19265 | 50313512 |
Respiratory arrest | 89.90 | 15.46 | 25 | 272322 | 29984 | 50302793 |
Pregnancy | 89.80 | 15.46 | 24 | 272323 | 29553 | 50303224 |
Bone lesion | 89.15 | 15.46 | 124 | 272223 | 5046 | 50327731 |
Lactic acidosis | 88.98 | 15.46 | 34 | 272313 | 33321 | 50299456 |
Seizure | 88.88 | 15.46 | 330 | 272017 | 117544 | 50215233 |
Memory impairment | 88.03 | 15.46 | 729 | 271618 | 78631 | 50254146 |
Drug ineffective for unapproved indication | 87.99 | 15.46 | 7 | 272340 | 21274 | 50311503 |
Device dislocation | 86.59 | 15.46 | 8 | 272339 | 21538 | 50311239 |
Blood alkaline phosphatase increased | 86.48 | 15.46 | 47 | 272300 | 37479 | 50295298 |
Hyperkalaemia | 86.12 | 15.46 | 79 | 272268 | 48010 | 50284767 |
Underdose | 85.75 | 15.46 | 6 | 272341 | 20272 | 50312505 |
Monoclonal immunoglobulin increased | 85.23 | 15.46 | 29 | 272318 | 78 | 50332699 |
Blood cholesterol increased | 85.09 | 15.46 | 103 | 272244 | 55112 | 50277665 |
Chest discomfort | 84.93 | 15.46 | 238 | 272109 | 92484 | 50240293 |
Erythema | 82.21 | 15.46 | 457 | 271890 | 145957 | 50186820 |
Device issue | 81.38 | 15.46 | 7 | 272340 | 19965 | 50312812 |
Pregnancy test false positive | 81.06 | 15.46 | 32 | 272315 | 147 | 50332630 |
Inflammation | 80.68 | 15.46 | 113 | 272234 | 56799 | 50275978 |
Back pain | 80.61 | 15.46 | 1646 | 270701 | 218384 | 50114393 |
Cardio-respiratory arrest | 80.47 | 15.46 | 103 | 272244 | 53789 | 50278988 |
Pulmonary arterial hypertension | 80.45 | 15.46 | 8 | 272339 | 20311 | 50312466 |
Blood pressure fluctuation | 79.49 | 15.46 | 47 | 272300 | 35776 | 50297001 |
Nasopharyngitis | 79.38 | 15.46 | 1469 | 270878 | 191458 | 50141319 |
Metabolic acidosis | 79.25 | 15.46 | 56 | 272291 | 38769 | 50294008 |
Muscle spasticity | 79.21 | 15.46 | 3 | 272344 | 17181 | 50315596 |
Cardiac amyloidosis | 78.52 | 15.46 | 49 | 272298 | 682 | 50332095 |
Dysarthria | 77.61 | 15.46 | 53 | 272294 | 37350 | 50295427 |
Incorrect route of product administration | 77.57 | 15.46 | 6 | 272341 | 18660 | 50314117 |
No adverse event | 77.46 | 15.46 | 42 | 272305 | 33536 | 50299241 |
Ascites | 76.86 | 15.46 | 49 | 272298 | 35812 | 50296965 |
Metastases to liver | 76.83 | 15.46 | 9 | 272338 | 20095 | 50312682 |
Joint range of motion decreased | 76.79 | 15.46 | 6 | 272341 | 18506 | 50314271 |
Flushing | 76.54 | 15.46 | 153 | 272194 | 66862 | 50265915 |
Gait disturbance | 75.36 | 15.46 | 485 | 271862 | 149520 | 50183257 |
Eye disorder | 75.14 | 15.46 | 247 | 272100 | 18492 | 50314285 |
Palpitations | 74.27 | 15.46 | 260 | 272087 | 94246 | 50238531 |
Tremor | 72.64 | 15.46 | 941 | 271406 | 113962 | 50218815 |
Diverticulitis | 72.44 | 15.46 | 362 | 271985 | 32820 | 50299957 |
Musculoskeletal pain | 72.40 | 15.46 | 177 | 272170 | 72000 | 50260777 |
Multiple sclerosis | 71.69 | 15.46 | 12 | 272335 | 20481 | 50312296 |
Obesity | 70.83 | 15.46 | 5 | 272342 | 16770 | 50316007 |
Anaphylactic shock | 70.07 | 15.46 | 12 | 272335 | 20143 | 50312634 |
Abnormal behaviour | 69.91 | 15.46 | 11 | 272336 | 19647 | 50313130 |
Generalised tonic-clonic seizure | 69.88 | 15.46 | 27 | 272320 | 26283 | 50306494 |
Drug-induced liver injury | 69.54 | 15.46 | 32 | 272315 | 28063 | 50304714 |
Withdrawal syndrome | 69.45 | 15.46 | 7 | 272340 | 17583 | 50315194 |
Eye infection | 69.10 | 15.46 | 155 | 272192 | 9251 | 50323526 |
Hypogeusia | 68.84 | 15.46 | 53 | 272294 | 1053 | 50331724 |
Abdominal discomfort | 68.75 | 15.46 | 857 | 271490 | 230784 | 50101993 |
Cardiac failure congestive | 68.41 | 15.46 | 725 | 271622 | 83657 | 50249120 |
Liver injury | 68.34 | 15.46 | 24 | 272323 | 24782 | 50307995 |
Sleep apnoea syndrome | 67.65 | 15.46 | 22 | 272325 | 23846 | 50308931 |
Product prescribing error | 67.56 | 15.46 | 15 | 272332 | 20946 | 50311831 |
Swelling face | 67.06 | 15.46 | 499 | 271848 | 52096 | 50280681 |
Spinal compression fracture | 66.99 | 15.46 | 184 | 272163 | 12472 | 50320305 |
Blood iron decreased | 66.66 | 15.46 | 174 | 272173 | 11441 | 50321336 |
White blood cell count abnormal | 66.22 | 15.46 | 111 | 272236 | 5329 | 50327448 |
Prescribed overdose | 65.79 | 15.46 | 3 | 272344 | 14597 | 50318180 |
Toxic epidermal necrolysis | 65.72 | 15.46 | 16 | 272331 | 20976 | 50311801 |
Coronavirus infection | 65.72 | 15.46 | 80 | 272267 | 2849 | 50329928 |
Vomiting | 65.56 | 15.46 | 1934 | 270413 | 458824 | 49873953 |
Blood pressure diastolic decreased | 65.42 | 15.46 | 7 | 272340 | 16774 | 50316003 |
Weight decreased | 64.64 | 15.46 | 1603 | 270744 | 219642 | 50113135 |
Accidental exposure to product | 64.05 | 15.46 | 22 | 272325 | 23035 | 50309742 |
Diabetic ketoacidosis | 63.56 | 15.46 | 10 | 272337 | 17862 | 50314915 |
Acute leukaemia | 63.42 | 15.46 | 50 | 272297 | 1030 | 50331747 |
Amyloidosis | 63.15 | 15.46 | 48 | 272299 | 935 | 50331842 |
Unresponsive to stimuli | 62.67 | 15.46 | 44 | 272303 | 30565 | 50302212 |
Hepatitis | 62.08 | 15.46 | 47 | 272300 | 31406 | 50301371 |
Increased tendency to bruise | 61.94 | 15.46 | 148 | 272199 | 9208 | 50323569 |
Pallor | 61.29 | 15.46 | 24 | 272323 | 23175 | 50309602 |
Transaminases increased | 61.04 | 15.46 | 37 | 272310 | 27787 | 50304990 |
Oedema peripheral | 60.91 | 15.46 | 1191 | 271156 | 156770 | 50176007 |
Eye swelling | 60.77 | 15.46 | 242 | 272105 | 19902 | 50312875 |
Hypoacusis | 60.66 | 15.46 | 246 | 272101 | 20401 | 50312376 |
Blister | 60.60 | 15.46 | 245 | 272102 | 85173 | 50247604 |
Compression fracture | 60.54 | 15.46 | 111 | 272236 | 5726 | 50327051 |
Heart rate increased | 60.37 | 15.46 | 213 | 272134 | 77037 | 50255740 |
Clostridium difficile colitis | 59.98 | 15.46 | 221 | 272126 | 17521 | 50315256 |
Tumour lysis syndrome | 59.87 | 15.46 | 127 | 272220 | 7294 | 50325483 |
Dyspnoea | 59.69 | 15.46 | 2377 | 269970 | 545231 | 49787546 |
Dizziness | 59.35 | 15.46 | 2352 | 269995 | 344017 | 49988760 |
Osteolysis | 59.27 | 15.46 | 71 | 272276 | 2486 | 50330291 |
Pathological fracture | 59.15 | 15.46 | 129 | 272218 | 7553 | 50325224 |
Hyperviscosity syndrome | 58.90 | 15.46 | 25 | 272322 | 143 | 50332634 |
Right ventricular failure | 58.59 | 15.46 | 8 | 272339 | 15885 | 50316892 |
Dysphonia | 58.39 | 15.46 | 384 | 271963 | 38508 | 50294269 |
Insomnia | 58.13 | 15.46 | 1290 | 271057 | 173575 | 50159202 |
Intraductal proliferative breast lesion | 57.79 | 15.46 | 70 | 272277 | 2480 | 50330297 |
Metastases to bone | 57.75 | 15.46 | 13 | 272334 | 17982 | 50314795 |
Depressed mood | 57.32 | 15.46 | 59 | 272288 | 33964 | 50298813 |
Device malfunction | 57.22 | 15.46 | 7 | 272340 | 15114 | 50317663 |
Hepatic steatosis | 56.98 | 15.46 | 30 | 272317 | 24354 | 50308423 |
Feeling jittery | 56.85 | 15.46 | 160 | 272187 | 11000 | 50321777 |
Prescribed underdose | 56.55 | 15.46 | 9 | 272338 | 15940 | 50316837 |
Weight increased | 56.53 | 15.46 | 756 | 271591 | 201135 | 50131642 |
Therapeutic response unexpected | 56.39 | 15.46 | 9 | 272338 | 15906 | 50316871 |
Hepatotoxicity | 55.93 | 15.46 | 39 | 272308 | 27187 | 50305590 |
Fracture | 55.50 | 15.46 | 208 | 272139 | 16625 | 50316152 |
Impaired work ability | 54.98 | 15.46 | 5 | 272342 | 13635 | 50319142 |
Irritable bowel syndrome | 54.92 | 15.46 | 122 | 272225 | 51319 | 50281458 |
Dyskinesia | 54.52 | 15.46 | 42 | 272305 | 27819 | 50304958 |
Skin cancer | 54.19 | 15.46 | 141 | 272206 | 9253 | 50323524 |
Rib fracture | 54.09 | 15.46 | 226 | 272121 | 18995 | 50313782 |
Blood electrolytes decreased | 53.80 | 15.46 | 45 | 272302 | 1011 | 50331766 |
Dyspnoea exertional | 53.48 | 15.46 | 123 | 272224 | 51110 | 50281667 |
Procedural pain | 53.34 | 15.46 | 6 | 272341 | 13826 | 50318951 |
Hallucination, visual | 53.18 | 15.46 | 12 | 272335 | 16570 | 50316207 |
Liver function test abnormal | 52.56 | 15.46 | 99 | 272248 | 44240 | 50288537 |
Vitamin D decreased | 52.48 | 15.46 | 130 | 272217 | 8276 | 50324501 |
Body temperature decreased | 52.30 | 15.46 | 12 | 272335 | 16383 | 50316394 |
Fear | 52.06 | 15.46 | 8 | 272339 | 14541 | 50318236 |
Feeling abnormal | 51.37 | 15.46 | 955 | 271392 | 124537 | 50208240 |
Status epilepticus | 51.24 | 15.46 | 6 | 272341 | 13400 | 50319377 |
Extrapyramidal disorder | 51.20 | 15.46 | 3 | 272344 | 11767 | 50321010 |
Crying | 50.92 | 15.46 | 23 | 272324 | 20393 | 50312384 |
Hypercholesterolaemia | 50.86 | 15.46 | 3 | 272344 | 11700 | 50321077 |
Bone erosion | 50.78 | 15.46 | 3 | 272344 | 11684 | 50321093 |
Arthropathy | 50.33 | 15.46 | 575 | 271772 | 157331 | 50175446 |
Leukaemia | 50.28 | 15.46 | 77 | 272270 | 3422 | 50329355 |
Joint swelling | 49.87 | 15.46 | 975 | 271372 | 244311 | 50088466 |
Encephalopathy | 49.73 | 15.46 | 65 | 272282 | 33646 | 50299131 |
International normalised ratio increased | 49.72 | 15.46 | 98 | 272249 | 43054 | 50289723 |
Dry eye | 49.46 | 15.46 | 319 | 272028 | 31776 | 50301001 |
Pancreatitis acute | 49.06 | 15.46 | 34 | 272313 | 23778 | 50308999 |
Pulmonary fibrosis | 48.89 | 15.46 | 36 | 272311 | 24401 | 50308376 |
Obstructive airways disorder | 48.86 | 15.46 | 12 | 272335 | 15640 | 50317137 |
Neuralgia | 48.77 | 15.46 | 240 | 272107 | 21623 | 50311154 |
Cyanosis | 48.67 | 15.46 | 11 | 272336 | 15173 | 50317604 |
Cardiac arrest | 48.63 | 15.46 | 258 | 272089 | 83393 | 50249384 |
Stress | 48.56 | 15.46 | 139 | 272208 | 53654 | 50279123 |
Adenocarcinoma of colon | 48.43 | 15.46 | 59 | 272288 | 2103 | 50330674 |
Disability | 48.13 | 15.46 | 6 | 272341 | 12769 | 50320008 |
Myoclonus | 47.36 | 15.46 | 10 | 272337 | 14460 | 50318317 |
Blood potassium abnormal | 47.35 | 15.46 | 59 | 272288 | 2153 | 50330624 |
Respiratory depression | 46.85 | 15.46 | 5 | 272342 | 12005 | 50320772 |
Leukocytosis | 46.83 | 15.46 | 32 | 272315 | 22547 | 50310230 |
Coagulopathy | 46.69 | 15.46 | 19 | 272328 | 17925 | 50314852 |
Sputum discoloured | 46.51 | 15.46 | 8 | 272339 | 13387 | 50319390 |
Light chain analysis abnormal | 46.47 | 15.46 | 20 | 272327 | 119 | 50332658 |
Aggression | 46.43 | 15.46 | 28 | 272319 | 21088 | 50311689 |
Product administration error | 46.38 | 15.46 | 24 | 272323 | 19675 | 50313102 |
Sinus tachycardia | 46.01 | 15.46 | 29 | 272318 | 21325 | 50311452 |
Haematemesis | 45.67 | 15.46 | 49 | 272298 | 27676 | 50305101 |
Respiratory syncytial virus infection | 45.50 | 15.46 | 91 | 272256 | 5011 | 50327766 |
Rash macular | 45.44 | 15.46 | 215 | 272132 | 19062 | 50313715 |
Product storage error | 45.43 | 15.46 | 6 | 272341 | 12218 | 50320559 |
Therapeutic response decreased | 44.91 | 15.46 | 119 | 272228 | 47112 | 50285665 |
Angioedema | 44.77 | 15.46 | 84 | 272263 | 37592 | 50295185 |
Blood calcium abnormal | 44.72 | 15.46 | 41 | 272306 | 1045 | 50331732 |
Delirium | 44.64 | 15.46 | 86 | 272261 | 38106 | 50294671 |
Pneumonia aspiration | 44.50 | 15.46 | 61 | 272286 | 30943 | 50301834 |
Hypothermia | 44.41 | 15.46 | 6 | 272341 | 12010 | 50320767 |
Blood pressure abnormal | 44.11 | 15.46 | 160 | 272187 | 12587 | 50320190 |
Neutrophil count increased | 44.08 | 15.46 | 11 | 272336 | 14184 | 50318593 |
Poor venous access | 43.89 | 15.46 | 3 | 272344 | 10337 | 50322440 |
Hepatocellular injury | 43.70 | 15.46 | 45 | 272302 | 25902 | 50306875 |
Blood bilirubin increased | 43.06 | 15.46 | 66 | 272281 | 31972 | 50300805 |
Epilepsy | 42.85 | 15.46 | 32 | 272315 | 21535 | 50311242 |
Protein total abnormal | 42.65 | 15.46 | 27 | 272320 | 386 | 50332391 |
Joint stiffness | 42.13 | 15.46 | 61 | 272286 | 30247 | 50302530 |
Tachypnoea | 42.09 | 15.46 | 13 | 272334 | 14564 | 50318213 |
Transfusion | 42.07 | 15.46 | 9 | 272338 | 12896 | 50319881 |
Drug resistance | 42.01 | 15.46 | 25 | 272322 | 18964 | 50313813 |
Iron deficiency anaemia | 41.93 | 15.46 | 19 | 272328 | 16815 | 50315962 |
Human chorionic gonadotropin abnormal | 41.87 | 15.46 | 13 | 272334 | 23 | 50332754 |
Hyperlipidaemia | 41.64 | 15.46 | 21 | 272326 | 17469 | 50315308 |
Foot deformity | 41.51 | 15.46 | 26 | 272321 | 19184 | 50313593 |
Sleep disorder | 41.45 | 15.46 | 163 | 272184 | 57120 | 50275657 |
Muscle rigidity | 41.29 | 15.46 | 3 | 272344 | 9826 | 50322951 |
Heavy menstrual bleeding | 41.17 | 15.46 | 16 | 272331 | 15521 | 50317256 |
Vision blurred | 41.16 | 15.46 | 623 | 271724 | 78024 | 50254753 |
Pulmonary hypertension | 41.05 | 15.46 | 73 | 272274 | 33344 | 50299433 |
Viral infection | 40.80 | 15.46 | 289 | 272058 | 29697 | 50303080 |
Complication associated with device | 40.68 | 15.46 | 14 | 272333 | 14641 | 50318136 |
Myalgia | 40.67 | 15.46 | 450 | 271897 | 123869 | 50208908 |
Tooth infection | 40.55 | 15.46 | 167 | 272180 | 13945 | 50318832 |
Vitamin B12 decreased | 40.52 | 15.46 | 62 | 272285 | 2753 | 50330024 |
Cholecystitis chronic | 40.48 | 15.46 | 3 | 272344 | 9666 | 50323111 |
Lower limb fracture | 40.47 | 15.46 | 168 | 272179 | 14078 | 50318699 |
Device breakage | 39.86 | 15.46 | 3 | 272344 | 9544 | 50323233 |
Agranulocytosis | 39.78 | 15.46 | 34 | 272313 | 21387 | 50311390 |
Anhedonia | 39.75 | 15.46 | 3 | 272344 | 9521 | 50323256 |
Metastases to lung | 39.57 | 15.46 | 6 | 272341 | 11014 | 50321763 |
Rhinorrhoea | 39.39 | 15.46 | 438 | 271909 | 51145 | 50281632 |
Rales | 39.32 | 15.46 | 4 | 272343 | 9974 | 50322803 |
Liver function test decreased | 39.31 | 15.46 | 13 | 272334 | 31 | 50332746 |
Coronary artery disease | 39.23 | 15.46 | 62 | 272285 | 29664 | 50303113 |
Altered state of consciousness | 39.22 | 15.46 | 36 | 272311 | 21874 | 50310903 |
Respiratory distress | 38.91 | 15.46 | 65 | 272282 | 30424 | 50302353 |
Psychotic disorder | 38.85 | 15.46 | 36 | 272311 | 21776 | 50311001 |
Anosmia | 38.57 | 15.46 | 73 | 272274 | 3858 | 50328919 |
Platelet count abnormal | 38.57 | 15.46 | 61 | 272286 | 2788 | 50329989 |
Gastrointestinal motility disorder | 38.52 | 15.46 | 79 | 272268 | 4430 | 50328347 |
Blood urea increased | 38.49 | 15.46 | 42 | 272305 | 23543 | 50309234 |
Upper respiratory tract infection | 38.44 | 15.46 | 532 | 271815 | 65366 | 50267411 |
Grip strength decreased | 38.41 | 15.46 | 9 | 272338 | 12112 | 50320665 |
Melaena | 38.41 | 15.46 | 53 | 272294 | 26811 | 50305966 |
Blood magnesium abnormal | 38.25 | 15.46 | 27 | 272320 | 467 | 50332310 |
Drug tolerance decreased | 37.90 | 15.46 | 3 | 272344 | 9157 | 50323620 |
Blood calcium increased | 37.70 | 15.46 | 109 | 272238 | 7610 | 50325167 |
Acute kidney injury | 37.59 | 15.46 | 937 | 271410 | 227121 | 50105656 |
Oral disorder | 37.57 | 15.46 | 110 | 272237 | 7734 | 50325043 |
White blood cell disorder | 37.31 | 15.46 | 51 | 272296 | 2041 | 50330736 |
Transformation to acute myeloid leukaemia | 37.26 | 15.46 | 19 | 272328 | 174 | 50332603 |
Angina pectoris | 37.11 | 15.46 | 52 | 272295 | 26136 | 50306641 |
Blood immunoglobulin A increased | 36.98 | 15.46 | 24 | 272323 | 359 | 50332418 |
Hypokinesia | 36.92 | 15.46 | 10 | 272337 | 12207 | 50320570 |
Gastrointestinal haemorrhage | 36.82 | 15.46 | 237 | 272110 | 73084 | 50259693 |
Speech disorder | 36.57 | 15.46 | 86 | 272261 | 35462 | 50297315 |
Middle insomnia | 36.56 | 15.46 | 5 | 272342 | 9916 | 50322861 |
Infection | 36.54 | 15.46 | 1203 | 271144 | 171751 | 50161026 |
Arthritis | 36.44 | 15.46 | 295 | 272052 | 86426 | 50246351 |
Cholestasis | 36.43 | 15.46 | 50 | 272297 | 25351 | 50307426 |
Parkinsonism | 36.32 | 15.46 | 3 | 272344 | 8844 | 50323933 |
Bone marrow failure | 36.29 | 15.46 | 264 | 272083 | 27360 | 50305417 |
Accidental overdose | 36.28 | 15.46 | 31 | 272316 | 19502 | 50313275 |
Failure to thrive | 36.23 | 15.46 | 95 | 272252 | 6263 | 50326514 |
Injection site rash | 36.21 | 15.46 | 21 | 272326 | 16156 | 50316621 |
Abortion induced | 36.17 | 15.46 | 4 | 272343 | 9340 | 50323437 |
Uterine disorder | 36.16 | 15.46 | 57 | 272290 | 2598 | 50330179 |
Colitis ulcerative | 36.16 | 15.46 | 23 | 272324 | 16831 | 50315946 |
Pneumonia influenzal | 36.10 | 15.46 | 42 | 272305 | 1425 | 50331352 |
Blood immunoglobulin G increased | 35.86 | 15.46 | 40 | 272307 | 1295 | 50331482 |
Circulatory collapse | 35.63 | 15.46 | 33 | 272314 | 19967 | 50312810 |
Skin hyperpigmentation | 35.51 | 15.46 | 84 | 272263 | 5192 | 50327585 |
Invasive ductal breast carcinoma | 35.32 | 15.46 | 90 | 272257 | 5831 | 50326946 |
Torsade de pointes | 35.18 | 15.46 | 10 | 272337 | 11825 | 50320952 |
Blood calcium decreased | 35.16 | 15.46 | 211 | 272136 | 20495 | 50312282 |
Transplant rejection | 35.04 | 15.46 | 5 | 272342 | 9604 | 50323173 |
Spinal disorder | 34.96 | 15.46 | 111 | 272236 | 8159 | 50324618 |
Food poisoning | 34.75 | 15.46 | 63 | 272284 | 3221 | 50329556 |
Mucosal inflammation | 34.59 | 15.46 | 106 | 272241 | 40036 | 50292741 |
Skin necrosis | 34.57 | 15.46 | 8 | 272339 | 10859 | 50321918 |
Affect lability | 34.45 | 15.46 | 4 | 272343 | 8994 | 50323783 |
Hallucination | 34.24 | 15.46 | 132 | 272215 | 46525 | 50286252 |
Urinary retention | 34.20 | 15.46 | 55 | 272292 | 26135 | 50306642 |
Disease complication | 34.18 | 15.46 | 57 | 272290 | 2725 | 50330052 |
Acute hepatic failure | 34.17 | 15.46 | 21 | 272326 | 15656 | 50317121 |
Blood lactate dehydrogenase increased | 34.01 | 15.46 | 33 | 272314 | 19529 | 50313248 |
Ear swelling | 33.81 | 15.46 | 36 | 272311 | 1105 | 50331672 |
Muscle strain | 33.57 | 15.46 | 99 | 272248 | 6989 | 50325788 |
Hypoxia | 33.57 | 15.46 | 151 | 272196 | 50972 | 50281805 |
Nervousness | 33.36 | 15.46 | 259 | 272088 | 27392 | 50305385 |
Post procedural complication | 33.25 | 15.46 | 20 | 272327 | 15084 | 50317693 |
Respiratory rate increased | 33.15 | 15.46 | 10 | 272337 | 11375 | 50321402 |
Ovarian cyst | 33.02 | 15.46 | 17 | 272330 | 13979 | 50318798 |
Gastritis | 32.98 | 15.46 | 81 | 272266 | 32902 | 50299875 |
Refractory cytopenia with multilineage dysplasia | 32.80 | 15.46 | 16 | 272331 | 132 | 50332645 |
Nail discolouration | 32.70 | 15.46 | 51 | 272296 | 2303 | 50330474 |
Red blood cell count abnormal | 32.52 | 15.46 | 32 | 272315 | 893 | 50331884 |
Jaundice | 32.22 | 15.46 | 58 | 272289 | 26371 | 50306406 |
Mitral valve incompetence | 32.12 | 15.46 | 28 | 272319 | 17443 | 50315334 |
Panic attack | 32.06 | 15.46 | 34 | 272313 | 19308 | 50313469 |
Hallucination, auditory | 32.01 | 15.46 | 9 | 272338 | 10719 | 50322058 |
Cellulitis | 31.86 | 15.46 | 547 | 271800 | 70251 | 50262526 |
Hepatic failure | 31.71 | 15.46 | 80 | 272267 | 32203 | 50300574 |
Myositis | 31.67 | 15.46 | 3 | 272344 | 7917 | 50324860 |
Malignant neoplasm of unknown primary site | 31.49 | 15.46 | 19 | 272328 | 248 | 50332529 |
Large intestine infection | 31.47 | 15.46 | 41 | 272306 | 1565 | 50331212 |
Incorrect product administration duration | 31.21 | 15.46 | 6 | 272341 | 9269 | 50323508 |
Breath sounds abnormal | 31.03 | 15.46 | 3 | 272344 | 7789 | 50324988 |
Diabetes mellitus inadequate control | 30.97 | 15.46 | 16 | 272331 | 13129 | 50319648 |
Tuberculosis | 30.95 | 15.46 | 8 | 272339 | 10075 | 50322702 |
Tricuspid valve incompetence | 30.90 | 15.46 | 15 | 272332 | 12755 | 50320022 |
Pelvic fracture | 30.52 | 15.46 | 133 | 272214 | 11387 | 50321390 |
Haematoma | 30.44 | 15.46 | 75 | 272272 | 30435 | 50302342 |
Neurotoxicity | 30.42 | 15.46 | 21 | 272326 | 14719 | 50318058 |
Shock | 30.27 | 15.46 | 40 | 272307 | 20610 | 50312167 |
Platelet disorder | 30.15 | 15.46 | 39 | 272308 | 1478 | 50331299 |
Aphasia | 30.06 | 15.46 | 68 | 272279 | 28426 | 50304351 |
Feeding disorder | 30.03 | 15.46 | 125 | 272222 | 10488 | 50322289 |
Red cell distribution width increased | 29.96 | 15.46 | 5 | 272342 | 8554 | 50324223 |
Pancreatitis | 29.73 | 15.46 | 123 | 272224 | 42491 | 50290286 |
Hypothyroidism | 29.48 | 15.46 | 90 | 272257 | 34035 | 50298742 |
Protein total decreased | 29.41 | 15.46 | 78 | 272269 | 5178 | 50327599 |
Hyperglycaemia | 29.36 | 15.46 | 99 | 272248 | 36306 | 50296471 |
Uveitis | 29.33 | 15.46 | 7 | 272340 | 9303 | 50323474 |
Pain in jaw | 29.32 | 15.46 | 107 | 272240 | 38321 | 50294456 |
Cholecystectomy | 29.30 | 15.46 | 7 | 272340 | 9296 | 50323481 |
Metastases to central nervous system | 29.27 | 15.46 | 12 | 272335 | 11270 | 50321507 |
Upper gastrointestinal haemorrhage | 29.11 | 15.46 | 26 | 272321 | 16009 | 50316768 |
Hysterectomy | 29.02 | 15.46 | 4 | 272343 | 7886 | 50324891 |
Cardiogenic shock | 28.67 | 15.46 | 25 | 272322 | 15574 | 50317203 |
Posterior reversible encephalopathy syndrome | 28.58 | 15.46 | 23 | 272324 | 14905 | 50317872 |
Endometrial adenocarcinoma | 28.52 | 15.46 | 32 | 272315 | 1043 | 50331734 |
Colitis | 28.43 | 15.46 | 325 | 272022 | 38204 | 50294573 |
Scar | 28.42 | 15.46 | 14 | 272333 | 11804 | 50320973 |
Body temperature increased | 28.27 | 15.46 | 81 | 272266 | 31260 | 50301517 |
Nerve injury | 28.21 | 15.46 | 104 | 272243 | 8246 | 50324531 |
Spinal osteoarthritis | 27.88 | 15.46 | 21 | 272326 | 14071 | 50318706 |
Proteinuria | 27.71 | 15.46 | 29 | 272318 | 16568 | 50316209 |
Therapy interrupted | 27.58 | 15.46 | 41 | 272306 | 20111 | 50312666 |
Bursitis | 27.50 | 15.46 | 48 | 272299 | 22087 | 50310690 |
Peripheral coldness | 27.46 | 15.46 | 119 | 272228 | 10164 | 50322613 |
Metastases to lymph nodes | 27.20 | 15.46 | 3 | 272344 | 7021 | 50325756 |
Transient ischaemic attack | 27.15 | 15.46 | 279 | 272068 | 31931 | 50300846 |
Localised infection | 27.12 | 15.46 | 232 | 272115 | 25253 | 50307524 |
White blood cell count increased | 26.99 | 15.46 | 126 | 272221 | 42114 | 50290663 |
Injection site discolouration | 26.96 | 15.46 | 3 | 272344 | 6971 | 50325806 |
Osteoporosis | 26.87 | 15.46 | 137 | 272210 | 44742 | 50288035 |
Blood pressure diastolic increased | 26.84 | 15.46 | 4 | 272343 | 7439 | 50325338 |
Shock haemorrhagic | 26.83 | 15.46 | 6 | 272341 | 8338 | 50324439 |
Confusional state | 26.68 | 15.46 | 779 | 271568 | 185149 | 50147628 |
Pigmentation disorder | 26.51 | 15.46 | 61 | 272286 | 3703 | 50329074 |
Joint effusion | 26.28 | 15.46 | 19 | 272328 | 13002 | 50319775 |
Hemiparesis | 26.28 | 15.46 | 42 | 272305 | 20006 | 50312771 |
Delusion | 26.21 | 15.46 | 12 | 272335 | 10557 | 50322220 |
Myocardial ischaemia | 26.10 | 15.46 | 15 | 272332 | 11598 | 50321179 |
Ejection fraction decreased | 26.01 | 15.46 | 37 | 272310 | 18483 | 50314294 |
Left ventricular dysfunction | 25.94 | 15.46 | 12 | 272335 | 10494 | 50322283 |
Colon cancer | 25.88 | 15.46 | 104 | 272243 | 8587 | 50324190 |
Hypotonia | 25.85 | 15.46 | 6 | 272341 | 8128 | 50324649 |
Coordination abnormal | 25.77 | 15.46 | 15 | 272332 | 11519 | 50321258 |
Hepatic encephalopathy | 25.40 | 15.46 | 10 | 272337 | 9626 | 50323151 |
Performance status decreased | 24.99 | 15.46 | 54 | 272293 | 3141 | 50329636 |
Eczema | 24.92 | 15.46 | 53 | 272294 | 22649 | 50310128 |
Ventricular tachycardia | 24.92 | 15.46 | 29 | 272318 | 15792 | 50316985 |
Blood triglycerides increased | 24.87 | 15.46 | 15 | 272332 | 11297 | 50321480 |
Photophobia | 24.86 | 15.46 | 26 | 272321 | 14861 | 50317916 |
Ventricular fibrillation | 24.65 | 15.46 | 13 | 272334 | 10546 | 50322231 |
Chalazion | 24.61 | 15.46 | 18 | 272329 | 330 | 50332447 |
Hypercalcaemia | 24.54 | 15.46 | 212 | 272135 | 23140 | 50309637 |
Pseudomonas infection | 24.51 | 15.46 | 10 | 272337 | 9420 | 50323357 |
Schizophrenia | 24.44 | 15.46 | 5 | 272342 | 7392 | 50325385 |
Paraproteinaemia | 24.43 | 15.46 | 14 | 272333 | 165 | 50332612 |
Lacrimation increased | 24.43 | 15.46 | 166 | 272181 | 16826 | 50315951 |
Optic neuritis | 24.18 | 15.46 | 4 | 272343 | 6886 | 50325891 |
Refractory anaemia with an excess of blasts | 24.16 | 15.46 | 19 | 272328 | 390 | 50332387 |
Major depression | 24.15 | 15.46 | 4 | 272343 | 6880 | 50325897 |
Pulseless electrical activity | 23.94 | 15.46 | 4 | 272343 | 6837 | 50325940 |
Traumatic fracture | 23.89 | 15.46 | 22 | 272325 | 564 | 50332213 |
Post procedural haemorrhage | 23.84 | 15.46 | 5 | 272342 | 7265 | 50325512 |
Miosis | 23.68 | 15.46 | 3 | 272344 | 6307 | 50326470 |
Productive cough | 23.65 | 15.46 | 176 | 272171 | 52518 | 50280259 |
Restlessness | 23.49 | 15.46 | 64 | 272283 | 25109 | 50307668 |
Spinal operation | 23.44 | 15.46 | 3 | 272344 | 6257 | 50326520 |
Mouth ulceration | 23.44 | 15.46 | 75 | 272272 | 27949 | 50304828 |
Amnesia | 23.37 | 15.46 | 338 | 272009 | 41922 | 50290855 |
Malignant neoplasm progression | 23.31 | 15.46 | 244 | 272103 | 67880 | 50264897 |
Angina unstable | 23.29 | 15.46 | 4 | 272343 | 6702 | 50326075 |
Atelectasis | 23.27 | 15.46 | 39 | 272308 | 18231 | 50314546 |
Anuria | 23.23 | 15.46 | 16 | 272331 | 11228 | 50321549 |
Gingival pain | 23.04 | 15.46 | 78 | 272269 | 5928 | 50326849 |
Infusion site extravasation | 22.47 | 15.46 | 5 | 272342 | 6971 | 50325806 |
Plasma cell myeloma in remission | 22.34 | 15.46 | 6 | 272341 | 4 | 50332773 |
Fluid retention | 22.31 | 15.46 | 390 | 271957 | 50259 | 50282518 |
Glycosylated haemoglobin increased | 22.04 | 15.46 | 15 | 272332 | 10591 | 50322186 |
Hepatic cirrhosis | 21.95 | 15.46 | 38 | 272309 | 17539 | 50315238 |
Malignant melanoma | 21.86 | 15.46 | 110 | 272237 | 9998 | 50322779 |
Hepatic function abnormal | 21.77 | 15.46 | 96 | 272251 | 32585 | 50300192 |
Lethargy | 21.76 | 15.46 | 166 | 272181 | 49266 | 50283511 |
Nightmare | 21.75 | 15.46 | 33 | 272314 | 16053 | 50316724 |
Motor dysfunction | 21.73 | 15.46 | 8 | 272339 | 8023 | 50324754 |
Intermenstrual bleeding | 21.71 | 15.46 | 5 | 272342 | 6809 | 50325968 |
Asthma | 21.66 | 15.46 | 344 | 272003 | 88993 | 50243784 |
Therapy cessation | 21.48 | 15.46 | 70 | 272277 | 25941 | 50306836 |
Gingival bleeding | 21.43 | 15.46 | 119 | 272228 | 11234 | 50321543 |
Blood pressure decreased | 21.33 | 15.46 | 195 | 272152 | 55714 | 50277063 |
Deformity | 21.33 | 15.46 | 8 | 272339 | 7932 | 50324845 |
Rectal adenocarcinoma | 21.23 | 15.46 | 20 | 272327 | 528 | 50332249 |
Movement disorder | 21.22 | 15.46 | 39 | 272308 | 17593 | 50315184 |
Sinus bradycardia | 20.94 | 15.46 | 24 | 272323 | 13159 | 50319618 |
Cushingoid | 20.93 | 15.46 | 5 | 272342 | 6640 | 50326137 |
Chondrocalcinosis pyrophosphate | 20.84 | 15.46 | 27 | 272320 | 1025 | 50331752 |
Lipase increased | 20.72 | 15.46 | 10 | 272337 | 8531 | 50324246 |
Epstein-Barr virus infection | 20.64 | 15.46 | 6 | 272341 | 6991 | 50325786 |
Bronchospasm | 20.54 | 15.46 | 30 | 272317 | 14824 | 50317953 |
Apnoea | 20.50 | 15.46 | 6 | 272341 | 6960 | 50325817 |
Low density lipoprotein increased | 20.44 | 15.46 | 3 | 272344 | 5643 | 50327134 |
Allergic sinusitis | 20.30 | 15.46 | 20 | 272327 | 559 | 50332218 |
Chest pain | 20.20 | 15.46 | 763 | 271584 | 176119 | 50156658 |
Tardive dyskinesia | 20.12 | 15.46 | 7 | 272340 | 7272 | 50325505 |
Respiratory acidosis | 20.07 | 15.46 | 4 | 272343 | 6024 | 50326753 |
Arteriosclerosis coronary artery | 20.01 | 15.46 | 8 | 272339 | 7628 | 50325149 |
Haemodialysis | 19.96 | 15.46 | 10 | 272337 | 8352 | 50324425 |
Ataxia | 19.91 | 15.46 | 27 | 272320 | 13759 | 50319018 |
Parainfluenzae virus infection | 19.88 | 15.46 | 36 | 272311 | 1839 | 50330938 |
Balance disorder | 19.83 | 15.46 | 509 | 271838 | 70081 | 50262696 |
Tubulointerstitial nephritis | 19.81 | 15.46 | 32 | 272315 | 15179 | 50317598 |
Hot flush | 19.77 | 15.46 | 341 | 272006 | 43828 | 50288949 |
Hyperproteinaemia | 19.76 | 15.46 | 10 | 272337 | 90 | 50332687 |
Polyarthritis | 19.66 | 15.46 | 9 | 272338 | 7918 | 50324859 |
Superficial spreading melanoma stage unspecified | 19.62 | 15.46 | 11 | 272336 | 124 | 50332653 |
Kidney infection | 19.60 | 15.46 | 170 | 272177 | 18576 | 50314201 |
Deafness | 19.50 | 15.46 | 148 | 272199 | 15543 | 50317234 |
Mood swings | 19.46 | 15.46 | 35 | 272312 | 15919 | 50316858 |
Cardiomegaly | 19.43 | 15.46 | 35 | 272312 | 15910 | 50316867 |
Oliguria | 19.35 | 15.46 | 10 | 272337 | 8206 | 50324571 |
Malignant melanoma in situ | 19.27 | 15.46 | 23 | 272324 | 802 | 50331975 |
Irritability | 19.24 | 15.46 | 83 | 272264 | 28343 | 50304434 |
Pyelonephritis | 19.09 | 15.46 | 32 | 272315 | 14957 | 50317820 |
Wrong product administered | 19.06 | 15.46 | 3 | 272344 | 5357 | 50327420 |
Peritonitis | 18.86 | 15.46 | 34 | 272313 | 15452 | 50317325 |
Palmar-plantar erythrodysaesthesia syndrome | 18.83 | 15.46 | 51 | 272296 | 20047 | 50312730 |
Influenza like illness | 18.77 | 15.46 | 208 | 272139 | 57251 | 50275526 |
Genital haemorrhage | 18.74 | 15.46 | 6 | 272341 | 6568 | 50326209 |
Sensitive skin | 18.73 | 15.46 | 24 | 272323 | 901 | 50331876 |
Throat tightness | 18.71 | 15.46 | 54 | 272293 | 20793 | 50311984 |
Abdominal pain upper | 18.65 | 15.46 | 1042 | 271305 | 158267 | 50174510 |
Hypoaesthesia oral | 18.65 | 15.46 | 110 | 272237 | 10618 | 50322159 |
Nodule | 18.41 | 15.46 | 40 | 272307 | 16963 | 50315814 |
Osteonecrosis | 18.32 | 15.46 | 61 | 272286 | 22456 | 50310321 |
Bronchiectasis | 18.28 | 15.46 | 17 | 272330 | 10266 | 50322511 |
Walking aid user | 18.11 | 15.46 | 6 | 272341 | 6427 | 50326350 |
Hypotension | 18.03 | 15.46 | 1060 | 271287 | 234409 | 50098368 |
Brain injury | 18.03 | 15.46 | 5 | 272342 | 6009 | 50326768 |
Fistula | 17.92 | 15.46 | 11 | 272336 | 8207 | 50324570 |
Product dispensing error | 17.91 | 15.46 | 13 | 272334 | 8878 | 50323899 |
Nystagmus | 17.88 | 15.46 | 4 | 272343 | 5557 | 50327220 |
Clavicle fracture | 17.87 | 15.46 | 45 | 272302 | 2894 | 50329883 |
Bone density decreased | 17.77 | 15.46 | 20 | 272327 | 11055 | 50321722 |
Device failure | 17.73 | 15.46 | 4 | 272343 | 5524 | 50327253 |
Acute respiratory failure | 17.72 | 15.46 | 87 | 272260 | 28695 | 50304082 |
Central nervous system lesion | 17.69 | 15.46 | 15 | 272332 | 9474 | 50323303 |
Immunoglobulins increased | 17.69 | 15.46 | 14 | 272333 | 290 | 50332487 |
Toxic encephalopathy | 17.67 | 15.46 | 4 | 272343 | 5511 | 50327266 |
Myeloma cast nephropathy | 17.66 | 15.46 | 10 | 272337 | 115 | 50332662 |
Orthostatic hypotension | 17.64 | 15.46 | 90 | 272257 | 29391 | 50303386 |
Laryngeal oedema | 17.58 | 15.46 | 3 | 272344 | 5050 | 50327727 |
Pemphigoid | 17.54 | 15.46 | 5 | 272342 | 5902 | 50326875 |
Neutrophil count abnormal | 17.48 | 15.46 | 40 | 272307 | 2419 | 50330358 |
POEMS syndrome | 17.41 | 15.46 | 6 | 272341 | 17 | 50332760 |
Oesophageal squamous cell carcinoma | 17.30 | 15.46 | 10 | 272337 | 120 | 50332657 |
Sensory disturbance | 17.25 | 15.46 | 23 | 272324 | 11806 | 50320971 |
Precursor B-lymphoblastic lymphoma | 17.24 | 15.46 | 5 | 272342 | 6 | 50332771 |
Haematuria | 17.20 | 15.46 | 75 | 272272 | 25538 | 50307239 |
Body dysmorphic disorder | 17.16 | 15.46 | 13 | 272334 | 252 | 50332525 |
Haemodynamic instability | 17.14 | 15.46 | 11 | 272336 | 8013 | 50324764 |
Brain oedema | 17.09 | 15.46 | 25 | 272322 | 12345 | 50320432 |
Gastrointestinal fungal infection | 17.03 | 15.46 | 13 | 272334 | 255 | 50332522 |
Dysphagia | 16.99 | 15.46 | 304 | 272043 | 77214 | 50255563 |
Muscle twitching | 16.96 | 15.46 | 36 | 272311 | 15395 | 50317382 |
Onychoclasis | 16.96 | 15.46 | 64 | 272283 | 5132 | 50327645 |
Marasmus | 16.94 | 15.46 | 16 | 272331 | 424 | 50332353 |
Gastroenteritis viral | 16.93 | 15.46 | 165 | 272182 | 18621 | 50314156 |
Full blood count | 16.92 | 15.46 | 4 | 272343 | 0 | 50332777 |
Bradyphrenia | 16.86 | 15.46 | 6 | 272341 | 6146 | 50326631 |
Osteopenia | 16.85 | 15.46 | 42 | 272305 | 16976 | 50315801 |
Night sweats | 16.80 | 15.46 | 264 | 272083 | 33310 | 50299467 |
Breast cancer | 16.70 | 15.46 | 324 | 272023 | 42566 | 50290211 |
Adrenal insufficiency | 16.70 | 15.46 | 32 | 272315 | 14211 | 50318566 |
Rhinitis allergic | 16.61 | 15.46 | 9 | 272338 | 7191 | 50325586 |
Uterine leiomyoma | 16.61 | 15.46 | 11 | 272336 | 7880 | 50324897 |
Hydronephrosis | 16.55 | 15.46 | 13 | 272334 | 8528 | 50324249 |
Viral upper respiratory tract infection | 16.47 | 15.46 | 78 | 272269 | 6918 | 50325859 |
Treatment noncompliance | 16.41 | 15.46 | 95 | 272252 | 30055 | 50302722 |
Physical deconditioning | 16.36 | 15.46 | 16 | 272331 | 443 | 50332334 |
Basal cell carcinoma | 16.34 | 15.46 | 195 | 272152 | 23161 | 50309616 |
Amenorrhoea | 16.33 | 15.46 | 13 | 272334 | 8471 | 50324306 |
Activated partial thromboplastin time prolonged | 16.30 | 15.46 | 7 | 272340 | 6395 | 50326382 |
Oral herpes | 16.28 | 15.46 | 57 | 272290 | 20668 | 50312109 |
Muscular weakness | 16.27 | 15.46 | 388 | 271959 | 94625 | 50238152 |
Lentigo maligna | 16.26 | 15.46 | 11 | 272336 | 177 | 50332600 |
Bone marrow myelogram abnormal | 16.26 | 15.46 | 6 | 272341 | 22 | 50332755 |
Bipolar disorder | 16.25 | 15.46 | 8 | 272339 | 6749 | 50326028 |
Nasal abscess | 16.16 | 15.46 | 10 | 272337 | 137 | 50332640 |
Arteriosclerosis | 16.14 | 15.46 | 15 | 272332 | 9062 | 50323715 |
Pleural effusion | 16.14 | 15.46 | 325 | 272022 | 81129 | 50251648 |
Blood lactic acid increased | 16.09 | 15.46 | 5 | 272342 | 5580 | 50327197 |
Toxicity to various agents | 16.02 | 15.46 | 958 | 271389 | 211541 | 50121236 |
Vertigo | 16.00 | 15.46 | 190 | 272157 | 51642 | 50281135 |
Skin plaque | 15.98 | 15.46 | 7 | 272340 | 6321 | 50326456 |
Encephalitis | 15.93 | 15.46 | 10 | 272337 | 7370 | 50325407 |
Lymphopenia | 15.90 | 15.46 | 38 | 272309 | 15583 | 50317194 |
Target skin lesion | 15.79 | 15.46 | 9 | 272338 | 105 | 50332672 |
Enteritis | 15.77 | 15.46 | 9 | 272338 | 6986 | 50325791 |
Hepatomegaly | 15.72 | 15.46 | 21 | 272326 | 10772 | 50322005 |
Disorientation | 15.69 | 15.46 | 119 | 272228 | 35365 | 50297412 |
Hypertriglyceridaemia | 15.67 | 15.46 | 5 | 272342 | 5486 | 50327291 |
Acute generalised exanthematous pustulosis | 15.63 | 15.46 | 15 | 272332 | 8923 | 50323854 |
Bundle branch block left | 15.57 | 15.46 | 7 | 272340 | 6223 | 50326554 |
Anger | 15.56 | 15.46 | 23 | 272324 | 11310 | 50321467 |
Hypercapnia | 15.55 | 15.46 | 3 | 272344 | 4624 | 50328153 |
Febrile infection | 15.55 | 15.46 | 25 | 272322 | 1159 | 50331618 |
Crepitations | 15.52 | 15.46 | 7 | 272340 | 6212 | 50326565 |
Intentional dose omission | 15.52 | 15.46 | 4 | 272343 | 5046 | 50327731 |
Dry mouth | 15.46 | 15.46 | 404 | 271943 | 55774 | 50277003 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Death | 5114.67 | 14.68 | 10167 | 257443 | 331917 | 28975000 |
Full blood count decreased | 4602.03 | 14.68 | 2438 | 265172 | 13554 | 29293363 |
Thrombosis | 3379.99 | 14.68 | 2928 | 264682 | 40117 | 29266800 |
Neuropathy peripheral | 3260.25 | 14.68 | 3599 | 264011 | 67428 | 29239489 |
White blood cell count decreased | 2903.56 | 14.68 | 3668 | 263942 | 79694 | 29227223 |
Rash | 2708.32 | 14.68 | 5553 | 262057 | 184266 | 29122651 |
Pneumonia | 2702.29 | 14.68 | 7634 | 259976 | 312538 | 28994379 |
Fatigue | 2592.03 | 14.68 | 7471 | 260139 | 309350 | 28997567 |
Laboratory test abnormal | 2429.40 | 14.68 | 1696 | 265914 | 16489 | 29290428 |
Platelet count decreased | 2271.66 | 14.68 | 3677 | 263933 | 100995 | 29205922 |
Adverse drug reaction | 1859.12 | 14.68 | 1622 | 265988 | 22398 | 29284519 |
Diarrhoea | 1804.33 | 14.68 | 6831 | 260779 | 325867 | 28981050 |
Unevaluable event | 1712.25 | 14.68 | 1706 | 265904 | 28145 | 29278772 |
Drug interaction | 1441.59 | 14.68 | 87 | 267523 | 197298 | 29109619 |
Off label use | 1363.61 | 14.68 | 512 | 267098 | 300288 | 29006629 |
Plasma cell myeloma | 1342.93 | 14.68 | 1667 | 265943 | 35448 | 29271469 |
Constipation | 1302.64 | 14.68 | 3059 | 264551 | 111101 | 29195816 |
Muscle spasms | 1219.84 | 14.68 | 2144 | 265466 | 62938 | 29243979 |
Deep vein thrombosis | 1080.69 | 14.68 | 1895 | 265715 | 55504 | 29251413 |
COVID-19 | 875.35 | 14.68 | 1335 | 266275 | 34679 | 29272238 |
Plasma cell myeloma recurrent | 860.87 | 14.68 | 490 | 267120 | 3193 | 29303724 |
Tooth disorder | 755.90 | 14.68 | 653 | 266957 | 8876 | 29298041 |
Peripheral swelling | 755.11 | 14.68 | 1735 | 265875 | 62004 | 29244913 |
Cardiac disorder | 735.81 | 14.68 | 1257 | 266353 | 36006 | 29270911 |
Drug abuse | 699.01 | 14.68 | 4 | 267606 | 79879 | 29227038 |
Condition aggravated | 688.24 | 14.68 | 233 | 267377 | 146062 | 29160855 |
Completed suicide | 663.17 | 14.68 | 38 | 267572 | 90208 | 29216709 |
Product dose omission issue | 557.99 | 14.68 | 2028 | 265582 | 94355 | 29212562 |
Drug ineffective | 552.44 | 14.68 | 1583 | 266027 | 361587 | 28945330 |
Neutropenia | 519.03 | 14.68 | 2462 | 265148 | 129249 | 29177668 |
Overdose | 511.31 | 14.68 | 61 | 267549 | 79758 | 29227159 |
Renal disorder | 506.13 | 14.68 | 807 | 266803 | 21788 | 29285129 |
Rash pruritic | 480.83 | 14.68 | 784 | 266826 | 21579 | 29285338 |
Pulmonary thrombosis | 480.81 | 14.68 | 430 | 267180 | 6135 | 29300782 |
Ageusia | 470.31 | 14.68 | 488 | 267122 | 8450 | 29298467 |
Product use in unapproved indication | 437.63 | 14.68 | 122 | 267488 | 86753 | 29220164 |
Red blood cell count decreased | 433.70 | 14.68 | 808 | 266802 | 24794 | 29282123 |
Pulmonary embolism | 412.28 | 14.68 | 1574 | 266036 | 74960 | 29231957 |
Influenza | 403.96 | 14.68 | 1054 | 266556 | 40827 | 29266090 |
Squamous cell carcinoma of skin | 403.39 | 14.68 | 463 | 267147 | 9023 | 29297894 |
Full blood count abnormal | 395.18 | 14.68 | 578 | 267032 | 14435 | 29292482 |
Pancytopenia | 388.43 | 14.68 | 1636 | 265974 | 81532 | 29225385 |
Plasmacytoma | 387.76 | 14.68 | 282 | 267328 | 2933 | 29303984 |
Drug intolerance | 382.13 | 14.68 | 1132 | 266478 | 47247 | 29259670 |
Acute kidney injury | 371.79 | 14.68 | 1199 | 266411 | 264068 | 29042849 |
Neutrophil count decreased | 357.08 | 14.68 | 1033 | 266577 | 42534 | 29264383 |
Alanine aminotransferase increased | 343.77 | 14.68 | 107 | 267503 | 70837 | 29236080 |
Asthenia | 339.95 | 14.68 | 3201 | 264409 | 212049 | 29094868 |
Rhabdomyolysis | 336.33 | 14.68 | 70 | 267540 | 60738 | 29246179 |
Blood test abnormal | 331.82 | 14.68 | 330 | 267280 | 5419 | 29301498 |
Intentional overdose | 331.58 | 14.68 | 3 | 267607 | 38525 | 29268392 |
Taste disorder | 314.96 | 14.68 | 295 | 267315 | 4481 | 29302436 |
Aspartate aminotransferase increased | 313.79 | 14.68 | 77 | 267533 | 59648 | 29247269 |
Cataract | 295.89 | 14.68 | 637 | 266973 | 21741 | 29285176 |
Back disorder | 289.15 | 14.68 | 312 | 267298 | 5661 | 29301256 |
Intentional product misuse | 284.07 | 14.68 | 6 | 267604 | 34655 | 29272262 |
Hospitalisation | 282.71 | 14.68 | 40 | 267570 | 45948 | 29260969 |
Tachycardia | 278.69 | 14.68 | 154 | 267456 | 72256 | 29234661 |
Blood creatine phosphokinase increased | 270.48 | 14.68 | 27 | 267583 | 40617 | 29266300 |
Myelodysplastic syndrome | 268.70 | 14.68 | 535 | 267075 | 17259 | 29289658 |
Body height decreased | 266.64 | 14.68 | 233 | 267377 | 3217 | 29303700 |
Infection | 265.03 | 14.68 | 1383 | 266227 | 75368 | 29231549 |
Thrombocytopenia | 263.05 | 14.68 | 2102 | 265508 | 132721 | 29174196 |
Light chain analysis increased | 261.36 | 14.68 | 148 | 267462 | 953 | 29305964 |
Intentional product use issue | 261.15 | 14.68 | 37 | 267573 | 42461 | 29264456 |
Seasonal allergy | 260.22 | 14.68 | 274 | 267336 | 4828 | 29302089 |
Pruritus | 259.43 | 14.68 | 1878 | 265732 | 114971 | 29191946 |
Hip fracture | 258.97 | 14.68 | 392 | 267218 | 10100 | 29296817 |
Suicide attempt | 257.85 | 14.68 | 12 | 267598 | 34098 | 29272819 |
Hyperkalaemia | 255.07 | 14.68 | 118 | 267492 | 61274 | 29245643 |
Cytopenia | 251.40 | 14.68 | 374 | 267236 | 9485 | 29297432 |
Gallbladder disorder | 250.45 | 14.68 | 283 | 267327 | 5417 | 29301500 |
Injection site pain | 246.62 | 14.68 | 11 | 267599 | 32435 | 29274482 |
Bradycardia | 244.80 | 14.68 | 145 | 267465 | 65484 | 29241433 |
Inappropriate schedule of product administration | 242.20 | 14.68 | 53 | 267557 | 44419 | 29262498 |
Nasopharyngitis | 238.54 | 14.68 | 1121 | 266489 | 58544 | 29248373 |
Abdominal pain | 236.93 | 14.68 | 548 | 267062 | 134809 | 29172108 |
Rheumatoid arthritis | 234.60 | 14.68 | 14 | 267596 | 32138 | 29274779 |
Wrong technique in product usage process | 234.54 | 14.68 | 12 | 267598 | 31416 | 29275501 |
Hypoglycaemia | 234.01 | 14.68 | 73 | 267537 | 48273 | 29258644 |
Full blood count increased | 233.56 | 14.68 | 123 | 267487 | 671 | 29306246 |
Hiccups | 233.18 | 14.68 | 341 | 267269 | 8512 | 29298405 |
Vomiting | 231.40 | 14.68 | 1061 | 266549 | 211199 | 29095718 |
Hyponatraemia | 231.09 | 14.68 | 165 | 267445 | 67468 | 29239449 |
Dry skin | 230.19 | 14.68 | 592 | 267018 | 22715 | 29284202 |
Hypoaesthesia | 228.89 | 14.68 | 1025 | 266585 | 52442 | 29254475 |
Acute myeloid leukaemia | 225.14 | 14.68 | 476 | 267134 | 16037 | 29290880 |
Depressed level of consciousness | 220.46 | 14.68 | 35 | 267575 | 36907 | 29270010 |
Multiple allergies | 219.23 | 14.68 | 169 | 267441 | 1933 | 29304984 |
Haemoglobin decreased | 209.23 | 14.68 | 1686 | 265924 | 106689 | 29200228 |
Protein total increased | 207.28 | 14.68 | 164 | 267446 | 1954 | 29304963 |
Herpes zoster | 206.39 | 14.68 | 670 | 266940 | 29382 | 29277535 |
Headache | 205.25 | 14.68 | 844 | 266766 | 173163 | 29133754 |
Coma | 204.97 | 14.68 | 52 | 267558 | 39398 | 29267519 |
Hypertension | 204.92 | 14.68 | 471 | 267139 | 116143 | 29190774 |
Blood potassium decreased | 204.68 | 14.68 | 445 | 267165 | 15289 | 29291628 |
Plasma cell leukaemia | 202.42 | 14.68 | 112 | 267498 | 685 | 29306232 |
Spinal fracture | 200.84 | 14.68 | 270 | 267340 | 6216 | 29300701 |
Agitation | 197.52 | 14.68 | 109 | 267501 | 51195 | 29255722 |
Monoclonal immunoglobulin present | 195.36 | 14.68 | 114 | 267496 | 783 | 29306134 |
Metabolic acidosis | 194.99 | 14.68 | 50 | 267560 | 37612 | 29269305 |
Aggression | 194.25 | 14.68 | 42 | 267568 | 35499 | 29271418 |
Suicidal ideation | 187.76 | 14.68 | 42 | 267568 | 34674 | 29272243 |
Seizure | 187.35 | 14.68 | 348 | 267262 | 92775 | 29214142 |
Lactic acidosis | 186.61 | 14.68 | 26 | 267584 | 30221 | 29276696 |
C-reactive protein increased | 183.95 | 14.68 | 85 | 267525 | 44178 | 29262739 |
Gastric disorder | 182.65 | 14.68 | 339 | 267271 | 10365 | 29296552 |
Blood pressure increased | 180.51 | 14.68 | 242 | 267368 | 73561 | 29233356 |
Arthropathy | 175.45 | 14.68 | 510 | 267100 | 21044 | 29285873 |
Product use issue | 175.06 | 14.68 | 126 | 267484 | 51318 | 29255599 |
Interstitial lung disease | 173.23 | 14.68 | 160 | 267450 | 57558 | 29249359 |
Electrocardiogram QT prolonged | 168.82 | 14.68 | 58 | 267552 | 36079 | 29270838 |
Ascites | 162.25 | 14.68 | 64 | 267546 | 36555 | 29270362 |
Illness | 161.37 | 14.68 | 247 | 267363 | 6427 | 29300490 |
Bronchitis | 159.38 | 14.68 | 709 | 266901 | 36159 | 29270758 |
Skin cancer | 158.25 | 14.68 | 279 | 267331 | 8189 | 29298728 |
Renal failure | 157.79 | 14.68 | 1704 | 265906 | 116895 | 29190022 |
Back pain | 155.80 | 14.68 | 1511 | 266099 | 100773 | 29206144 |
Hernia | 155.71 | 14.68 | 275 | 267335 | 8083 | 29298834 |
Incorrect dose administered | 152.25 | 14.68 | 54 | 267556 | 32930 | 29273987 |
SARS-CoV-2 test positive | 152.15 | 14.68 | 168 | 267442 | 3131 | 29303786 |
Psoriasis | 150.06 | 14.68 | 52 | 267558 | 32175 | 29274742 |
Cardio-respiratory arrest | 148.64 | 14.68 | 143 | 267467 | 50458 | 29256459 |
Oxygen saturation decreased | 147.81 | 14.68 | 114 | 267496 | 44823 | 29262094 |
Drug level increased | 147.42 | 14.68 | 5 | 267605 | 18782 | 29288135 |
Localised infection | 146.94 | 14.68 | 361 | 267249 | 13455 | 29293462 |
Therapeutic product effect incomplete | 146.29 | 14.68 | 87 | 267523 | 39218 | 29267699 |
Skin discolouration | 144.56 | 14.68 | 384 | 267226 | 15025 | 29291892 |
Basal cell carcinoma | 140.40 | 14.68 | 403 | 267207 | 16507 | 29290410 |
Lactose intolerance | 138.81 | 14.68 | 102 | 267508 | 1079 | 29305838 |
International normalised ratio increased | 135.52 | 14.68 | 121 | 267489 | 44251 | 29262666 |
Gamma-glutamyltransferase increased | 133.67 | 14.68 | 38 | 267572 | 26699 | 29280218 |
Fall | 132.74 | 14.68 | 2296 | 265314 | 174882 | 29132035 |
Melaena | 130.88 | 14.68 | 59 | 267551 | 31117 | 29275800 |
Product prescribing error | 130.61 | 14.68 | 8 | 267602 | 17968 | 29288949 |
Sedation | 128.74 | 14.68 | 7 | 267603 | 17398 | 29289519 |
Dysarthria | 127.43 | 14.68 | 60 | 267550 | 30851 | 29276066 |
Depression | 127.18 | 14.68 | 373 | 267237 | 84774 | 29222143 |
Spinal disorder | 127.10 | 14.68 | 162 | 267448 | 3533 | 29303384 |
Blood alkaline phosphatase increased | 126.91 | 14.68 | 49 | 267561 | 28357 | 29278560 |
Medication error | 124.52 | 14.68 | 21 | 267589 | 21190 | 29285727 |
Anaphylactic reaction | 124.12 | 14.68 | 47 | 267563 | 27526 | 29279391 |
Haematuria | 123.62 | 14.68 | 130 | 267480 | 44009 | 29262908 |
Wheezing | 123.10 | 14.68 | 74 | 267536 | 33166 | 29273751 |
Respiratory arrest | 121.46 | 14.68 | 41 | 267569 | 25792 | 29281125 |
Swelling face | 120.63 | 14.68 | 432 | 267178 | 19918 | 29286999 |
Immune system disorder | 120.58 | 14.68 | 171 | 267439 | 4146 | 29302771 |
Psoriatic arthropathy | 118.59 | 14.68 | 3 | 267607 | 14688 | 29292229 |
Hepatocellular injury | 118.34 | 14.68 | 24 | 267586 | 21219 | 29285698 |
Angioedema | 118.26 | 14.68 | 71 | 267539 | 31844 | 29275073 |
Gastrointestinal haemorrhage | 116.90 | 14.68 | 351 | 267259 | 79182 | 29227735 |
Generalised tonic-clonic seizure | 116.77 | 14.68 | 17 | 267593 | 19122 | 29287795 |
Bone pain | 115.66 | 14.68 | 399 | 267211 | 18053 | 29288864 |
Myelodysplastic syndrome transformation | 115.50 | 14.68 | 61 | 267549 | 335 | 29306582 |
Abnormal behaviour | 115.37 | 14.68 | 33 | 267577 | 23094 | 29283823 |
Cholestasis | 114.27 | 14.68 | 35 | 267575 | 23427 | 29283490 |
General physical health deterioration | 114.26 | 14.68 | 510 | 267100 | 102347 | 29204570 |
Product quality issue | 112.75 | 14.68 | 8 | 267602 | 15887 | 29291030 |
Mucosal inflammation | 111.96 | 14.68 | 74 | 267536 | 31521 | 29275396 |
Upper limb fracture | 110.99 | 14.68 | 159 | 267451 | 3892 | 29303025 |
Drug hypersensitivity | 110.07 | 14.68 | 289 | 267321 | 68117 | 29238800 |
Dehydration | 109.82 | 14.68 | 1550 | 266060 | 113198 | 29193719 |
Gout | 109.79 | 14.68 | 370 | 267240 | 16541 | 29290376 |
Drug-induced liver injury | 107.84 | 14.68 | 31 | 267579 | 21624 | 29285293 |
Compression fracture | 107.25 | 14.68 | 127 | 267483 | 2561 | 29304356 |
Blood urea increased | 106.34 | 14.68 | 61 | 267549 | 28051 | 29278866 |
Musculoskeletal disorder | 106.24 | 14.68 | 179 | 267431 | 5061 | 29301856 |
Pallor | 104.88 | 14.68 | 30 | 267580 | 20994 | 29285923 |
Psychotic disorder | 103.48 | 14.68 | 28 | 267582 | 20326 | 29286591 |
Drug resistance | 103.35 | 14.68 | 33 | 267577 | 21507 | 29285410 |
Transaminases increased | 103.06 | 14.68 | 38 | 267572 | 22624 | 29284293 |
Hepatic function abnormal | 102.95 | 14.68 | 122 | 267488 | 39137 | 29267780 |
Hallucination, visual | 102.47 | 14.68 | 9 | 267601 | 15006 | 29291911 |
Tumour flare | 101.69 | 14.68 | 63 | 267547 | 489 | 29306428 |
Hordeolum | 101.46 | 14.68 | 72 | 267538 | 718 | 29306199 |
Eye disorder | 101.22 | 14.68 | 221 | 267389 | 7613 | 29299304 |
Acute leukaemia | 101.15 | 14.68 | 81 | 267529 | 983 | 29305934 |
Myoclonus | 99.55 | 14.68 | 5 | 267605 | 13304 | 29293613 |
Adenocarcinoma of colon | 99.29 | 14.68 | 129 | 267481 | 2869 | 29304048 |
Somnolence | 98.93 | 14.68 | 475 | 267135 | 93480 | 29213437 |
Rib fracture | 98.78 | 14.68 | 296 | 267314 | 12422 | 29294495 |
Dysgeusia | 98.68 | 14.68 | 437 | 267173 | 22237 | 29284680 |
Leukocytosis | 98.62 | 14.68 | 34 | 267576 | 21108 | 29285809 |
Respiratory depression | 98.30 | 14.68 | 6 | 267604 | 13517 | 29293400 |
Acute lymphocytic leukaemia | 97.93 | 14.68 | 120 | 267490 | 2511 | 29304406 |
Blood pressure systolic increased | 96.01 | 14.68 | 18 | 267592 | 16827 | 29290090 |
Upper gastrointestinal haemorrhage | 95.92 | 14.68 | 39 | 267571 | 21875 | 29285042 |
Anxiety | 95.55 | 14.68 | 422 | 267188 | 84943 | 29221974 |
Hypercalcaemia | 95.39 | 14.68 | 293 | 267317 | 12466 | 29294451 |
Disease progression | 95.31 | 14.68 | 1147 | 266463 | 80769 | 29226148 |
Malignant neoplasm progression | 94.08 | 14.68 | 347 | 267263 | 73512 | 29233405 |
Drug ineffective for unapproved indication | 93.10 | 14.68 | 10 | 267600 | 14204 | 29292713 |
Emotional distress | 93.02 | 14.68 | 9 | 267601 | 13886 | 29293031 |
Hypoxia | 92.62 | 14.68 | 180 | 267430 | 47199 | 29259718 |
Cardiac arrest | 92.28 | 14.68 | 429 | 267181 | 85162 | 29221755 |
Diabetic ketoacidosis | 91.98 | 14.68 | 17 | 267593 | 16056 | 29290861 |
Prostatic disorder | 91.64 | 14.68 | 122 | 267488 | 2781 | 29304136 |
Atrial fibrillation | 91.22 | 14.68 | 1402 | 266208 | 104244 | 29202673 |
Hypoacusis | 90.50 | 14.68 | 312 | 267298 | 14111 | 29292806 |
Delirium | 90.49 | 14.68 | 135 | 267475 | 39262 | 29267655 |
Blood bilirubin increased | 90.29 | 14.68 | 104 | 267506 | 33789 | 29273128 |
Hepatic failure | 90.28 | 14.68 | 91 | 267519 | 31421 | 29275496 |
Multiple organ dysfunction syndrome | 89.56 | 14.68 | 283 | 267327 | 62833 | 29244084 |
Joint swelling | 89.11 | 14.68 | 760 | 266850 | 48870 | 29258047 |
Dyskinesia | 88.95 | 14.68 | 35 | 267575 | 20026 | 29286891 |
Erythema | 88.76 | 14.68 | 367 | 267243 | 75239 | 29231678 |
Accidental overdose | 87.95 | 14.68 | 25 | 267585 | 17568 | 29289349 |
Pancreatitis | 87.60 | 14.68 | 110 | 267500 | 34404 | 29272513 |
Underdose | 87.08 | 14.68 | 5 | 267605 | 11864 | 29295053 |
Obstructive airways disorder | 86.19 | 14.68 | 3 | 267607 | 11013 | 29295904 |
Unresponsive to stimuli | 86.15 | 14.68 | 61 | 267549 | 25065 | 29281852 |
Sinus tachycardia | 86.10 | 14.68 | 16 | 267594 | 15053 | 29291864 |
Shock | 86.01 | 14.68 | 43 | 267567 | 21361 | 29285556 |
Gastrointestinal disorder | 85.34 | 14.68 | 497 | 267113 | 28209 | 29278708 |
Encephalopathy | 85.16 | 14.68 | 93 | 267517 | 30950 | 29275967 |
Hallucination | 84.71 | 14.68 | 173 | 267437 | 44539 | 29262378 |
Agranulocytosis | 84.58 | 14.68 | 39 | 267571 | 20301 | 29286616 |
Extrapyramidal disorder | 84.56 | 14.68 | 3 | 267607 | 10828 | 29296089 |
Pathological fracture | 83.95 | 14.68 | 136 | 267474 | 3719 | 29303198 |
Epilepsy | 83.66 | 14.68 | 31 | 267579 | 18401 | 29288516 |
Blood calcium increased | 83.33 | 14.68 | 123 | 267487 | 3096 | 29303821 |
Pancreatitis acute | 82.57 | 14.68 | 60 | 267550 | 24325 | 29282592 |
Pregnancy of partner | 81.36 | 14.68 | 45 | 267565 | 275 | 29306642 |
Tubulointerstitial nephritis | 81.21 | 14.68 | 29 | 267581 | 17614 | 29289303 |
Incorrect route of product administration | 80.97 | 14.68 | 4 | 267606 | 10797 | 29296120 |
Bone disorder | 80.31 | 14.68 | 168 | 267442 | 5615 | 29301302 |
Increased tendency to bruise | 78.03 | 14.68 | 126 | 267484 | 3436 | 29303481 |
Jaundice | 77.92 | 14.68 | 90 | 267520 | 29206 | 29277711 |
Mobility decreased | 77.87 | 14.68 | 71 | 267539 | 25709 | 29281208 |
Spinal compression fracture | 77.70 | 14.68 | 171 | 267439 | 5923 | 29300994 |
Asthma | 76.76 | 14.68 | 117 | 267493 | 33732 | 29273185 |
Anaphylactic shock | 76.54 | 14.68 | 14 | 267596 | 13322 | 29293595 |
Cardiogenic shock | 76.43 | 14.68 | 39 | 267571 | 19151 | 29287766 |
Hypokalaemia | 75.59 | 14.68 | 219 | 267391 | 49984 | 29256933 |
Malignant melanoma | 74.96 | 14.68 | 186 | 267424 | 6975 | 29299942 |
Cytomegalovirus infection | 74.92 | 14.68 | 60 | 267550 | 23155 | 29283762 |
Infusion related reaction | 73.98 | 14.68 | 181 | 267429 | 43705 | 29263212 |
Loss of personal independence in daily activities | 73.41 | 14.68 | 73 | 267537 | 25367 | 29281550 |
Ventricular tachycardia | 73.28 | 14.68 | 58 | 267552 | 22516 | 29284401 |
Hepatotoxicity | 73.15 | 14.68 | 35 | 267575 | 17832 | 29289085 |
Sinusitis | 73.11 | 14.68 | 547 | 267063 | 33803 | 29273114 |
Status epilepticus | 72.24 | 14.68 | 7 | 267603 | 10787 | 29296130 |
Muscle rigidity | 72.13 | 14.68 | 3 | 267607 | 9408 | 29297509 |
Cerebral infarction | 72.13 | 14.68 | 70 | 267540 | 24605 | 29282312 |
Brain oedema | 71.94 | 14.68 | 12 | 267598 | 12208 | 29294709 |
Chest discomfort | 71.14 | 14.68 | 198 | 267412 | 45785 | 29261132 |
Bone lesion | 70.97 | 14.68 | 104 | 267506 | 2600 | 29304317 |
Haematemesis | 70.67 | 14.68 | 71 | 267539 | 24555 | 29282362 |
Insomnia | 70.58 | 14.68 | 1162 | 266448 | 87599 | 29219318 |
Transplant rejection | 70.40 | 14.68 | 3 | 267607 | 9209 | 29297708 |
White blood cell count increased | 70.35 | 14.68 | 146 | 267464 | 37370 | 29269547 |
Sepsis | 70.09 | 14.68 | 1738 | 265872 | 140944 | 29165973 |
Coronary artery disease | 70.07 | 14.68 | 188 | 267422 | 44002 | 29262915 |
White blood cell count abnormal | 70.06 | 14.68 | 106 | 267504 | 2729 | 29304188 |
Treatment failure | 69.90 | 14.68 | 143 | 267467 | 36796 | 29270121 |
Paraesthesia | 69.78 | 14.68 | 770 | 266840 | 53075 | 29253842 |
Fear | 69.74 | 14.68 | 4 | 267606 | 9500 | 29297417 |
Liver function test abnormal | 69.46 | 14.68 | 96 | 267514 | 28822 | 29278095 |
Fluid retention | 69.44 | 14.68 | 407 | 267203 | 23153 | 29283764 |
Hepatitis | 69.25 | 14.68 | 52 | 267558 | 20731 | 29286186 |
Injection site swelling | 68.99 | 14.68 | 4 | 267606 | 9413 | 29297504 |
Respiratory failure | 68.96 | 14.68 | 555 | 267055 | 96576 | 29210341 |
Decreased appetite | 68.61 | 14.68 | 1761 | 265849 | 143581 | 29163336 |
Altered state of consciousness | 68.57 | 14.68 | 48 | 267562 | 19841 | 29287076 |
Circulatory collapse | 68.53 | 14.68 | 42 | 267568 | 18631 | 29288286 |
Surgery | 68.39 | 14.68 | 12 | 267598 | 11767 | 29295150 |
Hemiparesis | 68.07 | 14.68 | 23 | 267587 | 14463 | 29292454 |
Sinus disorder | 68.04 | 14.68 | 160 | 267450 | 5795 | 29301122 |
Synovitis | 68.02 | 14.68 | 9 | 267601 | 10881 | 29296036 |
Ventricular fibrillation | 67.97 | 14.68 | 29 | 267581 | 15804 | 29291113 |
Abdominal discomfort | 67.66 | 14.68 | 697 | 266913 | 47206 | 29259711 |
Osteonecrosis of jaw | 67.21 | 14.68 | 312 | 267298 | 16198 | 29290719 |
Paranoia | 67.18 | 14.68 | 6 | 267604 | 9871 | 29297046 |
Respiratory distress | 67.16 | 14.68 | 117 | 267493 | 31989 | 29274928 |
Withdrawal syndrome | 66.51 | 14.68 | 10 | 267600 | 10982 | 29295935 |
Hepatic encephalopathy | 66.13 | 14.68 | 18 | 267592 | 13017 | 29293900 |
Blood pressure fluctuation | 66.00 | 14.68 | 50 | 267560 | 19844 | 29287073 |
Treatment noncompliance | 65.99 | 14.68 | 73 | 267537 | 24154 | 29282763 |
Malignant neoplasm of unknown primary site | 65.26 | 14.68 | 42 | 267568 | 351 | 29306566 |
Anaemia | 64.81 | 14.68 | 2323 | 265287 | 198628 | 29108289 |
Dementia | 64.46 | 14.68 | 242 | 267368 | 11416 | 29295501 |
Tachypnoea | 64.38 | 14.68 | 28 | 267582 | 15087 | 29291830 |
Cyanosis | 64.29 | 14.68 | 12 | 267598 | 11255 | 29295662 |
Leukaemia | 64.16 | 14.68 | 120 | 267490 | 3690 | 29303227 |
Colitis ulcerative | 64.09 | 14.68 | 18 | 267592 | 12751 | 29294166 |
Nerve injury | 63.76 | 14.68 | 105 | 267505 | 2912 | 29304005 |
Palpitations | 63.60 | 14.68 | 124 | 267486 | 32480 | 29274437 |
Arteriosclerosis coronary artery | 63.36 | 14.68 | 10 | 267600 | 10595 | 29296322 |
Neutrophil count increased | 63.29 | 14.68 | 27 | 267583 | 14715 | 29292202 |
Blood lactate dehydrogenase increased | 62.80 | 14.68 | 49 | 267561 | 19160 | 29287757 |
Feeling abnormal | 62.26 | 14.68 | 760 | 266850 | 53685 | 29253232 |
Coagulopathy | 62.02 | 14.68 | 43 | 267567 | 17864 | 29289053 |
Product administration error | 61.76 | 14.68 | 26 | 267584 | 14284 | 29292633 |
Pulmonary hypertension | 61.43 | 14.68 | 47 | 267563 | 18561 | 29288356 |
White blood cell disorder | 61.40 | 14.68 | 70 | 267540 | 1353 | 29305564 |
Sleep apnoea syndrome | 61.30 | 14.68 | 42 | 267568 | 17557 | 29289360 |
Blood triglycerides increased | 60.97 | 14.68 | 20 | 267590 | 12814 | 29294103 |
Stress | 60.48 | 14.68 | 63 | 267547 | 21427 | 29285490 |
Accidental exposure to product | 60.20 | 14.68 | 12 | 267598 | 10741 | 29296176 |
Restlessness | 60.02 | 14.68 | 67 | 267543 | 22078 | 29284839 |
Prescribed overdose | 59.81 | 14.68 | 5 | 267605 | 8678 | 29298239 |
Delusion | 59.77 | 14.68 | 14 | 267596 | 11202 | 29295715 |
Obesity | 59.61 | 14.68 | 9 | 267601 | 9854 | 29297063 |
Swelling | 59.51 | 14.68 | 533 | 267077 | 34750 | 29272167 |
Injection site erythema | 59.21 | 14.68 | 26 | 267584 | 13930 | 29292987 |
Light chain analysis abnormal | 59.07 | 14.68 | 24 | 267586 | 62 | 29306855 |
Adverse event | 58.63 | 14.68 | 284 | 267326 | 15007 | 29291910 |
Disseminated intravascular coagulation | 58.03 | 14.68 | 57 | 267553 | 19923 | 29286994 |
Rectal haemorrhage | 57.83 | 14.68 | 143 | 267467 | 34406 | 29272511 |
Acute respiratory distress syndrome | 57.25 | 14.68 | 74 | 267536 | 22861 | 29284056 |
Toxic epidermal necrolysis | 57.23 | 14.68 | 48 | 267562 | 18105 | 29288812 |
Hypomagnesaemia | 56.55 | 14.68 | 45 | 267565 | 17423 | 29289494 |
Myositis | 56.48 | 14.68 | 12 | 267598 | 10271 | 29296646 |
Dystonia | 56.46 | 14.68 | 10 | 267600 | 9739 | 29297178 |
Confusional state | 56.33 | 14.68 | 816 | 266794 | 127061 | 29179856 |
Exposure during pregnancy | 56.07 | 14.68 | 6 | 267604 | 8548 | 29298369 |
Haematoma | 55.80 | 14.68 | 77 | 267533 | 23135 | 29283782 |
Hyperlipidaemia | 55.76 | 14.68 | 22 | 267588 | 12568 | 29294349 |
Hepatic steatosis | 55.71 | 14.68 | 33 | 267577 | 14913 | 29292004 |
Platelet disorder | 55.68 | 14.68 | 65 | 267545 | 1290 | 29305627 |
Blood creatinine increased | 55.57 | 14.68 | 497 | 267113 | 84605 | 29222312 |
Vitamin D decreased | 55.46 | 14.68 | 97 | 267513 | 2828 | 29304089 |
Dry eye | 54.95 | 14.68 | 168 | 267442 | 7128 | 29299789 |
Vitamin B12 decreased | 54.54 | 14.68 | 57 | 267553 | 995 | 29305922 |
Urinary tract infection | 54.49 | 14.68 | 939 | 266671 | 71415 | 29235502 |
Angina pectoris | 54.25 | 14.68 | 106 | 267504 | 27744 | 29279173 |
Hyperhidrosis | 53.89 | 14.68 | 352 | 267258 | 64188 | 29242729 |
Neurotoxicity | 53.44 | 14.68 | 33 | 267577 | 14580 | 29292337 |
Device malfunction | 53.20 | 14.68 | 7 | 267603 | 8500 | 29298417 |
Monoclonal immunoglobulin increased | 52.87 | 14.68 | 21 | 267589 | 50 | 29306867 |
Dysphonia | 52.36 | 14.68 | 325 | 267285 | 18871 | 29288046 |
Coronavirus infection | 52.21 | 14.68 | 101 | 267509 | 3187 | 29303730 |
Haemodynamic instability | 52.06 | 14.68 | 6 | 267604 | 8067 | 29298850 |
Acidosis | 51.94 | 14.68 | 12 | 267598 | 9693 | 29297224 |
Renal injury | 51.92 | 14.68 | 14 | 267596 | 10188 | 29296729 |
Tooth infection | 51.90 | 14.68 | 138 | 267472 | 5401 | 29301516 |
Hepatic cytolysis | 51.89 | 14.68 | 7 | 267603 | 8340 | 29298577 |
No adverse event | 51.76 | 14.68 | 49 | 267561 | 17429 | 29289488 |
Hypogeusia | 51.19 | 14.68 | 51 | 267559 | 839 | 29306078 |
Acute myocardial infarction | 50.87 | 14.68 | 245 | 267365 | 48193 | 29258724 |
Diabetes mellitus inadequate control | 50.86 | 14.68 | 23 | 267587 | 12111 | 29294806 |
Proteinuria | 50.80 | 14.68 | 41 | 267569 | 15763 | 29291154 |
Injection site bruising | 50.50 | 14.68 | 5 | 267605 | 7575 | 29299342 |
Venoocclusive liver disease | 50.48 | 14.68 | 3 | 267607 | 6914 | 29300003 |
Blood calcium decreased | 50.27 | 14.68 | 190 | 267420 | 8992 | 29297925 |
Inappropriate antidiuretic hormone secretion | 50.26 | 14.68 | 18 | 267592 | 10914 | 29296003 |
Hypotension | 50.12 | 14.68 | 1357 | 266253 | 192997 | 29113920 |
Pathogen resistance | 49.99 | 14.68 | 7 | 267603 | 8109 | 29298808 |
Body temperature decreased | 49.99 | 14.68 | 17 | 267593 | 10647 | 29296270 |
Injection site haemorrhage | 49.89 | 14.68 | 8 | 267602 | 8378 | 29298539 |
Protein total abnormal | 49.64 | 14.68 | 33 | 267577 | 293 | 29306624 |
Flushing | 49.31 | 14.68 | 119 | 267491 | 28873 | 29278044 |
Memory impairment | 49.30 | 14.68 | 526 | 267084 | 35944 | 29270973 |
Cardiomegaly | 49.16 | 14.68 | 32 | 267578 | 13744 | 29293173 |
Depressed mood | 48.84 | 14.68 | 46 | 267564 | 16402 | 29290515 |
Cerebrovascular accident | 48.49 | 14.68 | 971 | 266639 | 75940 | 29230977 |
Kidney transplant rejection | 48.34 | 14.68 | 4 | 267606 | 7001 | 29299916 |
Lower limb fracture | 48.29 | 14.68 | 104 | 267506 | 3548 | 29303369 |
Angina unstable | 48.10 | 14.68 | 19 | 267591 | 10846 | 29296071 |
Acute hepatic failure | 48.03 | 14.68 | 24 | 267586 | 11928 | 29294989 |
Hyperthermia | 47.88 | 14.68 | 13 | 267597 | 9417 | 29297500 |
Palmar-plantar erythrodysaesthesia syndrome | 47.81 | 14.68 | 38 | 267572 | 14721 | 29292196 |
Pneumonia aspiration | 47.80 | 14.68 | 171 | 267439 | 36566 | 29270351 |
Blood pressure decreased | 47.77 | 14.68 | 230 | 267380 | 45247 | 29261670 |
Chest pain | 47.40 | 14.68 | 720 | 266890 | 111253 | 29195664 |
Hepatitis cholestatic | 47.39 | 14.68 | 4 | 267606 | 6889 | 29300028 |
Metastases to liver | 47.36 | 14.68 | 24 | 267586 | 11832 | 29295085 |
Lipase increased | 47.31 | 14.68 | 9 | 267601 | 8328 | 29298589 |
Hallucination, auditory | 47.27 | 14.68 | 14 | 267596 | 9579 | 29297338 |
Mitral valve incompetence | 47.27 | 14.68 | 31 | 267579 | 13262 | 29293655 |
Skin exfoliation | 47.27 | 14.68 | 359 | 267251 | 22286 | 29284631 |
Cardiac amyloidosis | 46.95 | 14.68 | 49 | 267561 | 854 | 29306063 |
Drug reaction with eosinophilia and systemic symptoms | 46.74 | 14.68 | 116 | 267494 | 27876 | 29279041 |
Myalgia | 46.70 | 14.68 | 436 | 267174 | 73583 | 29233334 |
Metastases to lung | 45.61 | 14.68 | 8 | 267602 | 7847 | 29299070 |
Therapeutic response unexpected | 45.60 | 14.68 | 11 | 267599 | 8627 | 29298290 |
Torsade de pointes | 45.43 | 14.68 | 4 | 267606 | 6657 | 29300260 |
Hyperbilirubinaemia | 45.25 | 14.68 | 41 | 267569 | 14893 | 29292024 |
Cerebral haemorrhage | 45.20 | 14.68 | 140 | 267470 | 31286 | 29275631 |
Hypercholesterolaemia | 45.16 | 14.68 | 6 | 267604 | 7232 | 29299685 |
Myocardial ischaemia | 45.09 | 14.68 | 47 | 267563 | 15981 | 29290936 |
Adverse reaction | 44.99 | 14.68 | 86 | 267524 | 2689 | 29304228 |
Injury | 44.97 | 14.68 | 64 | 267546 | 18982 | 29287935 |
Duodenal ulcer | 44.58 | 14.68 | 14 | 267596 | 9224 | 29297693 |
Speech disorder | 44.52 | 14.68 | 91 | 267519 | 23425 | 29283492 |
Blood pressure abnormal | 44.45 | 14.68 | 149 | 267461 | 6641 | 29300276 |
Respiratory rate increased | 44.22 | 14.68 | 12 | 267598 | 8696 | 29298221 |
Injection site reaction | 44.16 | 14.68 | 23 | 267587 | 11165 | 29295752 |
Disturbance in attention | 43.97 | 14.68 | 79 | 267531 | 21345 | 29285572 |
Inflammation | 43.84 | 14.68 | 87 | 267523 | 22641 | 29284276 |
Dyspnoea exertional | 43.50 | 14.68 | 176 | 267434 | 36314 | 29270603 |
Anuria | 43.37 | 14.68 | 16 | 267594 | 9525 | 29297392 |
Blood albumin decreased | 43.34 | 14.68 | 26 | 267584 | 11669 | 29295248 |
COVID-19 pneumonia | 43.31 | 14.68 | 186 | 267424 | 9336 | 29297581 |
Clostridium difficile infection | 43.22 | 14.68 | 272 | 267338 | 15869 | 29291048 |
Left ventricular hypertrophy | 43.18 | 14.68 | 5 | 267605 | 6698 | 29300219 |
Dyslipidaemia | 43.13 | 14.68 | 3 | 267607 | 6058 | 29300859 |
Haemodialysis | 43.10 | 14.68 | 18 | 267592 | 9936 | 29296981 |
Blood loss anaemia | 43.08 | 14.68 | 7 | 267603 | 7259 | 29299658 |
Metastases to bone | 42.69 | 14.68 | 18 | 267592 | 9880 | 29297037 |
Balance disorder | 42.69 | 14.68 | 508 | 267102 | 35662 | 29271255 |
Activated partial thromboplastin time prolonged | 42.59 | 14.68 | 9 | 267601 | 7733 | 29299184 |
Anhedonia | 42.54 | 14.68 | 7 | 267603 | 7193 | 29299724 |
Hepatic enzyme increased | 42.22 | 14.68 | 160 | 267450 | 33639 | 29273278 |
Uveitis | 42.16 | 14.68 | 3 | 267607 | 5944 | 29300973 |
Rhinorrhoea | 42.06 | 14.68 | 336 | 267274 | 21183 | 29285734 |
Aphasia | 41.96 | 14.68 | 68 | 267542 | 19130 | 29287787 |
Shock haemorrhagic | 41.79 | 14.68 | 17 | 267593 | 9534 | 29297383 |
Type 2 diabetes mellitus | 41.49 | 14.68 | 37 | 267573 | 13544 | 29293373 |
Renal tubular necrosis | 41.38 | 14.68 | 41 | 267569 | 14274 | 29292643 |
Blood electrolytes decreased | 41.32 | 14.68 | 30 | 267580 | 311 | 29306606 |
Product storage error | 41.25 | 14.68 | 5 | 267605 | 6465 | 29300452 |
Myocarditis | 41.11 | 14.68 | 24 | 267586 | 10932 | 29295985 |
Gastritis | 40.93 | 14.68 | 71 | 267539 | 19446 | 29287471 |
Posterior reversible encephalopathy syndrome | 40.89 | 14.68 | 15 | 267595 | 8961 | 29297956 |
Osteolysis | 40.80 | 14.68 | 60 | 267550 | 1505 | 29305412 |
Liver injury | 40.69 | 14.68 | 33 | 267577 | 12657 | 29294260 |
Ataxia | 40.68 | 14.68 | 30 | 267580 | 12073 | 29294844 |
Respiratory tract congestion | 40.60 | 14.68 | 122 | 267488 | 5127 | 29301790 |
Peritonitis bacterial | 40.53 | 14.68 | 3 | 267607 | 5753 | 29301164 |
Haemorrhage intracranial | 40.51 | 14.68 | 43 | 267567 | 14499 | 29292418 |
Hypertriglyceridaemia | 40.49 | 14.68 | 9 | 267601 | 7466 | 29299451 |
Gynaecomastia | 40.47 | 14.68 | 12 | 267598 | 8205 | 29298712 |
Basosquamous carcinoma of skin | 40.44 | 14.68 | 12 | 267598 | 5 | 29306912 |
Pulmonary arterial hypertension | 40.29 | 14.68 | 9 | 267601 | 7440 | 29299477 |
Neuralgia | 40.28 | 14.68 | 200 | 267410 | 10674 | 29296243 |
Femur fracture | 40.22 | 14.68 | 147 | 267463 | 6844 | 29300073 |
Auditory disorder | 40.13 | 14.68 | 27 | 267583 | 245 | 29306672 |
Upper respiratory tract infection | 40.06 | 14.68 | 401 | 267209 | 26948 | 29279969 |
Oliguria | 40.00 | 14.68 | 9 | 267601 | 7403 | 29299514 |
Hepatic cirrhosis | 39.91 | 14.68 | 43 | 267567 | 14401 | 29292516 |
Blood iron decreased | 39.85 | 14.68 | 109 | 267501 | 4339 | 29302578 |
Nephropathy toxic | 39.74 | 14.68 | 24 | 267586 | 10732 | 29296185 |
Limb injury | 39.71 | 14.68 | 179 | 267431 | 9176 | 29297741 |
Hypothermia | 39.53 | 14.68 | 17 | 267593 | 9222 | 29297695 |
Ejection fraction decreased | 39.42 | 14.68 | 52 | 267558 | 15926 | 29290991 |
Vertebral lesion | 39.29 | 14.68 | 23 | 267587 | 159 | 29306758 |
Haemoptysis | 39.21 | 14.68 | 143 | 267467 | 30407 | 29276510 |
Glomerular filtration rate decreased | 39.08 | 14.68 | 27 | 267583 | 11239 | 29295678 |
B precursor type acute leukaemia | 38.82 | 14.68 | 21 | 267589 | 122 | 29306795 |
Contusion | 38.59 | 14.68 | 441 | 267169 | 30654 | 29276263 |
Mania | 38.59 | 14.68 | 15 | 267595 | 8648 | 29298269 |
Jaw disorder | 38.56 | 14.68 | 67 | 267543 | 1943 | 29304974 |
Toothache | 38.13 | 14.68 | 125 | 267485 | 5507 | 29301410 |
Dysphagia | 37.96 | 14.68 | 316 | 267294 | 54610 | 29252307 |
Blood immunoglobulin G increased | 37.84 | 14.68 | 43 | 267567 | 828 | 29306089 |
Joint range of motion decreased | 37.82 | 14.68 | 5 | 267605 | 6049 | 29300868 |
Eosinophilia | 37.65 | 14.68 | 91 | 267519 | 22070 | 29284847 |
Schizophrenia | 37.44 | 14.68 | 7 | 267603 | 6558 | 29300359 |
Pulmonary fibrosis | 37.14 | 14.68 | 52 | 267558 | 15530 | 29291387 |
Left ventricular dysfunction | 37.11 | 14.68 | 17 | 267593 | 8885 | 29298032 |
Disease recurrence | 37.05 | 14.68 | 54 | 267556 | 15860 | 29291057 |
Lacrimation increased | 37.03 | 14.68 | 143 | 267467 | 6837 | 29300080 |
Parkinsonism | 37.01 | 14.68 | 10 | 267600 | 7268 | 29299649 |
Blood pressure diastolic decreased | 36.96 | 14.68 | 9 | 267601 | 7013 | 29299904 |
Rales | 36.93 | 14.68 | 11 | 267599 | 7499 | 29299418 |
Impaired work ability | 36.85 | 14.68 | 4 | 267606 | 5636 | 29301281 |
Dyspnoea | 36.76 | 14.68 | 2505 | 265105 | 324227 | 28982690 |
Subarachnoid haemorrhage | 36.69 | 14.68 | 21 | 267589 | 9671 | 29297246 |
Tricuspid valve incompetence | 36.63 | 14.68 | 15 | 267595 | 8379 | 29298538 |
Cardiac valve disease | 36.40 | 14.68 | 80 | 267530 | 2768 | 29304149 |
Bronchospasm | 36.12 | 14.68 | 21 | 267589 | 9588 | 29297329 |
Arthralgia | 35.90 | 14.68 | 975 | 266635 | 138642 | 29168275 |
Weight decreased | 35.81 | 14.68 | 1689 | 265921 | 149216 | 29157701 |
Oesophagitis | 35.81 | 14.68 | 33 | 267577 | 11890 | 29295027 |
Coordination abnormal | 35.76 | 14.68 | 10 | 267600 | 7104 | 29299813 |
Hypokinesia | 35.48 | 14.68 | 12 | 267598 | 7542 | 29299375 |
Breath sounds abnormal | 35.33 | 14.68 | 4 | 267606 | 5453 | 29301464 |
Refractory anaemia with an excess of blasts | 35.16 | 14.68 | 29 | 267581 | 368 | 29306549 |
Aplastic anaemia | 35.15 | 14.68 | 12 | 267598 | 7498 | 29299419 |
Sinus bradycardia | 34.98 | 14.68 | 32 | 267578 | 11571 | 29295346 |
Bronchopulmonary aspergillosis | 34.95 | 14.68 | 36 | 267574 | 12308 | 29294609 |
Flatulence | 34.88 | 14.68 | 277 | 267333 | 17432 | 29289485 |
Disorientation | 34.77 | 14.68 | 143 | 267467 | 29372 | 29277545 |
Eye infection | 34.62 | 14.68 | 79 | 267531 | 2804 | 29304113 |
Chills | 34.58 | 14.68 | 446 | 267164 | 70854 | 29236063 |
Hepatitis acute | 34.56 | 14.68 | 8 | 267602 | 6454 | 29300463 |
Hypertensive crisis | 34.29 | 14.68 | 14 | 267596 | 7834 | 29299083 |
Plasma cell myeloma refractory | 34.26 | 14.68 | 17 | 267593 | 80 | 29306837 |
Oral disorder | 34.03 | 14.68 | 93 | 267517 | 3700 | 29303217 |
Febrile neutropenia | 33.95 | 14.68 | 765 | 266845 | 111475 | 29195442 |
Epstein-Barr virus infection | 33.92 | 14.68 | 9 | 267601 | 6620 | 29300297 |
Viral infection | 33.88 | 14.68 | 240 | 267370 | 14570 | 29292347 |
Fracture | 33.75 | 14.68 | 126 | 267484 | 5927 | 29300990 |
Lower gastrointestinal haemorrhage | 33.75 | 14.68 | 16 | 267594 | 8197 | 29298720 |
Knee arthroplasty | 33.55 | 14.68 | 6 | 267604 | 5803 | 29301114 |
Hypovolaemic shock | 33.53 | 14.68 | 7 | 267603 | 6065 | 29300852 |
Pneumonia viral | 33.28 | 14.68 | 74 | 267536 | 2581 | 29304336 |
Post transplant lymphoproliferative disorder | 33.23 | 14.68 | 5 | 267605 | 5488 | 29301429 |
Muscle spasticity | 33.12 | 14.68 | 3 | 267607 | 4880 | 29302037 |
Iron deficiency anaemia | 32.97 | 14.68 | 20 | 267590 | 8922 | 29297995 |
Papule | 32.88 | 14.68 | 83 | 267527 | 3146 | 29303771 |
Haemophagocytic lymphohistiocytosis | 32.84 | 14.68 | 28 | 267582 | 10476 | 29296441 |
Enterococcal infection | 32.63 | 14.68 | 17 | 267593 | 8251 | 29298666 |
Toxicity to various agents | 32.42 | 14.68 | 1264 | 266346 | 172397 | 29134520 |
Hypotonia | 32.36 | 14.68 | 11 | 267599 | 6891 | 29300026 |
B-cell type acute leukaemia | 32.12 | 14.68 | 24 | 267586 | 261 | 29306656 |
Post procedural complication | 32.10 | 14.68 | 28 | 267582 | 10361 | 29296556 |
Transfusion | 31.91 | 14.68 | 13 | 267597 | 7285 | 29299632 |
Eye swelling | 31.91 | 14.68 | 159 | 267451 | 8498 | 29298419 |
Injection site pruritus | 31.77 | 14.68 | 7 | 267603 | 5842 | 29301075 |
Sputum discoloured | 31.58 | 14.68 | 10 | 267600 | 6553 | 29300364 |
Subdural haematoma | 31.47 | 14.68 | 74 | 267536 | 18119 | 29288798 |
Rash macular | 31.30 | 14.68 | 181 | 267429 | 10244 | 29296673 |
Visual acuity reduced | 31.30 | 14.68 | 54 | 267556 | 14822 | 29292095 |
Productive cough | 31.15 | 14.68 | 161 | 267449 | 31098 | 29275819 |
Hyperviscosity syndrome | 31.09 | 14.68 | 20 | 267590 | 167 | 29306750 |
Acute respiratory failure | 31.05 | 14.68 | 128 | 267482 | 26274 | 29280643 |
Chondrocalcinosis pyrophosphate | 31.04 | 14.68 | 40 | 267570 | 882 | 29306035 |
Multiple fractures | 31.02 | 14.68 | 48 | 267562 | 1261 | 29305656 |
Granulocytopenia | 30.93 | 14.68 | 8 | 267602 | 5986 | 29300931 |
Product dispensing error | 30.92 | 14.68 | 6 | 267604 | 5474 | 29301443 |
Red blood cell count abnormal | 30.83 | 14.68 | 32 | 267578 | 554 | 29306363 |
Weight fluctuation | 30.69 | 14.68 | 94 | 267516 | 3992 | 29302925 |
Klebsiella infection | 30.69 | 14.68 | 14 | 267596 | 7335 | 29299582 |
Heart rate increased | 30.68 | 14.68 | 216 | 267394 | 38722 | 29268195 |
Blood magnesium decreased | 30.68 | 14.68 | 113 | 267497 | 5281 | 29301636 |
Limb discomfort | 30.63 | 14.68 | 169 | 267441 | 9399 | 29297518 |
Electrocardiogram abnormal | 30.50 | 14.68 | 14 | 267596 | 7308 | 29299609 |
Pneumonia influenzal | 30.44 | 14.68 | 48 | 267562 | 1282 | 29305635 |
Food poisoning | 30.33 | 14.68 | 47 | 267563 | 1236 | 29305681 |
Osteoarthritis | 30.23 | 14.68 | 75 | 267535 | 18028 | 29288889 |
Haematochezia | 30.21 | 14.68 | 203 | 267407 | 36780 | 29270137 |
Cardiac failure congestive | 30.18 | 14.68 | 907 | 266703 | 75674 | 29231243 |
Hepatomegaly | 30.16 | 14.68 | 24 | 267586 | 9293 | 29297624 |
Aspergillus infection | 29.79 | 14.68 | 31 | 267579 | 10550 | 29296367 |
Asphyxia | 29.61 | 14.68 | 6 | 267604 | 5309 | 29301608 |
Clavicle fracture | 29.53 | 14.68 | 59 | 267551 | 1907 | 29305010 |
Aphonia | 29.44 | 14.68 | 75 | 267535 | 2859 | 29304058 |
Arthropod bite | 29.40 | 14.68 | 66 | 267544 | 2317 | 29304600 |
Pneumonitis | 29.34 | 14.68 | 142 | 267468 | 27902 | 29279015 |
Pseudomonas infection | 29.22 | 14.68 | 33 | 267577 | 10819 | 29296098 |
Blood lactic acid increased | 29.18 | 14.68 | 8 | 267602 | 5758 | 29301159 |
Tumour marker increased | 29.15 | 14.68 | 30 | 267580 | 514 | 29306403 |
Tendonitis | 29.08 | 14.68 | 18 | 267592 | 7943 | 29298974 |
Cardiac failure | 28.87 | 14.68 | 524 | 267086 | 78763 | 29228154 |
Dialysis | 28.64 | 14.68 | 30 | 267580 | 10178 | 29296739 |
Right ventricular failure | 28.60 | 14.68 | 18 | 267592 | 7872 | 29299045 |
Malignant melanoma in situ | 28.59 | 14.68 | 44 | 267566 | 1150 | 29305767 |
POEMS syndrome | 28.50 | 14.68 | 12 | 267598 | 35 | 29306882 |
Dizziness | 28.43 | 14.68 | 2037 | 265573 | 187647 | 29119270 |
Eczema | 28.35 | 14.68 | 51 | 267559 | 13775 | 29293142 |
Prothrombin time prolonged | 28.28 | 14.68 | 23 | 267587 | 8809 | 29298108 |
Gastritis erosive | 28.21 | 14.68 | 7 | 267603 | 5386 | 29301531 |
Appendix disorder | 28.18 | 14.68 | 31 | 267579 | 575 | 29306342 |
Gastroenteritis viral | 28.01 | 14.68 | 115 | 267495 | 5657 | 29301260 |
Eosinophil count increased | 27.85 | 14.68 | 16 | 267594 | 7353 | 29299564 |
Euphoric mood | 27.83 | 14.68 | 5 | 267605 | 4820 | 29302097 |
Hydronephrosis | 27.62 | 14.68 | 23 | 267587 | 8707 | 29298210 |
Cholangitis | 27.59 | 14.68 | 17 | 267593 | 7520 | 29299397 |
Gingival pain | 27.35 | 14.68 | 59 | 267551 | 2015 | 29304902 |
Brain injury | 27.24 | 14.68 | 8 | 267602 | 5504 | 29301413 |
Pulmonary congestion | 27.22 | 14.68 | 44 | 267566 | 12392 | 29294525 |
Atelectasis | 27.11 | 14.68 | 62 | 267548 | 15330 | 29291587 |
Adenovirus infection | 27.01 | 14.68 | 4 | 267606 | 4443 | 29302474 |
Night sweats | 26.95 | 14.68 | 229 | 267381 | 14703 | 29292214 |
Motor dysfunction | 26.86 | 14.68 | 10 | 267600 | 5920 | 29300997 |
Hyperthyroidism | 26.84 | 14.68 | 23 | 267587 | 8585 | 29298332 |
Coronary artery bypass | 26.71 | 14.68 | 5 | 267605 | 4680 | 29302237 |
Peritonitis | 26.69 | 14.68 | 59 | 267551 | 14765 | 29292152 |
Viral upper respiratory tract infection | 26.66 | 14.68 | 66 | 267544 | 2471 | 29304446 |
Paraproteinaemia | 26.64 | 14.68 | 23 | 267587 | 312 | 29306605 |
Atrial flutter | 26.64 | 14.68 | 216 | 267394 | 13678 | 29293239 |
Coronary artery stenosis | 26.62 | 14.68 | 23 | 267587 | 8550 | 29298367 |
Rectal adenocarcinoma | 26.51 | 14.68 | 34 | 267576 | 746 | 29306171 |
Hiatus hernia | 26.47 | 14.68 | 14 | 267596 | 6738 | 29300179 |
Glycosylated haemoglobin increased | 26.11 | 14.68 | 28 | 267582 | 9398 | 29297519 |
Pleural effusion | 25.94 | 14.68 | 476 | 267134 | 71432 | 29235485 |
Platelet count abnormal | 25.92 | 14.68 | 63 | 267547 | 2331 | 29304586 |
Post procedural haemorrhage | 25.92 | 14.68 | 18 | 267592 | 7473 | 29299444 |
Refractory cytopenia with multilineage dysplasia | 25.85 | 14.68 | 16 | 267594 | 124 | 29306793 |
Dermatitis allergic | 25.79 | 14.68 | 111 | 267499 | 5577 | 29301340 |
Multiple sclerosis | 25.78 | 14.68 | 9 | 267601 | 5545 | 29301372 |
Cerebral haematoma | 25.78 | 14.68 | 4 | 267606 | 4292 | 29302625 |
Therapy non-responder | 25.77 | 14.68 | 408 | 267202 | 30503 | 29276414 |
Orthopnoea | 25.71 | 14.68 | 5 | 267605 | 4555 | 29302362 |
Arteriosclerosis | 25.69 | 14.68 | 33 | 267577 | 10223 | 29296694 |
Adrenal insufficiency | 25.59 | 14.68 | 38 | 267572 | 11076 | 29295841 |
Cytokine release syndrome | 25.49 | 14.68 | 50 | 267560 | 13069 | 29293848 |
Device dislocation | 25.45 | 14.68 | 5 | 267605 | 4522 | 29302395 |
Cellulitis | 25.38 | 14.68 | 568 | 267042 | 45272 | 29261645 |
Nightmare | 25.36 | 14.68 | 40 | 267570 | 11377 | 29295540 |
Skin sensitisation | 25.32 | 14.68 | 18 | 267592 | 180 | 29306737 |
Skin necrosis | 25.28 | 14.68 | 7 | 267603 | 5005 | 29301912 |
Exercise tolerance decreased | 25.25 | 14.68 | 4 | 267606 | 4227 | 29302690 |
Middle insomnia | 25.23 | 14.68 | 10 | 267600 | 5698 | 29301219 |
Hypernatraemia | 25.23 | 14.68 | 18 | 267592 | 7368 | 29299549 |
Electrocardiogram ST segment elevation | 25.17 | 14.68 | 5 | 267605 | 4487 | 29302430 |
Apnoea | 24.90 | 14.68 | 12 | 267598 | 6090 | 29300827 |
Lymphocyte count decreased | 24.86 | 14.68 | 90 | 267520 | 19181 | 29287736 |
Metastases to central nervous system | 24.86 | 14.68 | 17 | 267593 | 7114 | 29299803 |
Skin atrophy | 24.81 | 14.68 | 51 | 267559 | 1683 | 29305234 |
Monocyte count increased | 24.78 | 14.68 | 3 | 267607 | 3883 | 29303034 |
Gait disturbance | 24.78 | 14.68 | 491 | 267119 | 72858 | 29234059 |
Hyperglycaemia | 24.72 | 14.68 | 195 | 267415 | 34092 | 29272825 |
Spinal cord compression | 24.70 | 14.68 | 80 | 267530 | 3502 | 29303415 |
Drug eruption | 24.48 | 14.68 | 74 | 267536 | 16667 | 29290250 |
Colon cancer | 24.36 | 14.68 | 135 | 267475 | 7520 | 29299397 |
Crying | 24.28 | 14.68 | 9 | 267601 | 5342 | 29301575 |
Myopathy | 24.27 | 14.68 | 36 | 267574 | 10497 | 29296420 |
Pulse absent | 24.23 | 14.68 | 8 | 267602 | 5105 | 29301812 |
Toxic encephalopathy | 24.10 | 14.68 | 6 | 267604 | 4606 | 29302311 |
Cholecystitis infective | 24.10 | 14.68 | 48 | 267562 | 1548 | 29305369 |
Renal tubular disorder | 24.06 | 14.68 | 5 | 267605 | 4347 | 29302570 |
Atrioventricular block first degree | 24.04 | 14.68 | 9 | 267601 | 5310 | 29301607 |
Splenomegaly | 23.79 | 14.68 | 53 | 267557 | 13226 | 29293691 |
Amylase increased | 23.76 | 14.68 | 9 | 267601 | 5271 | 29301646 |
Skin plaque | 23.76 | 14.68 | 3 | 267607 | 3759 | 29303158 |
Stent placement | 23.70 | 14.68 | 5 | 267605 | 4301 | 29302616 |
Dermatitis acneiform | 23.66 | 14.68 | 10 | 267600 | 5481 | 29301436 |
Respiratory tract infection | 23.66 | 14.68 | 231 | 267379 | 15420 | 29291497 |
Necrosis | 23.61 | 14.68 | 8 | 267602 | 5022 | 29301895 |
Bladder disorder | 23.58 | 14.68 | 67 | 267543 | 2727 | 29304190 |
Abdominal pain lower | 23.55 | 14.68 | 26 | 267584 | 8612 | 29298305 |
Tenosynovitis | 23.52 | 14.68 | 3 | 267607 | 3730 | 29303187 |
Hypothyroidism | 23.48 | 14.68 | 70 | 267540 | 15836 | 29291081 |
Hypercapnia | 23.46 | 14.68 | 3 | 267607 | 3723 | 29303194 |
Anger | 23.40 | 14.68 | 39 | 267571 | 10851 | 29296066 |
Ventricular hypertrophy | 23.37 | 14.68 | 5 | 267605 | 4259 | 29302658 |
Hyperammonaemia | 23.32 | 14.68 | 11 | 267599 | 5652 | 29301265 |
Ischaemic cardiomyopathy | 23.14 | 14.68 | 11 | 267599 | 5627 | 29301290 |
Musculoskeletal pain | 23.11 | 14.68 | 160 | 267450 | 28793 | 29278124 |
Hepatitis C | 23.02 | 14.68 | 28 | 267582 | 8882 | 29298035 |
Neutrophilia | 22.97 | 14.68 | 3 | 267607 | 3663 | 29303254 |
Ischaemia | 22.96 | 14.68 | 5 | 267605 | 4207 | 29302710 |
Red cell distribution width increased | 22.95 | 14.68 | 7 | 267603 | 4700 | 29302217 |
Congestive cardiomyopathy | 22.85 | 14.68 | 16 | 267594 | 6614 | 29300303 |
Panic attack | 22.77 | 14.68 | 25 | 267585 | 8301 | 29298616 |
Ketoacidosis | 22.74 | 14.68 | 3 | 267607 | 3636 | 29303281 |
Brain herniation | 22.69 | 14.68 | 3 | 267607 | 3630 | 29303287 |
Partial seizures | 22.61 | 14.68 | 4 | 267606 | 3899 | 29303018 |
Urinary incontinence | 22.59 | 14.68 | 75 | 267535 | 16406 | 29290511 |
Renal impairment | 22.50 | 14.68 | 925 | 266685 | 80408 | 29226509 |
Hypertransaminasaemia | 22.47 | 14.68 | 3 | 267607 | 3603 | 29303314 |
Anosmia | 22.21 | 14.68 | 53 | 267557 | 1938 | 29304979 |
Neutrophil count abnormal | 22.20 | 14.68 | 45 | 267565 | 1470 | 29305447 |
Hepatic necrosis | 21.95 | 14.68 | 3 | 267607 | 3539 | 29303378 |
Disease complication | 21.91 | 14.68 | 59 | 267551 | 2327 | 29304590 |
Haemolytic anaemia | 21.89 | 14.68 | 32 | 267578 | 9387 | 29297530 |
Cardiomyopathy | 21.88 | 14.68 | 65 | 267545 | 14722 | 29292195 |
Muscle strain | 21.79 | 14.68 | 76 | 267534 | 3457 | 29303460 |
Central nervous system lesion | 21.72 | 14.68 | 12 | 267598 | 5636 | 29301281 |
Salmonellosis | 21.69 | 14.68 | 30 | 267580 | 710 | 29306207 |
Salivary hypersecretion | 21.67 | 14.68 | 21 | 267589 | 7388 | 29299529 |
Visceral leishmaniasis | 21.62 | 14.68 | 25 | 267585 | 491 | 29306426 |
Blood chloride decreased | 21.61 | 14.68 | 3 | 267607 | 3498 | 29303419 |
Hypoxic-ischaemic encephalopathy | 21.57 | 14.68 | 6 | 267604 | 4278 | 29302639 |
Chronic graft versus host disease | 21.53 | 14.68 | 5 | 267605 | 4024 | 29302893 |
Acute graft versus host disease | 21.51 | 14.68 | 13 | 267597 | 5811 | 29301106 |
Cardiotoxicity | 21.49 | 14.68 | 8 | 267602 | 4736 | 29302181 |
Intracranial pressure increased | 21.48 | 14.68 | 3 | 267607 | 3482 | 29303435 |
Hemiplegia | 21.33 | 14.68 | 17 | 267593 | 6577 | 29300340 |
Pelvic fracture | 21.33 | 14.68 | 56 | 267554 | 2175 | 29304742 |
Hypervolaemia | 21.30 | 14.68 | 84 | 267526 | 17461 | 29289456 |
Gastrointestinal motility disorder | 21.26 | 14.68 | 55 | 267555 | 2117 | 29304800 |
Bradykinesia | 21.17 | 14.68 | 3 | 267607 | 3444 | 29303473 |
Mental status changes | 21.05 | 14.68 | 208 | 267402 | 34719 | 29272198 |
Bradyphrenia | 21.04 | 14.68 | 6 | 267604 | 4208 | 29302709 |
Sternal fracture | 20.93 | 14.68 | 27 | 267583 | 596 | 29306321 |
Amyloidosis | 20.92 | 14.68 | 52 | 267558 | 1952 | 29304965 |
Blood immunoglobulin M increased | 20.90 | 14.68 | 16 | 267594 | 181 | 29306736 |
Blood immunoglobulin A increased | 20.85 | 14.68 | 19 | 267591 | 278 | 29306639 |
Lentigo maligna | 20.77 | 14.68 | 20 | 267590 | 315 | 29306602 |
Cardiac tamponade | 20.69 | 14.68 | 8 | 267602 | 4627 | 29302290 |
Chronic kidney disease | 20.66 | 14.68 | 220 | 267390 | 36196 | 29270721 |
Bundle branch block left | 20.60 | 14.68 | 11 | 267599 | 5266 | 29301651 |
Type 1 diabetes mellitus | 20.54 | 14.68 | 4 | 267606 | 3640 | 29303277 |
Aspiration | 20.47 | 14.68 | 38 | 267572 | 10142 | 29296775 |
Pneumothorax | 20.43 | 14.68 | 74 | 267536 | 15768 | 29291149 |
Cervical vertebral fracture | 20.42 | 14.68 | 47 | 267563 | 1678 | 29305239 |
Behaviour disorder | 20.32 | 14.68 | 4 | 267606 | 3612 | 29303305 |
Immunoglobulins abnormal | 20.29 | 14.68 | 7 | 267603 | 9 | 29306908 |
5q minus syndrome | 20.28 | 14.68 | 14 | 267596 | 133 | 29306784 |
Autoimmune hepatitis | 20.20 | 14.68 | 4 | 267606 | 3598 | 29303319 |
Musculoskeletal chest pain | 20.20 | 14.68 | 141 | 267469 | 8519 | 29298398 |
Ventricular hypokinesia | 20.18 | 14.68 | 8 | 267602 | 4557 | 29302360 |
Myeloma cast nephropathy | 20.16 | 14.68 | 10 | 267600 | 47 | 29306870 |
Erectile dysfunction | 20.14 | 14.68 | 89 | 267521 | 17920 | 29288997 |
Respiratory acidosis | 20.11 | 14.68 | 7 | 267603 | 4321 | 29302596 |
Device occlusion | 20.04 | 14.68 | 13 | 267597 | 5595 | 29301322 |
Portal vein thrombosis | 20.04 | 14.68 | 3 | 267607 | 3306 | 29303611 |
Vitamin B complex deficiency | 20.01 | 14.68 | 15 | 267595 | 164 | 29306753 |
Pyelonephritis | 19.97 | 14.68 | 12 | 267598 | 5381 | 29301536 |
Serum ferritin increased | 19.91 | 14.68 | 13 | 267597 | 5575 | 29301342 |
Oral infection | 19.82 | 14.68 | 48 | 267562 | 1772 | 29305145 |
Lymphadenopathy | 19.71 | 14.68 | 139 | 267471 | 24910 | 29282007 |
Duodenal ulcer haemorrhage | 19.55 | 14.68 | 8 | 267602 | 4471 | 29302446 |
Procedural pain | 19.49 | 14.68 | 7 | 267603 | 4237 | 29302680 |
Sudden death | 19.49 | 14.68 | 64 | 267546 | 14046 | 29292871 |
Kidney infection | 19.42 | 14.68 | 89 | 267521 | 4594 | 29302323 |
Bone loss | 19.34 | 14.68 | 24 | 267586 | 509 | 29306408 |
Gastric haemorrhage | 19.33 | 14.68 | 34 | 267576 | 9263 | 29297654 |
Portal hypertension | 19.29 | 14.68 | 4 | 267606 | 3482 | 29303435 |
Occult blood positive | 19.16 | 14.68 | 5 | 267605 | 3719 | 29303198 |
Haematocrit decreased | 19.14 | 14.68 | 169 | 267441 | 28853 | 29278064 |
Polyarthritis | 19.00 | 14.68 | 6 | 267604 | 3939 | 29302978 |
Pneumatosis intestinalis | 18.90 | 14.68 | 3 | 267607 | 3166 | 29303751 |
Superficial spreading melanoma stage I | 18.77 | 14.68 | 7 | 267603 | 13 | 29306904 |
Duodenitis | 18.69 | 14.68 | 7 | 267603 | 4128 | 29302789 |
Intraocular pressure increased | 18.67 | 14.68 | 10 | 267600 | 4779 | 29302138 |
Spinal osteoarthritis | 18.61 | 14.68 | 18 | 267592 | 6338 | 29300579 |
Gastric ulcer | 18.58 | 14.68 | 65 | 267545 | 13996 | 29292921 |
Nausea | 18.48 | 14.68 | 2314 | 265296 | 286941 | 29019976 |
Discomfort | 18.36 | 14.68 | 70 | 267540 | 14693 | 29292224 |
Lyme disease | 18.32 | 14.68 | 29 | 267581 | 777 | 29306140 |
Primary amyloidosis | 18.29 | 14.68 | 12 | 267598 | 104 | 29306813 |
Bladder transitional cell carcinoma stage 0 | 18.19 | 14.68 | 12 | 267598 | 105 | 29306812 |
Stevens-Johnson syndrome | 18.16 | 14.68 | 82 | 267528 | 16415 | 29290502 |
Parosmia | 18.01 | 14.68 | 41 | 267569 | 1453 | 29305464 |
Incorrect product administration duration | 18.00 | 14.68 | 7 | 267603 | 4034 | 29302883 |
Aplasia pure red cell | 17.96 | 14.68 | 14 | 267596 | 5477 | 29301440 |
Herpes simplex | 17.94 | 14.68 | 11 | 267599 | 4879 | 29302038 |
Encephalitis | 17.92 | 14.68 | 19 | 267591 | 6411 | 29300506 |
Lung adenocarcinoma | 17.86 | 14.68 | 76 | 267534 | 3799 | 29303118 |
Bronchiectasis | 17.76 | 14.68 | 20 | 267590 | 6565 | 29300352 |
Diverticulum intestinal | 17.74 | 14.68 | 4 | 267606 | 3286 | 29303631 |
Anal abscess | 17.67 | 14.68 | 13 | 267597 | 5238 | 29301679 |
Scar | 17.49 | 14.68 | 14 | 267596 | 5405 | 29301512 |
Bundle branch block right | 17.47 | 14.68 | 21 | 267589 | 6696 | 29300221 |
Hepatic fibrosis | 17.45 | 14.68 | 4 | 267606 | 3248 | 29303669 |
Spinal cord neoplasm | 17.42 | 14.68 | 13 | 267597 | 141 | 29306776 |
Hepatosplenomegaly | 17.29 | 14.68 | 6 | 267604 | 3711 | 29303206 |
Ecchymosis | 17.01 | 14.68 | 19 | 267591 | 6261 | 29300656 |
Syncope | 17.01 | 14.68 | 584 | 267026 | 80787 | 29226130 |
Bladder transitional cell carcinoma | 17.00 | 14.68 | 55 | 267555 | 2406 | 29304511 |
Colon cancer metastatic | 16.97 | 14.68 | 40 | 267570 | 1451 | 29305466 |
Benign prostatic hyperplasia | 16.95 | 14.68 | 52 | 267558 | 11658 | 29295259 |
Psychiatric symptom | 16.91 | 14.68 | 4 | 267606 | 3180 | 29303737 |
Normochromic normocytic anaemia | 16.86 | 14.68 | 6 | 267604 | 3652 | 29303265 |
Cardiac murmur | 16.85 | 14.68 | 21 | 267589 | 6592 | 29300325 |
Immunoglobulins increased | 16.82 | 14.68 | 14 | 267596 | 180 | 29306737 |
Cyst | 16.81 | 14.68 | 76 | 267534 | 3901 | 29303016 |
Idiopathic pulmonary fibrosis | 16.79 | 14.68 | 4 | 267606 | 3164 | 29303753 |
Haemorrhagic stroke | 16.67 | 14.68 | 17 | 267593 | 5839 | 29301078 |
Presyncope | 16.52 | 14.68 | 82 | 267528 | 16007 | 29290910 |
Hospice care | 16.47 | 14.68 | 13 | 267597 | 5055 | 29301862 |
Adenocarcinoma gastric | 16.45 | 14.68 | 33 | 267577 | 1070 | 29305847 |
Diverticulitis | 16.42 | 14.68 | 238 | 267372 | 17466 | 29289451 |
Renal cyst | 16.36 | 14.68 | 29 | 267581 | 7878 | 29299039 |
Upper-airway cough syndrome | 16.32 | 14.68 | 62 | 267548 | 2941 | 29303976 |
Intestinal obstruction | 16.28 | 14.68 | 255 | 267355 | 19022 | 29287895 |
Hepatitis fulminant | 16.21 | 14.68 | 6 | 267604 | 3565 | 29303352 |
Sciatica | 16.19 | 14.68 | 88 | 267522 | 4866 | 29302051 |
Papillary thyroid cancer | 16.17 | 14.68 | 23 | 267587 | 559 | 29306358 |
Polyuria | 16.16 | 14.68 | 26 | 267584 | 7336 | 29299581 |
Transitional cell cancer of the renal pelvis and ureter | 16.02 | 14.68 | 7 | 267603 | 23 | 29306894 |
Leukoencephalopathy | 16.01 | 14.68 | 7 | 267603 | 3760 | 29303157 |
Furuncle | 16.01 | 14.68 | 61 | 267549 | 2898 | 29304019 |
Mental impairment | 15.95 | 14.68 | 37 | 267573 | 9104 | 29297813 |
Hip arthroplasty | 15.94 | 14.68 | 7 | 267603 | 3751 | 29303166 |
Colorectal adenocarcinoma | 15.92 | 14.68 | 14 | 267596 | 195 | 29306722 |
Urticaria | 15.88 | 14.68 | 625 | 266985 | 54035 | 29252882 |
Gait inability | 15.87 | 14.68 | 244 | 267366 | 18131 | 29288786 |
Mucormycosis | 15.82 | 14.68 | 14 | 267596 | 5144 | 29301773 |
Snoring | 15.81 | 14.68 | 3 | 267607 | 2781 | 29304136 |
Feeling jittery | 15.78 | 14.68 | 70 | 267540 | 3563 | 29303354 |
Neoplasm | 15.74 | 14.68 | 77 | 267533 | 4084 | 29302833 |
Cerebral ischaemia | 15.73 | 14.68 | 17 | 267593 | 5686 | 29301231 |
Supraventricular tachycardia | 15.70 | 14.68 | 42 | 267568 | 9842 | 29297075 |
Liver function test increased | 15.67 | 14.68 | 55 | 267555 | 11830 | 29295087 |
Bilirubin conjugated increased | 15.62 | 14.68 | 4 | 267606 | 3013 | 29303904 |
Bone erosion | 15.62 | 14.68 | 3 | 267607 | 2757 | 29304160 |
Acute coronary syndrome | 15.61 | 14.68 | 58 | 267552 | 12267 | 29294650 |
Emotional disorder | 15.59 | 14.68 | 13 | 267597 | 4918 | 29301999 |
Hypophosphataemia | 15.57 | 14.68 | 30 | 267580 | 7894 | 29299023 |
Hepatocellular carcinoma | 15.31 | 14.68 | 25 | 267585 | 7013 | 29299904 |
Prostate cancer | 15.31 | 14.68 | 320 | 267290 | 25207 | 29281710 |
Chest wall mass | 15.28 | 14.68 | 8 | 267602 | 43 | 29306874 |
Muscle twitching | 15.24 | 14.68 | 31 | 267579 | 7995 | 29298922 |
Squamous cell carcinoma of the hypopharynx | 15.19 | 14.68 | 6 | 267604 | 14 | 29306903 |
Cerebral atrophy | 15.16 | 14.68 | 9 | 267601 | 4063 | 29302854 |
Alanine aminotransferase abnormal | 15.16 | 14.68 | 4 | 267606 | 2953 | 29303964 |
Gingival discolouration | 15.15 | 14.68 | 5 | 267605 | 5 | 29306912 |
Respiration abnormal | 15.12 | 14.68 | 56 | 267554 | 2624 | 29304293 |
Gastrointestinal infection | 15.10 | 14.68 | 72 | 267538 | 3779 | 29303138 |
Lung consolidation | 15.09 | 14.68 | 14 | 267596 | 5029 | 29301888 |
Lethargy | 15.08 | 14.68 | 244 | 267366 | 37336 | 29269581 |
Anal squamous cell carcinoma | 15.05 | 14.68 | 9 | 267601 | 65 | 29306852 |
Irritability | 15.05 | 14.68 | 128 | 267482 | 22024 | 29284893 |
Amnesia | 14.96 | 14.68 | 288 | 267322 | 22355 | 29284562 |
Tongue disorder | 14.93 | 14.68 | 12 | 267598 | 4624 | 29302293 |
Mental disorder | 14.90 | 14.68 | 63 | 267547 | 12842 | 29294075 |
Oedema | 14.90 | 14.68 | 267 | 267343 | 40216 | 29266701 |
Plasma cell myeloma in remission | 14.86 | 14.68 | 4 | 267606 | 0 | 29306917 |
Hepatic amyloidosis | 14.86 | 14.68 | 4 | 267606 | 0 | 29306917 |
Hyperaesthesia teeth | 14.82 | 14.68 | 20 | 267590 | 462 | 29306455 |
Myasthenia gravis | 14.81 | 14.68 | 5 | 267605 | 3146 | 29303771 |
Respiratory syncytial virus infection | 14.78 | 14.68 | 69 | 267541 | 3590 | 29303327 |
Inadequate analgesia | 14.78 | 14.68 | 3 | 267607 | 2651 | 29304266 |
Disability | 14.77 | 14.68 | 11 | 267599 | 4405 | 29302512 |
Ventricular arrhythmia | 14.73 | 14.68 | 12 | 267598 | 4592 | 29302325 |
Swollen tongue | 14.71 | 14.68 | 59 | 267551 | 12207 | 29294710 |
Vitamin D deficiency | 14.68 | 14.68 | 17 | 267593 | 5512 | 29301405 |
Muscle haemorrhage | 14.68 | 14.68 | 6 | 267604 | 3356 | 29303561 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Death | 6348.29 | 14.19 | 9490 | 297733 | 473215 | 63718294 |
Full blood count decreased | 6337.77 | 14.19 | 2767 | 304456 | 19815 | 64171694 |
Pneumonia | 5023.22 | 14.19 | 9271 | 297952 | 550305 | 63641204 |
Thrombosis | 4328.04 | 14.19 | 3187 | 304036 | 67455 | 64124054 |
White blood cell count decreased | 4138.95 | 14.19 | 4395 | 302828 | 153442 | 64038067 |
Platelet count decreased | 3560.04 | 14.19 | 4183 | 303040 | 163528 | 64027981 |
Neuropathy peripheral | 3516.90 | 14.19 | 3515 | 303708 | 114010 | 64077499 |
Diarrhoea | 3259.41 | 14.19 | 9118 | 298105 | 713586 | 63477923 |
Rash | 2409.87 | 14.19 | 6134 | 301089 | 452415 | 63739094 |
Deep vein thrombosis | 2018.03 | 14.19 | 2495 | 304728 | 102687 | 64088822 |
Fatigue | 1775.88 | 14.19 | 7642 | 299581 | 741088 | 63450421 |
Unevaluable event | 1685.13 | 14.19 | 1605 | 305618 | 48884 | 64142625 |
Neutropenia | 1365.40 | 14.19 | 3312 | 303911 | 236312 | 63955197 |
Laboratory test abnormal | 1319.07 | 14.19 | 1017 | 306206 | 23046 | 64168463 |
Drug interaction | 1305.23 | 14.19 | 114 | 307109 | 361969 | 63829540 |
Plasma cell myeloma | 1221.51 | 14.19 | 1293 | 305930 | 44782 | 64146727 |
Muscle spasms | 1213.12 | 14.19 | 2305 | 304918 | 138718 | 64052791 |
Constipation | 1159.73 | 14.19 | 3030 | 304193 | 226307 | 63965202 |
Neutrophil count decreased | 1106.77 | 14.19 | 1589 | 305634 | 75607 | 64115902 |
Off label use | 1106.13 | 14.19 | 842 | 306381 | 631964 | 63559545 |
COVID-19 | 1079.58 | 14.19 | 1438 | 305785 | 63702 | 64127807 |
Plasma cell myeloma recurrent | 1051.90 | 14.19 | 471 | 306752 | 3594 | 64187915 |
Pancytopenia | 981.01 | 14.19 | 2131 | 305092 | 141178 | 64050331 |
Drug ineffective | 974.72 | 14.19 | 1568 | 305655 | 838679 | 63352830 |
Condition aggravated | 933.72 | 14.19 | 306 | 306917 | 372120 | 63819389 |
Completed suicide | 909.23 | 14.19 | 37 | 307186 | 224377 | 63967132 |
Pulmonary embolism | 896.21 | 14.19 | 2082 | 305141 | 144274 | 64047235 |
Thrombocytopenia | 861.86 | 14.19 | 2681 | 304542 | 221120 | 63970389 |
Pulmonary thrombosis | 721.52 | 14.19 | 509 | 306714 | 10009 | 64181500 |
Haemoglobin decreased | 702.44 | 14.19 | 2284 | 304939 | 192779 | 63998730 |
Rheumatoid arthritis | 672.42 | 14.19 | 25 | 307198 | 164269 | 64027240 |
Human chorionic gonadotropin increased | 646.22 | 14.19 | 218 | 307005 | 668 | 64190841 |
Red blood cell count decreased | 639.64 | 14.19 | 959 | 306264 | 47427 | 64144082 |
Plasmacytoma | 629.09 | 14.19 | 326 | 306897 | 3544 | 64187965 |
Drug abuse | 601.98 | 14.19 | 5 | 307218 | 132369 | 64059140 |
Squamous cell carcinoma of skin | 586.21 | 14.19 | 472 | 306751 | 11404 | 64180105 |
Rash pruritic | 565.81 | 14.19 | 996 | 306227 | 56408 | 64135101 |
Product dose omission issue | 561.39 | 14.19 | 2119 | 305104 | 192628 | 63998881 |
Adverse drug reaction | 559.90 | 14.19 | 872 | 306351 | 44592 | 64146917 |
Overdose | 509.81 | 14.19 | 76 | 307147 | 159490 | 64032019 |
Dehydration | 508.14 | 14.19 | 2212 | 305011 | 214551 | 63976958 |
Drug hypersensitivity | 498.78 | 14.19 | 255 | 306968 | 237560 | 63953949 |
Blood potassium decreased | 490.70 | 14.19 | 770 | 306453 | 39629 | 64151880 |
Asthenia | 481.03 | 14.19 | 3585 | 303638 | 424459 | 63767050 |
Anaemia | 468.37 | 14.19 | 3246 | 303977 | 375434 | 63816075 |
Cytopenia | 456.35 | 14.19 | 460 | 306763 | 15011 | 64176498 |
Myelodysplastic syndrome | 452.24 | 14.19 | 606 | 306617 | 26973 | 64164536 |
Injection site pain | 445.52 | 14.19 | 20 | 307203 | 111388 | 64080121 |
Headache | 432.83 | 14.19 | 1201 | 306022 | 528266 | 63663243 |
Cardiac disorder | 416.03 | 14.19 | 860 | 306363 | 54956 | 64136553 |
Synovitis | 412.64 | 14.19 | 13 | 307210 | 99077 | 64092432 |
Acute myeloid leukaemia | 407.48 | 14.19 | 575 | 306648 | 26888 | 64164621 |
Ageusia | 406.13 | 14.19 | 410 | 306813 | 13403 | 64178106 |
Hip fracture | 395.60 | 14.19 | 563 | 306660 | 26536 | 64164973 |
Arthralgia | 392.71 | 14.19 | 962 | 306261 | 441298 | 63750211 |
Sepsis | 381.93 | 14.19 | 2130 | 305093 | 228211 | 63963298 |
Influenza | 364.67 | 14.19 | 1227 | 305996 | 105304 | 64086205 |
Product use in unapproved indication | 347.49 | 14.19 | 205 | 307018 | 176413 | 64015096 |
Fall | 345.69 | 14.19 | 3262 | 303961 | 413564 | 63777945 |
Plasma cell leukaemia | 339.28 | 14.19 | 160 | 307063 | 1393 | 64190116 |
Renal failure | 334.94 | 14.19 | 1730 | 305493 | 179958 | 64011551 |
Systemic lupus erythematosus | 327.46 | 14.19 | 9 | 307214 | 77603 | 64113906 |
Atrial fibrillation | 322.97 | 14.19 | 1640 | 305583 | 169449 | 64022060 |
Peripheral swelling | 308.84 | 14.19 | 1876 | 305347 | 207277 | 63984232 |
Light chain analysis increased | 305.09 | 14.19 | 141 | 307082 | 1167 | 64190342 |
Exposure during pregnancy | 303.94 | 14.19 | 16 | 307207 | 77659 | 64113850 |
Intentional product misuse | 292.26 | 14.19 | 12 | 307211 | 72283 | 64119226 |
Intentional product use issue | 289.80 | 14.19 | 52 | 307171 | 95312 | 64096197 |
Renal disorder | 285.04 | 14.19 | 563 | 306660 | 34802 | 64156707 |
Suicide attempt | 283.03 | 14.19 | 13 | 307210 | 70994 | 64120515 |
Pain | 281.97 | 14.19 | 1519 | 305704 | 551992 | 63639517 |
Tooth disorder | 280.37 | 14.19 | 433 | 306790 | 21969 | 64169540 |
Blood pressure increased | 270.16 | 14.19 | 254 | 306969 | 172298 | 64019211 |
Disease progression | 265.82 | 14.19 | 1356 | 305867 | 140324 | 64051185 |
Pemphigus | 263.98 | 14.19 | 5 | 307218 | 60696 | 64130813 |
Product use issue | 262.34 | 14.19 | 203 | 307020 | 151512 | 64039997 |
Aspartate aminotransferase increased | 260.71 | 14.19 | 122 | 307101 | 119666 | 64071843 |
Alanine aminotransferase increased | 260.10 | 14.19 | 171 | 307052 | 138860 | 64052649 |
Monoclonal immunoglobulin present | 257.92 | 14.19 | 110 | 307113 | 735 | 64190774 |
Wrong technique in product usage process | 246.23 | 14.19 | 16 | 307207 | 64958 | 64126551 |
Dry skin | 245.56 | 14.19 | 664 | 306559 | 50497 | 64141012 |
Tachycardia | 243.91 | 14.19 | 212 | 307011 | 149367 | 64042142 |
Treatment failure | 243.58 | 14.19 | 126 | 307097 | 116690 | 64074819 |
Urinary tract infection | 242.68 | 14.19 | 1910 | 305313 | 229686 | 63961823 |
Taste disorder | 241.45 | 14.19 | 260 | 306963 | 9173 | 64182336 |
Coma | 239.24 | 14.19 | 61 | 307162 | 87554 | 64103955 |
SARS-CoV-2 test positive | 238.85 | 14.19 | 215 | 307008 | 6071 | 64185438 |
Hypertension | 234.39 | 14.19 | 558 | 306665 | 258703 | 63932806 |
Rhabdomyolysis | 233.51 | 14.19 | 73 | 307150 | 91653 | 64099856 |
Injection site erythema | 230.03 | 14.19 | 32 | 307191 | 70768 | 64120741 |
Therapeutic product effect decreased | 229.48 | 14.19 | 132 | 307091 | 115219 | 64076290 |
Spinal fracture | 228.48 | 14.19 | 320 | 306903 | 14854 | 64176655 |
Psoriasis | 220.25 | 14.19 | 38 | 307185 | 71665 | 64119844 |
Inappropriate schedule of product administration | 220.10 | 14.19 | 82 | 307141 | 92204 | 64099305 |
Acute lymphocytic leukaemia | 218.41 | 14.19 | 175 | 307048 | 4196 | 64187313 |
Depressed level of consciousness | 217.97 | 14.19 | 59 | 307164 | 81377 | 64110132 |
Hospitalisation | 207.97 | 14.19 | 51 | 307172 | 75156 | 64116353 |
Bronchitis | 206.86 | 14.19 | 1045 | 306178 | 107698 | 64083811 |
Therapeutic product effect incomplete | 206.44 | 14.19 | 118 | 307105 | 103364 | 64088145 |
Pruritus | 205.80 | 14.19 | 2334 | 304889 | 310066 | 63881443 |
Mobility decreased | 205.17 | 14.19 | 76 | 307147 | 85764 | 64105745 |
Adenocarcinoma of colon | 204.73 | 14.19 | 177 | 307046 | 4731 | 64186778 |
Basal cell carcinoma | 204.22 | 14.19 | 453 | 306770 | 30385 | 64161124 |
Tumour flare | 199.82 | 14.19 | 90 | 307133 | 697 | 64190812 |
Hyponatraemia | 199.26 | 14.19 | 248 | 306975 | 148091 | 64043418 |
Full blood count abnormal | 199.18 | 14.19 | 439 | 306784 | 29318 | 64162191 |
Abdominal pain | 198.57 | 14.19 | 790 | 306433 | 311585 | 63879924 |
Cerebrovascular accident | 198.41 | 14.19 | 1227 | 305996 | 136356 | 64055153 |
Anxiety | 197.08 | 14.19 | 419 | 306804 | 202230 | 63989279 |
Herpes zoster | 195.07 | 14.19 | 821 | 306402 | 78366 | 64113143 |
Discomfort | 194.33 | 14.19 | 71 | 307152 | 80807 | 64110702 |
Cataract | 192.90 | 14.19 | 610 | 306613 | 50652 | 64140857 |
Hypoglycaemia | 191.83 | 14.19 | 94 | 307129 | 89798 | 64101711 |
Oxygen saturation decreased | 190.90 | 14.19 | 139 | 307084 | 107037 | 64084472 |
Blood creatine phosphokinase increased | 188.98 | 14.19 | 27 | 307196 | 58531 | 64132978 |
Infection | 186.60 | 14.19 | 1512 | 305711 | 183368 | 64008141 |
Skin discolouration | 185.94 | 14.19 | 474 | 306749 | 34781 | 64156728 |
Infusion related reaction | 184.52 | 14.19 | 312 | 306911 | 164155 | 64027354 |
Bradycardia | 182.67 | 14.19 | 176 | 307047 | 118043 | 64073466 |
Suicidal ideation | 182.29 | 14.19 | 46 | 307177 | 66496 | 64125013 |
Anaphylactic reaction | 174.13 | 14.19 | 55 | 307168 | 68609 | 64122900 |
Agitation | 168.90 | 14.19 | 106 | 307117 | 88261 | 64103248 |
Somnolence | 164.26 | 14.19 | 464 | 306759 | 203181 | 63988328 |
Glossodynia | 163.74 | 14.19 | 52 | 307171 | 64644 | 64126865 |
Medication error | 163.69 | 14.19 | 22 | 307201 | 49944 | 64141565 |
Hypoaesthesia | 163.43 | 14.19 | 1179 | 306044 | 137929 | 64053580 |
Sedation | 160.76 | 14.19 | 9 | 307214 | 41453 | 64150056 |
Injection site swelling | 160.26 | 14.19 | 9 | 307214 | 41344 | 64150165 |
Protein total increased | 159.72 | 14.19 | 131 | 307092 | 3250 | 64188259 |
Depression | 158.87 | 14.19 | 403 | 306820 | 182888 | 64008621 |
Blood pressure systolic increased | 156.82 | 14.19 | 24 | 307199 | 49429 | 64142080 |
Injection site bruising | 154.23 | 14.19 | 4 | 307219 | 36369 | 64155140 |
Alopecia | 153.32 | 14.19 | 352 | 306871 | 165338 | 64026171 |
Hyperkalaemia | 152.26 | 14.19 | 154 | 307069 | 100975 | 64090534 |
Metabolic acidosis | 148.69 | 14.19 | 76 | 307147 | 70882 | 64120627 |
Injection site pruritus | 147.31 | 14.19 | 8 | 307215 | 37818 | 64153691 |
C-reactive protein increased | 145.79 | 14.19 | 142 | 307081 | 94767 | 64096742 |
Electrocardiogram QT prolonged | 144.14 | 14.19 | 101 | 307122 | 79347 | 64112162 |
Lactic acidosis | 144.03 | 14.19 | 56 | 307167 | 61354 | 64130155 |
Fibromyalgia | 140.90 | 14.19 | 7 | 307216 | 35724 | 64155785 |
Injection site reaction | 140.54 | 14.19 | 26 | 307197 | 46638 | 64144871 |
Wheezing | 137.73 | 14.19 | 109 | 307114 | 80470 | 64111039 |
Drug level increased | 137.12 | 14.19 | 6 | 307217 | 34190 | 64157319 |
Respiratory arrest | 136.94 | 14.19 | 41 | 307182 | 52944 | 64138565 |
Blood cholesterol increased | 136.38 | 14.19 | 35 | 307188 | 50031 | 64141478 |
Hiccups | 135.67 | 14.19 | 183 | 307040 | 8193 | 64183316 |
Hepatic enzyme increased | 134.52 | 14.19 | 259 | 306964 | 129684 | 64061825 |
Drug withdrawal syndrome | 134.36 | 14.19 | 3 | 307220 | 31288 | 64160221 |
Full blood count increased | 133.72 | 14.19 | 58 | 307165 | 406 | 64191103 |
COVID-19 pneumonia | 133.27 | 14.19 | 263 | 306960 | 16241 | 64175268 |
Pericarditis | 132.42 | 14.19 | 66 | 307157 | 62450 | 64129059 |
Incorrect dose administered | 131.99 | 14.19 | 62 | 307161 | 60703 | 64130806 |
Gout | 131.16 | 14.19 | 305 | 306918 | 21108 | 64170401 |
Helicobacter infection | 127.81 | 14.19 | 16 | 307207 | 38346 | 64153163 |
Emotional distress | 127.77 | 14.19 | 12 | 307211 | 36026 | 64155483 |
Blood pressure fluctuation | 127.22 | 14.19 | 44 | 307179 | 51827 | 64139682 |
Dysgeusia | 127.10 | 14.19 | 502 | 306721 | 46545 | 64144964 |
Wound | 126.30 | 14.19 | 107 | 307116 | 76370 | 64115139 |
Aggression | 120.90 | 14.19 | 35 | 307188 | 46197 | 64145312 |
Acute leukaemia | 120.54 | 14.19 | 82 | 307141 | 1516 | 64189993 |
Loss of personal independence in daily activities | 120.11 | 14.19 | 101 | 307122 | 72353 | 64119156 |
Vomiting | 119.73 | 14.19 | 1876 | 305347 | 549241 | 63642268 |
Decreased appetite | 119.61 | 14.19 | 1943 | 305280 | 279346 | 63912163 |
Blood test abnormal | 114.01 | 14.19 | 214 | 307009 | 12729 | 64178780 |
Product quality issue | 113.90 | 14.19 | 7 | 307216 | 29792 | 64161717 |
Bone pain | 113.84 | 14.19 | 489 | 306734 | 47083 | 64144426 |
Back disorder | 113.82 | 14.19 | 185 | 307038 | 9805 | 64181704 |
Musculoskeletal stiffness | 113.74 | 14.19 | 262 | 306961 | 122944 | 64068565 |
Rib fracture | 113.32 | 14.19 | 310 | 306913 | 23728 | 64167781 |
Stress | 112.41 | 14.19 | 75 | 307148 | 60459 | 64131050 |
Cardio-respiratory arrest | 111.84 | 14.19 | 185 | 307038 | 98208 | 64093301 |
Cardiac failure congestive | 111.79 | 14.19 | 1030 | 306193 | 129550 | 64061959 |
Gallbladder disorder | 111.43 | 14.19 | 249 | 306974 | 16781 | 64174728 |
Migraine | 110.66 | 14.19 | 82 | 307141 | 62595 | 64128914 |
Upper limb fracture | 110.63 | 14.19 | 229 | 306994 | 14637 | 64176872 |
Product prescribing error | 109.83 | 14.19 | 18 | 307205 | 35251 | 64156258 |
Dysarthria | 109.78 | 14.19 | 74 | 307149 | 59332 | 64132177 |
Ascites | 109.62 | 14.19 | 81 | 307142 | 61920 | 64129589 |
Inflammation | 109.51 | 14.19 | 90 | 307133 | 65210 | 64126299 |
Erythema | 108.30 | 14.19 | 490 | 306733 | 186580 | 64004929 |
Gamma-glutamyltransferase increased | 107.69 | 14.19 | 48 | 307175 | 48462 | 64143047 |
Hypercalcaemia | 107.51 | 14.19 | 362 | 306861 | 31054 | 64160455 |
Knee arthroplasty | 107.39 | 14.19 | 5 | 307218 | 26994 | 64164515 |
Injury | 107.21 | 14.19 | 67 | 307156 | 55925 | 64135584 |
Interstitial lung disease | 107.18 | 14.19 | 188 | 307035 | 97544 | 64093965 |
Malignant neoplasm of unknown primary site | 106.46 | 14.19 | 56 | 307167 | 629 | 64190880 |
Drug ineffective for unapproved indication | 106.15 | 14.19 | 12 | 307211 | 31121 | 64160388 |
Pathological fracture | 105.65 | 14.19 | 169 | 307054 | 8836 | 64182673 |
Osteoarthritis | 105.34 | 14.19 | 88 | 307135 | 63248 | 64128261 |
Cardiac amyloidosis | 105.29 | 14.19 | 72 | 307151 | 1343 | 64190166 |
Spinal compression fracture | 104.60 | 14.19 | 223 | 307000 | 14552 | 64176957 |
Multiple allergies | 103.41 | 14.19 | 133 | 307090 | 5681 | 64185828 |
Malignant melanoma | 102.77 | 14.19 | 205 | 307018 | 12759 | 64178750 |
Swelling face | 102.39 | 14.19 | 554 | 306669 | 58612 | 64132897 |
Seizure | 100.93 | 14.19 | 430 | 306793 | 166462 | 64025047 |
Clostridium difficile infection | 99.40 | 14.19 | 388 | 306835 | 35775 | 64155734 |
Abortion spontaneous | 98.90 | 14.19 | 5 | 307218 | 25138 | 64166371 |
Palpitations | 97.41 | 14.19 | 221 | 307002 | 104267 | 64087242 |
Pallor | 96.66 | 14.19 | 32 | 307191 | 38749 | 64152760 |
International normalised ratio increased | 96.50 | 14.19 | 142 | 307081 | 79025 | 64112484 |
Blood alkaline phosphatase increased | 96.33 | 14.19 | 76 | 307147 | 56203 | 64135306 |
Anaphylactic shock | 95.51 | 14.19 | 15 | 307208 | 30313 | 64161196 |
Bone lesion | 95.30 | 14.19 | 120 | 307103 | 5017 | 64186492 |
Hallucination, visual | 94.22 | 14.19 | 11 | 307212 | 27823 | 64163686 |
Hordeolum | 94.12 | 14.19 | 81 | 307142 | 2151 | 64189358 |
Hepatocellular injury | 93.94 | 14.19 | 49 | 307174 | 45186 | 64146323 |
Muscle injury | 93.20 | 14.19 | 9 | 307214 | 26428 | 64165081 |
Underdose | 93.19 | 14.19 | 8 | 307215 | 25821 | 64165688 |
Flushing | 93.03 | 14.19 | 144 | 307079 | 78504 | 64113005 |
Myoclonus | 92.79 | 14.19 | 7 | 307216 | 25111 | 64166398 |
Drug-induced liver injury | 92.62 | 14.19 | 56 | 307167 | 47587 | 64143922 |
Generalised tonic-clonic seizure | 92.38 | 14.19 | 37 | 307186 | 39820 | 64151689 |
Abnormal behaviour | 90.63 | 14.19 | 24 | 307199 | 33598 | 64157911 |
Cellulitis | 90.10 | 14.19 | 758 | 306465 | 92899 | 64098610 |
Impaired healing | 88.85 | 14.19 | 94 | 307129 | 60379 | 64131130 |
Surgery | 88.75 | 14.19 | 14 | 307209 | 28199 | 64163310 |
Withdrawal syndrome | 88.36 | 14.19 | 6 | 307217 | 23486 | 64168023 |
Folliculitis | 87.95 | 14.19 | 18 | 307205 | 30059 | 64161450 |
Weight increased | 87.18 | 14.19 | 626 | 306597 | 212722 | 63978787 |
Osteolysis | 85.70 | 14.19 | 85 | 307138 | 2718 | 64188791 |
Leukaemia | 85.22 | 14.19 | 113 | 307110 | 4975 | 64186534 |
Depressed mood | 84.32 | 14.19 | 45 | 307178 | 40967 | 64150542 |
Injection site haemorrhage | 83.68 | 14.19 | 9 | 307214 | 24269 | 64167240 |
Dyskinesia | 82.79 | 14.19 | 42 | 307181 | 39346 | 64152163 |
Pyrexia | 82.69 | 14.19 | 3348 | 303875 | 555296 | 63636213 |
Upper respiratory tract infection | 82.60 | 14.19 | 612 | 306611 | 72173 | 64119336 |
Respiratory depression | 82.59 | 14.19 | 8 | 307215 | 23435 | 64168074 |
Incorrect route of product administration | 81.95 | 14.19 | 8 | 307215 | 23290 | 64168219 |
Pneumonia influenzal | 81.81 | 14.19 | 79 | 307144 | 2443 | 64189066 |
Pregnancy test false positive | 80.45 | 14.19 | 27 | 307196 | 81 | 64191428 |
Extrapyramidal disorder | 79.84 | 14.19 | 3 | 307220 | 19549 | 64171960 |
Melaena | 78.93 | 14.19 | 83 | 307140 | 53465 | 64138044 |
Chest discomfort | 78.56 | 14.19 | 286 | 306937 | 115820 | 64075689 |
Gait disturbance | 77.88 | 14.19 | 490 | 306733 | 171665 | 64019844 |
Diabetic ketoacidosis | 77.29 | 14.19 | 23 | 307200 | 29822 | 64161687 |
Hepatitis | 76.21 | 14.19 | 63 | 307160 | 45519 | 64145990 |
Hip arthroplasty | 75.98 | 14.19 | 7 | 307216 | 21344 | 64170165 |
Blood magnesium decreased | 75.44 | 14.19 | 189 | 307034 | 13716 | 64177793 |
Type 2 diabetes mellitus | 74.98 | 14.19 | 34 | 307189 | 33986 | 64157523 |
Malignant melanoma in situ | 74.63 | 14.19 | 65 | 307158 | 1755 | 64189754 |
Accidental exposure to product | 74.60 | 14.19 | 17 | 307206 | 26347 | 64165162 |
Compression fracture | 74.52 | 14.19 | 113 | 307110 | 5639 | 64185870 |
Obstructive airways disorder | 74.08 | 14.19 | 11 | 307212 | 23174 | 64168335 |
White blood cell count increased | 73.27 | 14.19 | 126 | 307097 | 65888 | 64125621 |
Body temperature decreased | 72.81 | 14.19 | 17 | 307206 | 25911 | 64165598 |
Renal impairment | 72.76 | 14.19 | 972 | 306251 | 134045 | 64057464 |
Myelodysplastic syndrome transformation | 72.69 | 14.19 | 43 | 307180 | 616 | 64190893 |
Dementia | 72.57 | 14.19 | 241 | 306982 | 20525 | 64170984 |
Localised infection | 72.13 | 14.19 | 310 | 306913 | 29851 | 64161658 |
Arthritis | 72.00 | 14.19 | 185 | 307038 | 83629 | 64107880 |
Transaminases increased | 71.67 | 14.19 | 64 | 307159 | 44530 | 64146979 |
General physical health deterioration | 71.37 | 14.19 | 626 | 306597 | 203799 | 63987710 |
Back pain | 71.30 | 14.19 | 1626 | 305597 | 248545 | 63942964 |
Unresponsive to stimuli | 71.08 | 14.19 | 81 | 307142 | 50312 | 64141197 |
Hepatotoxicity | 70.90 | 14.19 | 52 | 307171 | 39910 | 64151599 |
Pulmonary arterial hypertension | 70.51 | 14.19 | 17 | 307206 | 25350 | 64166159 |
Angioedema | 70.46 | 14.19 | 116 | 307107 | 61705 | 64129804 |
Dystonia | 70.43 | 14.19 | 5 | 307218 | 18860 | 64172649 |
Blood pressure diastolic decreased | 70.30 | 14.19 | 11 | 307212 | 22290 | 64169219 |
Muscle rigidity | 70.27 | 14.19 | 3 | 307220 | 17470 | 64174039 |
Device dislocation | 70.14 | 14.19 | 9 | 307214 | 21169 | 64170340 |
Diverticulitis | 69.12 | 14.19 | 365 | 306858 | 38253 | 64153256 |
Prescribed overdose | 68.91 | 14.19 | 8 | 307215 | 20323 | 64171186 |
Tumour lysis syndrome | 68.28 | 14.19 | 226 | 306997 | 19214 | 64172295 |
Fear | 68.21 | 14.19 | 8 | 307215 | 20163 | 64171346 |
Psychotic disorder | 68.12 | 14.19 | 40 | 307183 | 34538 | 64156971 |
Spinal disorder | 68.03 | 14.19 | 137 | 307086 | 8585 | 64182924 |
Obesity | 67.47 | 14.19 | 9 | 307214 | 20553 | 64170956 |
Hepatic steatosis | 66.78 | 14.19 | 32 | 307191 | 30975 | 64160534 |
Neutrophil count increased | 65.92 | 14.19 | 19 | 307204 | 25155 | 64166354 |
Hypersensitivity | 65.77 | 14.19 | 608 | 306615 | 195844 | 63995665 |
Musculoskeletal pain | 65.64 | 14.19 | 185 | 307038 | 81109 | 64110400 |
Status epilepticus | 65.38 | 14.19 | 12 | 307211 | 21651 | 64169858 |
Intraductal proliferative breast lesion | 65.34 | 14.19 | 65 | 307158 | 2086 | 64189423 |
Cholestasis | 64.52 | 14.19 | 71 | 307152 | 44801 | 64146708 |
Ill-defined disorder | 64.12 | 14.19 | 69 | 307154 | 43983 | 64147526 |
Immune system disorder | 63.60 | 14.19 | 137 | 307086 | 9004 | 64182505 |
Product administration error | 63.51 | 14.19 | 26 | 307197 | 27617 | 64163892 |
Rectal adenocarcinoma | 63.36 | 14.19 | 52 | 307171 | 1291 | 64190218 |
Hyperviscosity syndrome | 63.11 | 14.19 | 32 | 307191 | 331 | 64191178 |
Osteonecrosis of jaw | 62.98 | 14.19 | 364 | 306859 | 39461 | 64152048 |
Refractory cytopenia with multilineage dysplasia | 62.54 | 14.19 | 29 | 307194 | 242 | 64191267 |
Sinus tachycardia | 62.33 | 14.19 | 38 | 307185 | 32150 | 64159359 |
Joint range of motion decreased | 62.21 | 14.19 | 9 | 307214 | 19334 | 64172175 |
Leukocytosis | 62.06 | 14.19 | 53 | 307170 | 37687 | 64153822 |
Hypogeusia | 62.03 | 14.19 | 54 | 307169 | 1457 | 64190052 |
Blood bilirubin increased | 61.93 | 14.19 | 112 | 307111 | 57441 | 64134068 |
Palmar-plantar erythrodysaesthesia syndrome | 61.67 | 14.19 | 30 | 307193 | 28789 | 64162720 |
Liver injury | 61.30 | 14.19 | 33 | 307190 | 29899 | 64161610 |
Amyloidosis | 60.79 | 14.19 | 67 | 307156 | 2427 | 64189082 |
Refractory anaemia with an excess of blasts | 60.48 | 14.19 | 42 | 307181 | 804 | 64190705 |
Asthma | 60.25 | 14.19 | 241 | 306982 | 94984 | 64096525 |
Blood urea increased | 60.10 | 14.19 | 73 | 307150 | 44080 | 64147429 |
B precursor type acute leukaemia | 59.82 | 14.19 | 29 | 307194 | 270 | 64191239 |
Monoclonal immunoglobulin increased | 59.82 | 14.19 | 19 | 307204 | 45 | 64191464 |
Accidental overdose | 59.10 | 14.19 | 44 | 307179 | 33513 | 64157996 |
Oedema peripheral | 58.98 | 14.19 | 1364 | 305859 | 208953 | 63982556 |
Coagulopathy | 58.65 | 14.19 | 40 | 307183 | 31880 | 64159629 |
Transient ischaemic attack | 58.64 | 14.19 | 386 | 306837 | 43796 | 64147713 |
Transplant rejection | 58.59 | 14.19 | 7 | 307216 | 17394 | 64174115 |
Heart rate increased | 58.55 | 14.19 | 256 | 306967 | 98419 | 64093090 |
Multiple sclerosis | 58.23 | 14.19 | 10 | 307213 | 18931 | 64172578 |
Drug resistance | 58.08 | 14.19 | 49 | 307174 | 35053 | 64156456 |
Osteoporosis | 57.88 | 14.19 | 69 | 307154 | 42011 | 64149498 |
Hypercholesterolaemia | 57.60 | 14.19 | 4 | 307219 | 15369 | 64176140 |
Haematemesis | 57.56 | 14.19 | 84 | 307139 | 46915 | 64144594 |
Colitis ulcerative | 57.39 | 14.19 | 19 | 307204 | 23009 | 64168500 |
Clostridium difficile colitis | 57.00 | 14.19 | 269 | 306954 | 26954 | 64164555 |
Crying | 56.75 | 14.19 | 13 | 307210 | 20077 | 64171432 |
Liver function test abnormal | 56.69 | 14.19 | 124 | 307099 | 59277 | 64132232 |
Prostate cancer | 56.53 | 14.19 | 215 | 307008 | 19580 | 64171929 |
Pregnancy | 56.03 | 14.19 | 15 | 307208 | 20850 | 64170659 |
Viral infection | 55.64 | 14.19 | 328 | 306895 | 35812 | 64155697 |
Fracture | 55.47 | 14.19 | 206 | 307017 | 18549 | 64172960 |
Toxic epidermal necrolysis | 55.46 | 14.19 | 57 | 307166 | 37109 | 64154400 |
Lung adenocarcinoma | 55.30 | 14.19 | 109 | 307114 | 6724 | 64184785 |
Encephalopathy | 55.14 | 14.19 | 124 | 307099 | 58695 | 64132814 |
Irritable bowel syndrome | 54.98 | 14.19 | 58 | 307165 | 37311 | 64154198 |
Hallucination | 54.89 | 14.19 | 171 | 307052 | 72617 | 64118892 |
Blood immunoglobulin G increased | 54.76 | 14.19 | 55 | 307168 | 1786 | 64189723 |
Shock | 54.44 | 14.19 | 61 | 307162 | 38179 | 64153330 |
Prescribed underdose | 54.32 | 14.19 | 10 | 307213 | 18005 | 64173504 |
Delusion | 54.32 | 14.19 | 10 | 307213 | 18004 | 64173505 |
Respiratory syncytial virus infection | 54.13 | 14.19 | 112 | 307111 | 7156 | 64184353 |
Sleep apnoea syndrome | 54.00 | 14.19 | 38 | 307185 | 29794 | 64161715 |
Torsade de pointes | 53.75 | 14.19 | 9 | 307214 | 17354 | 64174155 |
Gastric disorder | 53.65 | 14.19 | 278 | 306945 | 28919 | 64162590 |
Sleep disorder | 53.46 | 14.19 | 129 | 307094 | 59580 | 64131929 |
Body height decreased | 53.46 | 14.19 | 114 | 307109 | 7440 | 64184069 |
Right ventricular failure | 53.01 | 14.19 | 18 | 307205 | 21453 | 64170056 |
Pulmonary hypertension | 52.93 | 14.19 | 77 | 307146 | 43062 | 64148447 |
Hypokinesia | 52.73 | 14.19 | 8 | 307215 | 16588 | 64174921 |
Device malfunction | 52.72 | 14.19 | 10 | 307213 | 17623 | 64173886 |
Delirium | 52.57 | 14.19 | 162 | 307061 | 69032 | 64122477 |
Metastases to bone | 52.46 | 14.19 | 16 | 307207 | 20419 | 64171090 |
Skin exfoliation | 52.40 | 14.19 | 380 | 306843 | 44505 | 64147004 |
Cyanosis | 52.28 | 14.19 | 20 | 307203 | 22135 | 64169374 |
Gastrooesophageal reflux disease | 52.23 | 14.19 | 211 | 307012 | 82932 | 64108577 |
Injection site warmth | 51.94 | 14.19 | 3 | 307220 | 13459 | 64178050 |
Jaundice | 51.66 | 14.19 | 95 | 307128 | 48417 | 64143092 |
Sputum discoloured | 51.56 | 14.19 | 11 | 307212 | 17845 | 64173664 |
Impaired work ability | 51.55 | 14.19 | 6 | 307217 | 15213 | 64176296 |
Hemiparesis | 51.39 | 14.19 | 40 | 307183 | 29787 | 64161722 |
Lactose intolerance | 50.60 | 14.19 | 55 | 307168 | 1961 | 64189548 |
Parkinsonism | 50.38 | 14.19 | 5 | 307218 | 14368 | 64177141 |
Acute kidney injury | 50.38 | 14.19 | 1694 | 305529 | 447546 | 63743963 |
Upper gastrointestinal haemorrhage | 50.34 | 14.19 | 56 | 307167 | 35164 | 64156345 |
Invasive ductal breast carcinoma | 50.30 | 14.19 | 88 | 307135 | 4954 | 64186555 |
Hypothermia | 50.16 | 14.19 | 16 | 307207 | 19840 | 64171669 |
Seasonal allergy | 50.15 | 14.19 | 146 | 307077 | 11580 | 64179929 |
Hepatic failure | 50.13 | 14.19 | 119 | 307104 | 55275 | 64136234 |
Anhedonia | 50.12 | 14.19 | 4 | 307219 | 13702 | 64177807 |
Mucosal inflammation | 50.10 | 14.19 | 143 | 307080 | 62441 | 64129068 |
Pemphigoid | 49.78 | 14.19 | 3 | 307220 | 12983 | 64178526 |
Myositis | 49.58 | 14.19 | 9 | 307214 | 16368 | 64175141 |
Epilepsy | 49.38 | 14.19 | 52 | 307171 | 33479 | 64158030 |
Blood electrolytes decreased | 49.33 | 14.19 | 44 | 307179 | 1227 | 64190282 |
Atrial flutter | 49.30 | 14.19 | 203 | 307020 | 19177 | 64172332 |
Respiratory tract infection | 49.15 | 14.19 | 326 | 306897 | 37081 | 64154428 |
Agranulocytosis | 49.14 | 14.19 | 66 | 307157 | 38163 | 64153346 |
Hyperlipidaemia | 49.04 | 14.19 | 24 | 307199 | 22952 | 64168557 |
Tubulointerstitial nephritis | 48.91 | 14.19 | 45 | 307178 | 30864 | 64160645 |
Speech disorder | 48.85 | 14.19 | 98 | 307125 | 48343 | 64143166 |
Haematuria | 48.53 | 14.19 | 138 | 307085 | 60333 | 64131176 |
Hepatic encephalopathy | 48.10 | 14.19 | 20 | 307203 | 21046 | 64170463 |
Procedural pain | 48.09 | 14.19 | 8 | 307215 | 15500 | 64176009 |
Therapeutic response unexpected | 48.03 | 14.19 | 11 | 307212 | 16990 | 64174519 |
Blood triglycerides increased | 48.02 | 14.19 | 15 | 307208 | 18851 | 64172658 |
Tachypnoea | 47.89 | 14.19 | 34 | 307189 | 26537 | 64164972 |
Respiratory rate increased | 47.70 | 14.19 | 14 | 307209 | 18317 | 64173192 |
Acute hepatic failure | 47.61 | 14.19 | 33 | 307190 | 26079 | 64165430 |
Pelvic fracture | 47.59 | 14.19 | 134 | 307089 | 10429 | 64181080 |
Pancreatitis acute | 47.37 | 14.19 | 82 | 307141 | 42773 | 64148736 |
Skin cancer | 47.34 | 14.19 | 145 | 307078 | 11829 | 64179680 |
Blood calcium increased | 47.28 | 14.19 | 117 | 307106 | 8425 | 64183084 |
Metastases to liver | 46.73 | 14.19 | 28 | 307195 | 23913 | 64167596 |
Ventricular fibrillation | 46.44 | 14.19 | 28 | 307195 | 23832 | 64167677 |
Transformation to acute myeloid leukaemia | 46.30 | 14.19 | 36 | 307187 | 825 | 64190684 |
Plasma cell myeloma refractory | 46.19 | 14.19 | 18 | 307205 | 92 | 64191417 |
Glycosylated haemoglobin increased | 45.99 | 14.19 | 10 | 307213 | 16009 | 64175500 |
Myalgia | 45.99 | 14.19 | 508 | 306715 | 158109 | 64033400 |
Restlessness | 45.94 | 14.19 | 74 | 307149 | 39711 | 64151798 |
Cardiogenic shock | 45.86 | 14.19 | 52 | 307171 | 32375 | 64159134 |
Metastases to lung | 44.91 | 14.19 | 9 | 307214 | 15255 | 64176254 |
Myocardial infarction | 44.80 | 14.19 | 1070 | 306153 | 164751 | 64026758 |
Circulatory collapse | 44.62 | 14.19 | 57 | 307166 | 33675 | 64157834 |
Chondrocalcinosis pyrophosphate | 44.59 | 14.19 | 47 | 307176 | 1617 | 64189892 |
Post procedural complication | 44.53 | 14.19 | 23 | 307200 | 21330 | 64170179 |
Poor venous access | 44.38 | 14.19 | 4 | 307219 | 12413 | 64179096 |
Proteinuria | 44.29 | 14.19 | 40 | 307183 | 27683 | 64163826 |
Altered state of consciousness | 44.24 | 14.19 | 70 | 307153 | 37832 | 64153677 |
Eye swelling | 43.64 | 14.19 | 216 | 307007 | 22065 | 64169444 |
Iron deficiency anaemia | 43.57 | 14.19 | 25 | 307198 | 21864 | 64169645 |
Adenocarcinoma pancreas | 43.39 | 14.19 | 49 | 307174 | 1824 | 64189685 |
Coronavirus infection | 43.29 | 14.19 | 87 | 307136 | 5443 | 64186066 |
B-cell type acute leukaemia | 43.22 | 14.19 | 27 | 307196 | 429 | 64191080 |
Bladder transitional cell carcinoma | 42.54 | 14.19 | 54 | 307169 | 2276 | 64189233 |
Colon cancer | 42.01 | 14.19 | 145 | 307078 | 12594 | 64178915 |
Tenosynovitis | 41.79 | 14.19 | 4 | 307219 | 11829 | 64179680 |
Injection site urticaria | 41.63 | 14.19 | 3 | 307220 | 11178 | 64180331 |
Gastrointestinal haemorrhage | 41.50 | 14.19 | 416 | 306807 | 131896 | 64059613 |
Bone marrow failure | 41.37 | 14.19 | 379 | 306844 | 47573 | 64143936 |
Treatment noncompliance | 41.30 | 14.19 | 91 | 307132 | 43391 | 64148118 |
White blood cell count abnormal | 41.19 | 14.19 | 79 | 307144 | 4775 | 64186734 |
Rash macular | 41.11 | 14.19 | 222 | 307001 | 23463 | 64168046 |
Skin necrosis | 41.02 | 14.19 | 9 | 307214 | 14320 | 64177189 |
Adenocarcinoma gastric | 40.88 | 14.19 | 44 | 307179 | 1551 | 64189958 |
Nasopharyngitis | 40.86 | 14.19 | 1223 | 306000 | 194850 | 63996659 |
Paraesthesia | 40.69 | 14.19 | 882 | 306341 | 133640 | 64057869 |
Disturbance in attention | 40.65 | 14.19 | 84 | 307139 | 40990 | 64150519 |
Eczema | 40.59 | 14.19 | 49 | 307174 | 29671 | 64161838 |
Visceral leishmaniasis | 40.59 | 14.19 | 35 | 307188 | 932 | 64190577 |
Hallucination, auditory | 40.45 | 14.19 | 15 | 307208 | 16924 | 64174585 |
Spinal cord compression | 40.28 | 14.19 | 86 | 307137 | 5617 | 64185892 |
Paranoia | 39.87 | 14.19 | 14 | 307209 | 16338 | 64175171 |
Neurotoxicity | 39.80 | 14.19 | 43 | 307180 | 27361 | 64164148 |
Dyspnoea exertional | 39.76 | 14.19 | 198 | 307025 | 73532 | 64117977 |
Coordination abnormal | 39.73 | 14.19 | 11 | 307212 | 14953 | 64176556 |
Transfusion | 39.63 | 14.19 | 18 | 307205 | 17976 | 64173533 |
Light chain analysis abnormal | 39.31 | 14.19 | 17 | 307206 | 118 | 64191391 |
Blood loss anaemia | 39.22 | 14.19 | 9 | 307214 | 13883 | 64177626 |
Rales | 38.96 | 14.19 | 12 | 307211 | 15217 | 64176292 |
Schizophrenia | 38.85 | 14.19 | 4 | 307219 | 11164 | 64180345 |
Panic attack | 38.84 | 14.19 | 26 | 307197 | 20927 | 64170582 |
Brain oedema | 38.80 | 14.19 | 29 | 307194 | 22046 | 64169463 |
Diabetes mellitus inadequate control | 38.80 | 14.19 | 27 | 307196 | 21294 | 64170215 |
Hypoxia | 38.76 | 14.19 | 253 | 306970 | 87896 | 64103613 |
Anuria | 38.70 | 14.19 | 21 | 307202 | 18943 | 64172566 |
Uveitis | 38.44 | 14.19 | 7 | 307216 | 12701 | 64178808 |
Ventricular tachycardia | 38.39 | 14.19 | 65 | 307158 | 34200 | 64157309 |
Disability | 38.37 | 14.19 | 6 | 307217 | 12166 | 64179343 |
Arteriosclerosis coronary artery | 38.37 | 14.19 | 13 | 307210 | 15516 | 64175993 |
Gastritis | 38.21 | 14.19 | 92 | 307131 | 42526 | 64148983 |
Eye infection | 38.21 | 14.19 | 114 | 307109 | 9167 | 64182342 |
Infusion site pain | 38.12 | 14.19 | 3 | 307220 | 10394 | 64181115 |
Hepatic function abnormal | 38.05 | 14.19 | 167 | 307056 | 64146 | 64127363 |
Lentigo maligna | 37.86 | 14.19 | 25 | 307198 | 439 | 64191070 |
Haemodynamic instability | 37.70 | 14.19 | 12 | 307211 | 14900 | 64176609 |
Hypothyroidism | 37.34 | 14.19 | 86 | 307137 | 40371 | 64151138 |
Cervical vertebral fracture | 37.00 | 14.19 | 59 | 307164 | 3076 | 64188433 |
Blister | 36.82 | 14.19 | 230 | 306993 | 80737 | 64110772 |
Basosquamous carcinoma of skin | 36.63 | 14.19 | 10 | 307213 | 10 | 64191499 |
Joint stiffness | 36.59 | 14.19 | 55 | 307168 | 30349 | 64161160 |
Failure to thrive | 36.58 | 14.19 | 121 | 307102 | 10283 | 64181226 |
Confusional state | 36.37 | 14.19 | 956 | 306267 | 260188 | 63931321 |
Productive cough | 35.90 | 14.19 | 203 | 307020 | 73000 | 64118509 |
Injection site rash | 35.85 | 14.19 | 15 | 307208 | 15727 | 64175782 |
Concomitant disease aggravated | 35.69 | 14.19 | 6 | 307217 | 11536 | 64179973 |
Posterior reversible encephalopathy syndrome | 35.60 | 14.19 | 34 | 307189 | 22912 | 64168597 |
Lower respiratory tract infection | 35.58 | 14.19 | 284 | 306939 | 94330 | 64097179 |
Haematoma | 35.33 | 14.19 | 108 | 307115 | 46142 | 64145367 |
Prostatic disorder | 35.26 | 14.19 | 42 | 307181 | 1657 | 64189852 |
Middle insomnia | 35.07 | 14.19 | 9 | 307214 | 12868 | 64178641 |
Mitral valve incompetence | 34.99 | 14.19 | 42 | 307181 | 25496 | 64166013 |
Motor dysfunction | 34.97 | 14.19 | 6 | 307217 | 11367 | 64180142 |
Hernia | 34.70 | 14.19 | 142 | 307081 | 13376 | 64178133 |
Primary amyloidosis | 34.58 | 14.19 | 15 | 307208 | 105 | 64191404 |
Therapy non-responder | 34.48 | 14.19 | 472 | 306751 | 65427 | 64126082 |
Colon cancer metastatic | 34.21 | 14.19 | 44 | 307179 | 1879 | 64189630 |
Hepatic cirrhosis | 34.21 | 14.19 | 45 | 307178 | 26253 | 64165256 |
Pulmonary fibrosis | 34.10 | 14.19 | 56 | 307167 | 29822 | 64161687 |
Hepatitis cholestatic | 34.07 | 14.19 | 8 | 307215 | 12147 | 64179362 |
Irritability | 34.00 | 14.19 | 78 | 307145 | 36668 | 64154841 |
Tendonitis | 33.94 | 14.19 | 28 | 307195 | 20254 | 64171255 |
Ovarian cyst | 33.47 | 14.19 | 6 | 307217 | 11012 | 64180497 |
Neuralgia | 33.09 | 14.19 | 226 | 306997 | 25958 | 64165551 |
Red cell distribution width increased | 32.77 | 14.19 | 9 | 307214 | 12300 | 64179209 |
Blood pressure decreased | 32.75 | 14.19 | 258 | 306965 | 85941 | 64105568 |
Food poisoning | 32.51 | 14.19 | 59 | 307164 | 3419 | 64188090 |
Cardiac arrest | 32.43 | 14.19 | 527 | 306696 | 153537 | 64037972 |
Cardiomegaly | 32.40 | 14.19 | 39 | 307184 | 23645 | 64167864 |
Joint swelling | 32.26 | 14.19 | 780 | 306443 | 214602 | 63976907 |
Nystagmus | 32.19 | 14.19 | 3 | 307220 | 9065 | 64182444 |
Dysphagia | 32.19 | 14.19 | 339 | 306884 | 106473 | 64085036 |
Pancreatitis | 32.18 | 14.19 | 160 | 307063 | 59447 | 64132062 |
Pregnancy of partner | 32.08 | 14.19 | 18 | 307205 | 232 | 64191277 |
Clavicle fracture | 31.80 | 14.19 | 61 | 307162 | 3688 | 64187821 |
Endometrial adenocarcinoma | 31.76 | 14.19 | 30 | 307193 | 902 | 64190607 |
Oliguria | 31.45 | 14.19 | 15 | 307208 | 14561 | 64176948 |
Anger | 31.30 | 14.19 | 18 | 307205 | 15723 | 64175786 |
Activated partial thromboplastin time prolonged | 31.26 | 14.19 | 11 | 307212 | 12820 | 64178689 |
Blood calcium abnormal | 31.10 | 14.19 | 34 | 307189 | 1220 | 64190289 |
Coronary artery disease | 31.06 | 14.19 | 165 | 307058 | 60268 | 64131241 |
Hypomagnesaemia | 30.95 | 14.19 | 84 | 307139 | 37292 | 64154217 |
Shock haemorrhagic | 30.90 | 14.19 | 21 | 307202 | 16770 | 64174739 |
Lipase increased | 30.80 | 14.19 | 15 | 307208 | 14387 | 64177122 |
Metastases to lymph nodes | 30.64 | 14.19 | 3 | 307220 | 8714 | 64182795 |
Aplastic anaemia | 30.54 | 14.19 | 14 | 307209 | 13906 | 64177603 |
Electrocardiogram abnormal | 30.45 | 14.19 | 13 | 307210 | 13468 | 64178041 |
Dyslipidaemia | 30.43 | 14.19 | 4 | 307219 | 9238 | 64182271 |
Hypotonia | 30.22 | 14.19 | 8 | 307215 | 11204 | 64180305 |
Aphasia | 30.20 | 14.19 | 97 | 307126 | 40809 | 64150700 |
Tardive dyskinesia | 30.15 | 14.19 | 4 | 307219 | 9174 | 64182335 |
Blood lactate dehydrogenase increased | 29.98 | 14.19 | 71 | 307152 | 33007 | 64158502 |
Respiratory distress | 29.69 | 14.19 | 138 | 307085 | 52193 | 64139316 |
Heparin-induced thrombocytopenia | 29.59 | 14.19 | 3 | 307220 | 8476 | 64183033 |
Autoimmune hepatitis | 29.56 | 14.19 | 6 | 307217 | 10078 | 64181431 |
Squamous cell carcinoma of lung | 29.55 | 14.19 | 42 | 307181 | 1976 | 64189533 |
Hepatic cytolysis | 29.49 | 14.19 | 15 | 307208 | 14034 | 64177475 |
Inflammatory marker increased | 29.47 | 14.19 | 3 | 307220 | 8448 | 64183061 |
Traumatic fracture | 29.33 | 14.19 | 27 | 307196 | 785 | 64190724 |
Pneumonia viral | 29.33 | 14.19 | 93 | 307130 | 7729 | 64183780 |
Hyperthyroidism | 29.32 | 14.19 | 26 | 307197 | 18153 | 64173356 |
Flatulence | 29.31 | 14.19 | 279 | 306944 | 35387 | 64156122 |
Venoocclusive liver disease | 29.27 | 14.19 | 6 | 307217 | 10009 | 64181500 |
Acidosis | 29.24 | 14.19 | 25 | 307198 | 17770 | 64173739 |
Performance status decreased | 29.19 | 14.19 | 73 | 307150 | 5291 | 64186218 |
Injection site induration | 29.09 | 14.19 | 4 | 307219 | 8928 | 64182581 |
Angina unstable | 28.93 | 14.19 | 19 | 307204 | 15448 | 64176061 |
Blood lactic acid increased | 28.85 | 14.19 | 7 | 307216 | 10394 | 64181115 |
Bradyphrenia | 28.84 | 14.19 | 5 | 307218 | 9401 | 64182108 |
Dysphonia | 28.84 | 14.19 | 343 | 306880 | 46039 | 64145470 |
Throat tightness | 28.74 | 14.19 | 41 | 307182 | 23119 | 64168390 |
Foot deformity | 28.60 | 14.19 | 22 | 307201 | 16482 | 64175027 |
Scar | 28.58 | 14.19 | 14 | 307209 | 13384 | 64178125 |
Toxic encephalopathy | 28.44 | 14.19 | 6 | 307217 | 9809 | 64181700 |
Septic shock | 28.35 | 14.19 | 680 | 306543 | 104757 | 64086752 |
Heavy menstrual bleeding | 28.33 | 14.19 | 11 | 307212 | 12066 | 64179443 |
Squamous cell carcinoma | 28.27 | 14.19 | 136 | 307087 | 13733 | 64177776 |
Ejection fraction decreased | 28.16 | 14.19 | 59 | 307164 | 28648 | 64162861 |
Squamous cell carcinoma of the hypopharynx | 27.95 | 14.19 | 8 | 307215 | 11 | 64191498 |
Weight decreased | 27.69 | 14.19 | 1644 | 305579 | 284095 | 63907414 |
Orthopnoea | 27.69 | 14.19 | 5 | 307218 | 9129 | 64182380 |
Left ventricular dysfunction | 27.64 | 14.19 | 24 | 307199 | 16930 | 64174579 |
Blood immunoglobulin A increased | 27.47 | 14.19 | 22 | 307201 | 527 | 64190982 |
Renal injury | 27.47 | 14.19 | 20 | 307203 | 15409 | 64176100 |
Febrile neutropenia | 27.46 | 14.19 | 1124 | 306099 | 186533 | 64004976 |
Gastric ulcer | 27.31 | 14.19 | 65 | 307158 | 30169 | 64161340 |
Peritonitis bacterial | 27.31 | 14.19 | 5 | 307218 | 9038 | 64182471 |
Disorientation | 27.28 | 14.19 | 155 | 307068 | 55673 | 64135836 |
Brain injury | 27.07 | 14.19 | 7 | 307216 | 9958 | 64181551 |
Lower limb fracture | 27.02 | 14.19 | 132 | 307091 | 13413 | 64178096 |
Grip strength decreased | 26.98 | 14.19 | 11 | 307212 | 11713 | 64179796 |
Haemodialysis | 26.85 | 14.19 | 25 | 307198 | 17052 | 64174457 |
Increased tendency to bruise | 26.82 | 14.19 | 101 | 307122 | 9154 | 64182355 |
Human chorionic gonadotropin abnormal | 26.79 | 14.19 | 8 | 307215 | 14 | 64191495 |
Pneumonia aspiration | 26.62 | 14.19 | 169 | 307054 | 59102 | 64132407 |
Ataxia | 26.52 | 14.19 | 40 | 307183 | 22044 | 64169465 |
Complication associated with device | 26.26 | 14.19 | 20 | 307203 | 15060 | 64176449 |
Wrong product administered | 26.26 | 14.19 | 3 | 307220 | 7717 | 64183792 |
Incorrect product administration duration | 26.23 | 14.19 | 7 | 307216 | 9751 | 64181758 |
Nightmare | 26.22 | 14.19 | 37 | 307186 | 20956 | 64170553 |
Myocardial ischaemia | 26.14 | 14.19 | 44 | 307179 | 23207 | 64168302 |
Hiatus hernia | 26.11 | 14.19 | 34 | 307189 | 19923 | 64171586 |
Tenderness | 26.05 | 14.19 | 33 | 307190 | 19569 | 64171940 |
Anosmia | 26.05 | 14.19 | 62 | 307161 | 4355 | 64187154 |
Dizziness | 25.89 | 14.19 | 2382 | 304841 | 427781 | 63763728 |
Urinary incontinence | 25.81 | 14.19 | 87 | 307136 | 36064 | 64155445 |
Hyperhidrosis | 25.72 | 14.19 | 429 | 306794 | 124491 | 64067018 |
Tremor | 25.53 | 14.19 | 904 | 306319 | 147326 | 64044183 |
Colorectal adenocarcinoma | 25.48 | 14.19 | 17 | 307206 | 304 | 64191205 |
Pneumonia pneumococcal | 25.46 | 14.19 | 51 | 307172 | 3183 | 64188326 |
Asphyxia | 25.46 | 14.19 | 7 | 307216 | 9559 | 64181950 |
Gastroenteritis viral | 25.35 | 14.19 | 171 | 307052 | 19558 | 64171951 |
Epstein-Barr virus infection | 25.23 | 14.19 | 14 | 307209 | 12474 | 64179035 |
Kidney transplant rejection | 25.23 | 14.19 | 7 | 307216 | 9504 | 64182005 |
Plasma cell myeloma in remission | 25.16 | 14.19 | 7 | 307216 | 8 | 64191501 |
Eye disorder | 25.12 | 14.19 | 165 | 307058 | 18704 | 64172805 |
Disseminated intravascular coagulation | 25.09 | 14.19 | 75 | 307148 | 32273 | 64159236 |
Hepatomegaly | 25.06 | 14.19 | 26 | 307197 | 16856 | 64174653 |
Nephropathy toxic | 24.86 | 14.19 | 28 | 307195 | 17486 | 64174023 |
Nausea | 24.66 | 14.19 | 3324 | 303899 | 782476 | 63409033 |
White blood cell disorder | 24.62 | 14.19 | 45 | 307178 | 2622 | 64188887 |
Dyspnoea | 24.50 | 14.19 | 3024 | 304199 | 715650 | 63475859 |
Movement disorder | 24.40 | 14.19 | 42 | 307181 | 21958 | 64169551 |
Product dispensing error | 24.37 | 14.19 | 12 | 307211 | 11438 | 64180071 |
Tricuspid valve incompetence | 24.34 | 14.19 | 27 | 307196 | 16976 | 64174533 |
Salmonellosis | 24.30 | 14.19 | 31 | 307192 | 1313 | 64190196 |
Mania | 24.27 | 14.19 | 25 | 307198 | 16261 | 64175248 |
Therapy partial responder | 24.24 | 14.19 | 105 | 307118 | 10143 | 64181366 |
Peripheral sensory neuropathy | 24.23 | 14.19 | 113 | 307110 | 11265 | 64180244 |
Muscle strain | 24.23 | 14.19 | 90 | 307133 | 8104 | 64183405 |
Marasmus | 24.12 | 14.19 | 25 | 307198 | 843 | 64190666 |
Bladder transitional cell carcinoma stage 0 | 24.10 | 14.19 | 12 | 307211 | 119 | 64191390 |
Duodenal ulcer | 24.06 | 14.19 | 20 | 307203 | 14415 | 64177094 |
Venous thrombosis | 24.05 | 14.19 | 76 | 307147 | 6305 | 64185204 |
Venous thrombosis limb | 23.87 | 14.19 | 55 | 307168 | 3782 | 64187727 |
No adverse event | 23.79 | 14.19 | 64 | 307159 | 28497 | 64163012 |
Cholecystitis infective | 23.77 | 14.19 | 44 | 307179 | 2589 | 64188920 |
Post transplant lymphoproliferative disorder | 23.56 | 14.19 | 8 | 307215 | 9536 | 64181973 |
Bronchospasm | 23.49 | 14.19 | 42 | 307181 | 21640 | 64169869 |
Catatonia | 23.48 | 14.19 | 4 | 307219 | 7616 | 64183893 |
Eye movement disorder | 23.46 | 14.19 | 3 | 307220 | 7076 | 64184433 |
Bone density decreased | 23.45 | 14.19 | 9 | 307214 | 9943 | 64181566 |
Cytogenetic abnormality | 23.44 | 14.19 | 27 | 307196 | 1027 | 64190482 |
Nasal congestion | 23.39 | 14.19 | 177 | 307046 | 59481 | 64132028 |
Papule | 23.36 | 14.19 | 75 | 307148 | 6275 | 64185234 |
Atrioventricular block first degree | 23.23 | 14.19 | 11 | 307212 | 10723 | 64180786 |
Bile acid malabsorption | 23.14 | 14.19 | 13 | 307210 | 168 | 64191341 |
Tuberculosis | 23.08 | 14.19 | 17 | 307206 | 13021 | 64178488 |
Respiratory acidosis | 23.08 | 14.19 | 9 | 307214 | 9846 | 64181663 |
Intracranial pressure increased | 23.07 | 14.19 | 3 | 307220 | 6986 | 64184523 |
Abdominal pain lower | 23.05 | 14.19 | 58 | 307165 | 26411 | 64165098 |
Glomerular filtration rate decreased | 22.98 | 14.19 | 36 | 307187 | 19536 | 64171973 |
Chalazion | 22.95 | 14.19 | 18 | 307205 | 418 | 64191091 |
Platelet disorder | 22.92 | 14.19 | 40 | 307183 | 2247 | 64189262 |
Emotional disorder | 22.89 | 14.19 | 16 | 307207 | 12591 | 64178918 |
Pseudomonas infection | 22.85 | 14.19 | 31 | 307192 | 17852 | 64173657 |
Morganella infection | 22.76 | 14.19 | 26 | 307197 | 980 | 64190529 |
Pathogen resistance | 22.67 | 14.19 | 16 | 307207 | 12527 | 64178982 |
Paraproteinaemia | 22.57 | 14.19 | 17 | 307206 | 371 | 64191138 |
Infusion site erythema | 22.57 | 14.19 | 3 | 307220 | 6870 | 64184639 |
Blood calcium decreased | 22.56 | 14.19 | 203 | 307020 | 25351 | 64166158 |
Cholecystitis chronic | 22.56 | 14.19 | 8 | 307215 | 9279 | 64182230 |
Spinal osteoarthritis | 22.54 | 14.19 | 21 | 307202 | 14320 | 64177189 |
Mouth ulceration | 22.54 | 14.19 | 79 | 307144 | 32365 | 64159144 |
Ketoacidosis | 22.53 | 14.19 | 3 | 307220 | 6860 | 64184649 |
Sinus bradycardia | 22.50 | 14.19 | 47 | 307176 | 22846 | 64168663 |
Salivary hypersecretion | 22.49 | 14.19 | 15 | 307208 | 12098 | 64179411 |
Superficial spreading melanoma stage unspecified | 22.39 | 14.19 | 15 | 307208 | 270 | 64191239 |
Metastases to central nervous system | 22.31 | 14.19 | 20 | 307203 | 13892 | 64177617 |
Myopathy | 22.24 | 14.19 | 31 | 307192 | 17649 | 64173860 |
Blood potassium abnormal | 22.23 | 14.19 | 42 | 307181 | 2510 | 64188999 |
Pain in jaw | 22.23 | 14.19 | 109 | 307114 | 40646 | 64150863 |
Transitional cell carcinoma | 22.11 | 14.19 | 39 | 307184 | 2210 | 64189299 |
Malaise | 22.08 | 14.19 | 1607 | 305616 | 394640 | 63796869 |
Haemoptysis | 21.95 | 14.19 | 140 | 307083 | 48908 | 64142601 |
Arteriosclerosis | 21.87 | 14.19 | 26 | 307197 | 15851 | 64175658 |
Metabolic disorder | 21.70 | 14.19 | 5 | 307218 | 7692 | 64183817 |
Device occlusion | 21.70 | 14.19 | 10 | 307213 | 9903 | 64181606 |
Angina pectoris | 21.57 | 14.19 | 126 | 307097 | 44955 | 64146554 |
Central nervous system lesion | 21.57 | 14.19 | 15 | 307208 | 11834 | 64179675 |
Abdominal discomfort | 21.44 | 14.19 | 683 | 306540 | 181639 | 64009870 |
Affect lability | 21.40 | 14.19 | 8 | 307215 | 8982 | 64182527 |
Laryngeal oedema | 21.34 | 14.19 | 4 | 307219 | 7109 | 64184400 |
Arthropathy | 21.28 | 14.19 | 427 | 306796 | 120540 | 64070969 |
Skin plaque | 21.21 | 14.19 | 8 | 307215 | 8932 | 64182577 |
Throat irritation | 21.18 | 14.19 | 82 | 307141 | 32629 | 64158880 |
Nodule | 21.08 | 14.19 | 33 | 307190 | 17914 | 64173595 |
Photophobia | 21.08 | 14.19 | 31 | 307192 | 17262 | 64174247 |
Post procedural haemorrhage | 21 | 14.19 | 17 | 307206 | 12414 | 64179095 |
Enterococcal infection | 20.99 | 14.19 | 21 | 307202 | 13845 | 64177664 |
Vertigo | 20.88 | 14.19 | 180 | 307043 | 58831 | 64132678 |
Viral upper respiratory tract infection | 20.86 | 14.19 | 86 | 307137 | 8129 | 64183380 |
Heart rate decreased | 20.83 | 14.19 | 165 | 307058 | 54902 | 64136607 |
Acute respiratory distress syndrome | 20.74 | 14.19 | 105 | 307118 | 38830 | 64152679 |
Appendix disorder | 20.73 | 14.19 | 31 | 307192 | 1528 | 64189981 |
Musculoskeletal chest pain | 20.72 | 14.19 | 174 | 307049 | 21305 | 64170204 |
Hypertriglyceridaemia | 20.64 | 14.19 | 14 | 307209 | 11191 | 64180318 |
Cardiac murmur | 20.57 | 14.19 | 15 | 307208 | 11548 | 64179961 |
Muscle twitching | 20.41 | 14.19 | 37 | 307186 | 18961 | 64172548 |
Injection site discolouration | 20.34 | 14.19 | 4 | 307219 | 6871 | 64184638 |
Blood immunoglobulin M increased | 20.28 | 14.19 | 17 | 307206 | 435 | 64191074 |
Parainfluenzae virus infection | 20.23 | 14.19 | 59 | 307164 | 4684 | 64186825 |
Kidney infection | 20.23 | 14.19 | 150 | 307073 | 17688 | 64173821 |
Pulmonary sepsis | 20.16 | 14.19 | 45 | 307178 | 3030 | 64188479 |
Ventricular hypokinesia | 20.09 | 14.19 | 6 | 307217 | 7763 | 64183746 |
Lethargy | 20.04 | 14.19 | 235 | 306988 | 72359 | 64119150 |
Mental disorder | 20.02 | 14.19 | 62 | 307161 | 26383 | 64165126 |
Multiple organ dysfunction syndrome | 19.99 | 14.19 | 351 | 306872 | 101062 | 64090447 |
Oesophagitis | 19.94 | 14.19 | 46 | 307177 | 21584 | 64169925 |
Electrocardiogram ST segment elevation | 19.91 | 14.19 | 5 | 307218 | 7254 | 64184255 |
Exercise tolerance decreased | 19.86 | 14.19 | 6 | 307217 | 7704 | 64183805 |
Cholangiocarcinoma | 19.84 | 14.19 | 35 | 307188 | 1983 | 64189526 |
Osteopenia | 19.80 | 14.19 | 27 | 307196 | 15513 | 64175996 |
Hypercapnia | 19.79 | 14.19 | 6 | 307217 | 7688 | 64183821 |
Sinus disorder | 19.64 | 14.19 | 143 | 307080 | 16765 | 64174744 |
Invasive lobular breast carcinoma | 19.45 | 14.19 | 18 | 307205 | 527 | 64190982 |
Neuroendocrine carcinoma of the skin | 19.42 | 14.19 | 24 | 307199 | 984 | 64190525 |
Myeloma cast nephropathy | 19.39 | 14.19 | 11 | 307212 | 145 | 64191364 |
Acute erythroid leukaemia | 19.31 | 14.19 | 13 | 307210 | 236 | 64191273 |
Inappropriate antidiuretic hormone secretion | 19.29 | 14.19 | 49 | 307174 | 22240 | 64169269 |
Immunoglobulins increased | 19.15 | 14.19 | 17 | 307206 | 471 | 64191038 |
Hepatitis B DNA increased | 19.07 | 14.19 | 19 | 307204 | 611 | 64190898 |
Campylobacter gastroenteritis | 19.02 | 14.19 | 25 | 307198 | 1091 | 64190418 |
Intestinal obstruction | 19.02 | 14.19 | 260 | 306963 | 36026 | 64155483 |
Stupor | 18.97 | 14.19 | 3 | 307220 | 6032 | 64185477 |
Amenorrhoea | 18.94 | 14.19 | 4 | 307219 | 6535 | 64184974 |
Haemorrhage intracranial | 18.80 | 14.19 | 55 | 307168 | 23829 | 64167680 |
Protein total abnormal | 18.79 | 14.19 | 17 | 307206 | 483 | 64191026 |
Hyperammonaemia | 18.75 | 14.19 | 12 | 307211 | 9892 | 64181617 |
Gastrointestinal stromal tumour | 18.68 | 14.19 | 28 | 307195 | 1383 | 64190126 |
Feeling hot | 18.61 | 14.19 | 134 | 307089 | 45529 | 64145980 |
Ear swelling | 18.56 | 14.19 | 27 | 307196 | 1298 | 64190211 |
Febrile infection | 18.51 | 14.19 | 42 | 307181 | 2859 | 64188650 |
Prothrombin time prolonged | 18.43 | 14.19 | 29 | 307194 | 15712 | 64175797 |
Gastrointestinal infection | 18.43 | 14.19 | 82 | 307141 | 8014 | 64183495 |
Abdominal tenderness | 18.35 | 14.19 | 11 | 307212 | 9394 | 64182115 |
Abortion induced | 18.31 | 14.19 | 4 | 307219 | 6384 | 64185125 |
Swollen tongue | 18.20 | 14.19 | 95 | 307128 | 34859 | 64156650 |
Oral herpes | 18.18 | 14.19 | 50 | 307173 | 22102 | 64169407 |
Pulse absent | 18.12 | 14.19 | 10 | 307213 | 8936 | 64182573 |
Exfoliative rash | 17.99 | 14.19 | 47 | 307176 | 3499 | 64188010 |
Retching | 17.97 | 14.19 | 28 | 307195 | 15228 | 64176281 |
Apnoea | 17.92 | 14.19 | 14 | 307209 | 10408 | 64181101 |
Rhinitis allergic | 17.91 | 14.19 | 8 | 307215 | 8070 | 64183439 |
Cardiac valve disease | 17.89 | 14.19 | 60 | 307163 | 5135 | 64186374 |
Hyperthermia | 17.88 | 14.19 | 29 | 307194 | 15521 | 64175988 |
Walking aid user | 17.87 | 14.19 | 4 | 307219 | 6277 | 64185232 |
Varicophlebitis | 17.84 | 14.19 | 5 | 307218 | 6 | 64191503 |
Hepatitis fulminant | 17.84 | 14.19 | 4 | 307219 | 6270 | 64185239 |
Hypernatraemia | 17.84 | 14.19 | 19 | 307204 | 12170 | 64179339 |
Cholecystectomy | 17.74 | 14.19 | 8 | 307215 | 8024 | 64183485 |
Oesophageal squamous cell carcinoma | 17.74 | 14.19 | 16 | 307207 | 453 | 64191056 |
Squamous cell carcinoma of the oral cavity | 17.68 | 14.19 | 16 | 307207 | 455 | 64191054 |
Gastritis erosive | 17.66 | 14.19 | 12 | 307211 | 9583 | 64181926 |
5q minus syndrome | 17.65 | 14.19 | 13 | 307210 | 274 | 64191235 |
Nerve injury | 17.62 | 14.19 | 78 | 307145 | 7607 | 64183902 |
Normochromic normocytic anaemia | 17.61 | 14.19 | 5 | 307218 | 6685 | 64184824 |
Visual acuity reduced | 17.60 | 14.19 | 68 | 307155 | 27073 | 64164436 |
Type 1 diabetes mellitus | 17.56 | 14.19 | 3 | 307220 | 5702 | 64185807 |
Adrenal insufficiency | 17.54 | 14.19 | 52 | 307171 | 22435 | 64169074 |
Hydronephrosis | 17.53 | 14.19 | 25 | 307198 | 14100 | 64177409 |
Device failure | 17.51 | 14.19 | 3 | 307220 | 5689 | 64185820 |
Eosinophil count increased | 17.50 | 14.19 | 25 | 307198 | 14087 | 64177422 |
Hypertensive crisis | 17.48 | 14.19 | 38 | 307185 | 18210 | 64173299 |
Granuloma | 17.41 | 14.19 | 5 | 307218 | 6636 | 64184873 |
Pleurisy viral | 17.41 | 14.19 | 4 | 307219 | 0 | 64191509 |
Bundle branch block right | 17.40 | 14.19 | 14 | 307209 | 10255 | 64181254 |
Exposure to toxic agent | 17.37 | 14.19 | 4 | 307219 | 6155 | 64185354 |
Hepatitis acute | 17.32 | 14.19 | 23 | 307200 | 13366 | 64178143 |
Crepitations | 17.30 | 14.19 | 8 | 307215 | 7907 | 64183602 |
Spinal operation | 17.26 | 14.19 | 4 | 307219 | 6129 | 64185380 |
Liver function test decreased | 17.19 | 14.19 | 9 | 307214 | 100 | 64191409 |
Diverticulum intestinal | 17.01 | 14.19 | 7 | 307216 | 7413 | 64184096 |
Blood chloride decreased | 17.00 | 14.19 | 7 | 307216 | 7409 | 64184100 |
Pneumonia respiratory syncytial viral | 16.98 | 14.19 | 27 | 307196 | 1404 | 64190105 |
Brain herniation | 16.98 | 14.19 | 5 | 307218 | 6528 | 64184981 |
Polyarthritis | 16.77 | 14.19 | 13 | 307210 | 9702 | 64181807 |
Granulocytopenia | 16.75 | 14.19 | 15 | 307208 | 10425 | 64181084 |
Necrosis | 16.74 | 14.19 | 9 | 307214 | 8162 | 64183347 |
Tongue oedema | 16.67 | 14.19 | 4 | 307219 | 5986 | 64185523 |
Precursor B-lymphoblastic lymphoma | 16.65 | 14.19 | 5 | 307218 | 9 | 64191500 |
Nasal abscess | 16.62 | 14.19 | 10 | 307213 | 148 | 64191361 |
Alanine aminotransferase abnormal | 16.62 | 14.19 | 6 | 307217 | 6882 | 64184627 |
Bronchiectasis | 16.61 | 14.19 | 26 | 307197 | 14114 | 64177395 |
Bundle branch block left | 16.61 | 14.19 | 14 | 307209 | 10020 | 64181489 |
Body dysmorphic disorder | 16.53 | 14.19 | 12 | 307211 | 247 | 64191262 |
JC virus CSF test positive | 16.51 | 14.19 | 10 | 307213 | 150 | 64191359 |
Vertebral lesion | 16.50 | 14.19 | 15 | 307208 | 429 | 64191080 |
Stress cardiomyopathy | 16.48 | 14.19 | 12 | 307211 | 9245 | 64182264 |
Photosensitivity reaction | 16.47 | 14.19 | 39 | 307184 | 18134 | 64173375 |
Superficial spreading melanoma stage I | 16.38 | 14.19 | 6 | 307217 | 25 | 64191484 |
Meningitis pneumococcal | 16.35 | 14.19 | 14 | 307209 | 369 | 64191140 |
Musculoskeletal discomfort | 16.35 | 14.19 | 33 | 307190 | 16244 | 64175265 |
Hyperproteinaemia | 16.22 | 14.19 | 10 | 307213 | 155 | 64191354 |
Hyperglycaemia | 16.20 | 14.19 | 199 | 307024 | 60769 | 64130740 |
Immunosuppression | 16.20 | 14.19 | 97 | 307126 | 10649 | 64180860 |
Hypertransaminasaemia | 16.14 | 14.19 | 7 | 307216 | 7184 | 64184325 |
Feeling jittery | 16.03 | 14.19 | 96 | 307127 | 10539 | 64180970 |
Pulmonary congestion | 16.02 | 14.19 | 59 | 307164 | 23821 | 64167688 |
Sternal fracture | 16.00 | 14.19 | 34 | 307189 | 2213 | 64189296 |
Occult blood positive | 16.00 | 14.19 | 5 | 307218 | 6282 | 64185227 |
Cerebral infarction | 15.98 | 14.19 | 122 | 307101 | 40922 | 64150587 |
Ulcer | 15.96 | 14.19 | 56 | 307167 | 22934 | 64168575 |
Neutrophilia | 15.86 | 14.19 | 6 | 307217 | 6688 | 64184821 |
Immunoglobulins decreased | 15.82 | 14.19 | 25 | 307198 | 1293 | 64190216 |
Red blood cell count abnormal | 15.79 | 14.19 | 24 | 307199 | 1200 | 64190309 |
Pneumonia parainfluenzae viral | 15.77 | 14.19 | 12 | 307211 | 266 | 64191243 |
Portal hypertension | 15.73 | 14.19 | 5 | 307218 | 6214 | 64185295 |
Target skin lesion | 15.71 | 14.19 | 9 | 307214 | 121 | 64191388 |
Pneumonia bacterial | 15.69 | 14.19 | 124 | 307099 | 14911 | 64176598 |
Fistula | 15.69 | 14.19 | 14 | 307209 | 9747 | 64181762 |
Pyelonephritis | 15.69 | 14.19 | 37 | 307186 | 17229 | 64174280 |
Hypotension | 15.69 | 14.19 | 1582 | 305641 | 379392 | 63812117 |
Myasthenia gravis | 15.65 | 14.19 | 4 | 307219 | 5734 | 64185775 |
Prostate cancer stage II | 15.62 | 14.19 | 17 | 307206 | 607 | 64190902 |
Atypical pneumonia | 15.53 | 14.19 | 58 | 307165 | 5236 | 64186273 |
Platelet count abnormal | 15.52 | 14.19 | 49 | 307174 | 4063 | 64187446 |
Sarcoidosis | 15.44 | 14.19 | 5 | 307218 | 6141 | 64185368 |
Rash erythematous | 15.38 | 14.19 | 321 | 306902 | 48312 | 64143197 |
Frustration tolerance decreased | 15.36 | 14.19 | 5 | 307218 | 6120 | 64185389 |
Hyperaesthesia | 15.35 | 14.19 | 15 | 307208 | 9999 | 64181510 |
Ecchymosis | 15.34 | 14.19 | 27 | 307196 | 13995 | 64177514 |
Diffuse large B-cell lymphoma recurrent | 15.25 | 14.19 | 41 | 307182 | 3105 | 64188404 |
Transitional cell cancer of the renal pelvis and ureter | 15.24 | 14.19 | 7 | 307216 | 57 | 64191452 |
Body temperature increased | 15.23 | 14.19 | 107 | 307116 | 36559 | 64154950 |
Vitamin D deficiency | 15.21 | 14.19 | 20 | 307203 | 11672 | 64179837 |
Blood stem cell harvest failure | 15.20 | 14.19 | 8 | 307215 | 90 | 64191419 |
Scoliosis | 15.19 | 14.19 | 5 | 307218 | 6077 | 64185432 |
Hepatic amyloidosis | 15.18 | 14.19 | 4 | 307219 | 3 | 64191506 |
Long QT syndrome | 15.18 | 14.19 | 3 | 307220 | 5136 | 64186373 |
Full blood count | 15.18 | 14.19 | 4 | 307219 | 3 | 64191506 |
Ventricular hypertrophy | 15.18 | 14.19 | 6 | 307217 | 6510 | 64184999 |
Hyperbilirubinaemia | 15.16 | 14.19 | 51 | 307172 | 21154 | 64170355 |
Lung squamous cell carcinoma stage III | 15.15 | 14.19 | 5 | 307218 | 14 | 64191495 |
Optic neuritis | 15.14 | 14.19 | 10 | 307213 | 8106 | 64183403 |
Immunoglobulins abnormal | 15.04 | 14.19 | 7 | 307216 | 59 | 64191450 |
Acute biphenotypic leukaemia | 14.97 | 14.19 | 9 | 307214 | 133 | 64191376 |
Night sweats | 14.90 | 14.19 | 248 | 306975 | 35798 | 64155711 |
Hepatic fibrosis | 14.89 | 14.19 | 4 | 307219 | 5548 | 64185961 |
Encephalitis | 14.87 | 14.19 | 23 | 307200 | 12548 | 64178961 |
Blood thyroid stimulating hormone increased | 14.87 | 14.19 | 9 | 307214 | 7645 | 64183864 |
Sensory disturbance | 14.84 | 14.19 | 25 | 307198 | 13183 | 64178326 |
Lung squamous cell carcinoma stage IV | 14.84 | 14.19 | 7 | 307216 | 61 | 64191448 |
Renal tubular disorder | 14.81 | 14.19 | 5 | 307218 | 5982 | 64185527 |
Ischaemic cardiomyopathy | 14.81 | 14.19 | 7 | 307216 | 6831 | 64184678 |
Cytomegalovirus infection | 14.76 | 14.19 | 110 | 307113 | 37089 | 64154420 |
Blood magnesium abnormal | 14.75 | 14.19 | 16 | 307207 | 569 | 64190940 |
Pneumonia streptococcal | 14.70 | 14.19 | 34 | 307189 | 2344 | 64189165 |
Hydrocephalus | 14.64 | 14.19 | 9 | 307214 | 7582 | 64183927 |
Areflexia | 14.63 | 14.19 | 3 | 307220 | 5004 | 64186505 |
Vision blurred | 14.61 | 14.19 | 547 | 306676 | 89769 | 64101740 |
Refractory cytopenia with unilineage dysplasia | 14.60 | 14.19 | 19 | 307204 | 821 | 64190688 |
Large intestine infection | 14.55 | 14.19 | 36 | 307187 | 2592 | 64188917 |
Rectal haemorrhage | 14.52 | 14.19 | 207 | 307016 | 61610 | 64129899 |
POEMS syndrome | 14.47 | 14.19 | 6 | 307217 | 37 | 64191472 |
Dyspnoea at rest | 14.46 | 14.19 | 6 | 307217 | 6323 | 64185186 |
Humerus fracture | 14.43 | 14.19 | 75 | 307148 | 7810 | 64183699 |
Swelling | 14.39 | 14.19 | 620 | 306603 | 159598 | 64031911 |
Diverticular perforation | 14.38 | 14.19 | 56 | 307167 | 5157 | 64186352 |
Wound dehiscence | 14.37 | 14.19 | 5 | 307218 | 5869 | 64185640 |
Heat illness | 14.35 | 14.19 | 13 | 307210 | 370 | 64191139 |
Neutrophil count abnormal | 14.30 | 14.19 | 38 | 307185 | 2858 | 64188651 |
Blood iron decreased | 14.28 | 14.19 | 103 | 307120 | 12039 | 64179470 |
Gastrointestinal fungal infection | 14.21 | 14.19 | 13 | 307210 | 375 | 64191134 |
None
Source | Code | Description |
---|---|---|
ATC | L04AX04 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS Other immunosuppressants |
MeSH PA | D020533 | Angiogenesis Inhibitors |
MeSH PA | D000970 | Antineoplastic Agents |
MeSH PA | D006131 | Growth Inhibitors |
MeSH PA | D006133 | Growth Substances |
MeSH PA | D007155 | Immunologic Factors |
FDA EPC | N0000184014 | Thalidomide Analog |
CHEBI has role | CHEBI:35610 | antineoplastic agents |
CHEBI has role | CHEBI:48422 | angiogenesis antagonist |
CHEBI has role | CHEBI:50846 | Immunologic factor |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Follicular lymphoma | indication | 55150002 | |
Multiple myeloma | indication | 109989006 | DOID:9538 |
Myelodysplastic syndrome | indication | 109995007 | |
Mantle cell lymphoma | indication | 443487006 | |
Marginal zone lymphoma | indication | 447100004 | |
Deep venous thrombosis | contraindication | 128053003 | |
Impaired renal function disorder | contraindication | 197663003 | |
Pulmonary thromboembolism | contraindication | 233935004 | |
Pregnancy, function | contraindication | 289908002 | |
Thrombocytopenic disorder | contraindication | 302215000 | DOID:1588 |
Neutropenic disorder | contraindication | 303011007 | DOID:1227 |
Thromboembolic disorder | contraindication | 371039008 | |
Primary malignant neoplasm | contraindication | 372087000 | |
Breastfeeding (mother) | contraindication | 413712001 | |
Chemotherapy-Induced Hyperuricemia | contraindication |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 8.17 | acidic |
pKa2 | 3.13 | Basic |
Formulation strength | Trade name | Applicant | Application number | Approval date | Type | Dose form | Route | Patent number | Patent expiration date | Patent use |
---|---|---|---|---|---|---|---|---|---|---|
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 7189740 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 8404717 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 9056120 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 7189740 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 8404717 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 9056120 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 7189740 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 8404717 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 9056120 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 7189740 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 8404717 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 9056120 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 7189740 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 8404717 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 9056120 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 7189740 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 8404717 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 9056120 | April 11, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR TREATMENT OF PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA DUE TO LOW-OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q ABNORMALITY WITH OR WITHOUT ADDITIONAL CYTOGENETIC ABNORMALITIES |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 8530498 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 8648095 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 9101621 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO-HSCT) |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 9101622 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE, WHEREIN THOSE PATIENTS HAVE NOT RECEIVED PREVIOUS TREATMENT FOR MULTIPLE MYELOMA |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 9155730 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 9393238 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 8530498 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 8648095 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 9101621 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO-HSCT) |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 9101622 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE, WHEREIN THOSE PATIENTS HAVE NOT RECEIVED PREVIOUS TREATMENT FOR MULTIPLE MYELOMA |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 9155730 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 9393238 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 8530498 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 8648095 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 9101621 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO-HSCT) |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 9101622 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE, WHEREIN THOSE PATIENTS HAVE NOT RECEIVED PREVIOUS TREATMENT FOR MULTIPLE MYELOMA |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 9155730 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 9393238 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 8530498 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 8648095 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 9101621 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO-HSCT) |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 9101622 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE, WHEREIN THOSE PATIENTS HAVE NOT RECEIVED PREVIOUS TREATMENT FOR MULTIPLE MYELOMA |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 9155730 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 9393238 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 8530498 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 8648095 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 9101621 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO-HSCT) |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 9101622 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE, WHEREIN THOSE PATIENTS HAVE NOT RECEIVED PREVIOUS TREATMENT FOR MULTIPLE MYELOMA |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 9155730 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 9393238 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 8530498 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 8648095 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 9101621 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO-HSCT) |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 9101622 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE, WHEREIN THOSE PATIENTS HAVE NOT RECEIVED PREVIOUS TREATMENT FOR MULTIPLE MYELOMA |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 9155730 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 9393238 | May 15, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 7968569 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 8492406 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 7968569 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 8492406 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 7968569 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 8492406 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 7968569 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 8492406 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 7968569 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 8492406 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 7468363 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 7968569 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA, IN COMBINATION WITH DEXAMETHASONE |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 8492406 | Oct. 7, 2023 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PREVIOUSLY TREATED FOLLICULAR LYMPHOMA IN COMBINATION WITH A RITUXIMAB PRODUCT |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 8741929 | March 8, 2028 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 8741929 | March 8, 2028 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | 8741929 | March 8, 2028 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | 8741929 | March 8, 2028 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | 8741929 | March 8, 2028 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | 8741929 | March 8, 2028 | USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB |
Formulation strength | Trade name | Applicant | Application number | Approval date | Type | Dose form | Route | Exclusivity date | Description |
---|---|---|---|---|---|---|---|---|---|
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | Feb. 17, 2022 | FOR USE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE NOT RECEIVED AT LEAST ONE PRIOR THERAPY (FIRST LINE TREATMENT) |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | Feb. 17, 2022 | FOR USE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE NOT RECEIVED AT LEAST ONE PRIOR THERAPY (FIRST LINE TREATMENT) |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | Feb. 17, 2022 | FOR USE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE NOT RECEIVED AT LEAST ONE PRIOR THERAPY (FIRST LINE TREATMENT) |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | Feb. 17, 2022 | FOR USE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE NOT RECEIVED AT LEAST ONE PRIOR THERAPY (FIRST LINE TREATMENT) |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | Feb. 17, 2022 | FOR USE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE NOT RECEIVED AT LEAST ONE PRIOR THERAPY (FIRST LINE TREATMENT) |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | Feb. 17, 2022 | FOR USE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE NOT RECEIVED AT LEAST ONE PRIOR THERAPY (FIRST LINE TREATMENT) |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | May 28, 2022 | USED IN COMBINATION WITH A RITUXIMAB PRODUCT, ARE INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED FOLLICULAR LYMPHOMA (FL) |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | May 28, 2022 | USED IN COMBINATION WITH A RITUXIMAB PRODUCT, ARE INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA (MZL) |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | May 28, 2022 | USED IN COMBINATION WITH A RITUXIMAB PRODUCT, ARE INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED FOLLICULAR LYMPHOMA (FL) |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | May 28, 2022 | USED IN COMBINATION WITH A RITUXIMAB PRODUCT, ARE INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA (MZL) |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | May 28, 2022 | USED IN COMBINATION WITH A RITUXIMAB PRODUCT, ARE INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED FOLLICULAR LYMPHOMA (FL) |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | May 28, 2022 | USED IN COMBINATION WITH A RITUXIMAB PRODUCT, ARE INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA (MZL) |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | May 28, 2022 | USED IN COMBINATION WITH A RITUXIMAB PRODUCT, ARE INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED FOLLICULAR LYMPHOMA (FL) |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | May 28, 2022 | USED IN COMBINATION WITH A RITUXIMAB PRODUCT, ARE INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA (MZL) |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | May 28, 2022 | USED IN COMBINATION WITH A RITUXIMAB PRODUCT, ARE INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED FOLLICULAR LYMPHOMA (FL) |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | May 28, 2022 | USED IN COMBINATION WITH A RITUXIMAB PRODUCT, ARE INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA (MZL) |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | May 28, 2022 | USED IN COMBINATION WITH A RITUXIMAB PRODUCT, ARE INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED FOLLICULAR LYMPHOMA (FL) |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | May 28, 2022 | USED IN COMBINATION WITH A RITUXIMAB PRODUCT, ARE INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA (MZL) |
10MG | LENALIDOMIDE | ARROW INTL | A201452 | May 21, 2021 | RX | CAPSULE | ORAL | Aug. 30, 2022 | PATENT CHALLENGE |
15MG | LENALIDOMIDE | ARROW INTL | A201452 | May 21, 2021 | RX | CAPSULE | ORAL | Aug. 30, 2022 | PATENT CHALLENGE |
25MG | LENALIDOMIDE | ARROW INTL | A201452 | May 21, 2021 | RX | CAPSULE | ORAL | Aug. 30, 2022 | PATENT CHALLENGE |
5MG | LENALIDOMIDE | ARROW INTL | A201452 | May 21, 2021 | RX | CAPSULE | ORAL | Aug. 30, 2022 | PATENT CHALLENGE |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | Feb. 22, 2024 | TREATMENT OF MULTIPLE MYELOMA (MM), AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO-HSCT) |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | Feb. 22, 2024 | TREATMENT OF MULTIPLE MYELOMA (MM), AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO-HSCT) |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | Feb. 22, 2024 | TREATMENT OF MULTIPLE MYELOMA (MM), AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO-HSCT) |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | Feb. 22, 2024 | TREATMENT OF MULTIPLE MYELOMA (MM), AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO-HSCT) |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | Feb. 22, 2024 | TREATMENT OF MULTIPLE MYELOMA (MM), AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO-HSCT) |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | Feb. 22, 2024 | TREATMENT OF MULTIPLE MYELOMA (MM), AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO-HSCT) |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | May 28, 2026 | INDICATED IN COMBINATION WITH A RITUXIMAB PRODUCT FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED FOLLICULAR LYMPHOMA (FL) |
10MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | May 28, 2026 | INDICATED IN COMBINATION WITH A RITUXIMAB PRODUCT FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA (MZL) |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | May 28, 2026 | INDICATED IN COMBINATION WITH A RITUXIMAB PRODUCT FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED FOLLICULAR LYMPHOMA (FL) |
15MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | May 28, 2026 | INDICATED IN COMBINATION WITH A RITUXIMAB PRODUCT FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA (MZL) |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | May 28, 2026 | INDICATED IN COMBINATION WITH A RITUXIMAB PRODUCT FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED FOLLICULAR LYMPHOMA (FL) |
2.5MG | REVLIMID | CELGENE | N021880 | Dec. 21, 2011 | RX | CAPSULE | ORAL | May 28, 2026 | INDICATED IN COMBINATION WITH A RITUXIMAB PRODUCT FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA (MZL) |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | May 28, 2026 | INDICATED IN COMBINATION WITH A RITUXIMAB PRODUCT FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED FOLLICULAR LYMPHOMA (FL) |
20MG | REVLIMID | CELGENE | N021880 | June 5, 2013 | RX | CAPSULE | ORAL | May 28, 2026 | INDICATED IN COMBINATION WITH A RITUXIMAB PRODUCT FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA (MZL) |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | May 28, 2026 | INDICATED IN COMBINATION WITH A RITUXIMAB PRODUCT FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED FOLLICULAR LYMPHOMA (FL) |
25MG | REVLIMID | CELGENE | N021880 | June 29, 2006 | RX | CAPSULE | ORAL | May 28, 2026 | INDICATED IN COMBINATION WITH A RITUXIMAB PRODUCT FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA (MZL) |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | May 28, 2026 | INDICATED IN COMBINATION WITH A RITUXIMAB PRODUCT FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED FOLLICULAR LYMPHOMA (FL) |
5MG | REVLIMID | CELGENE | N021880 | Dec. 27, 2005 | RX | CAPSULE | ORAL | May 28, 2026 | INDICATED IN COMBINATION WITH A RITUXIMAB PRODUCT FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED MARGINAL ZONE LYMPHOMA (MZL) |
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Protein cereblon | Cytosolic other | MODULATOR | EC50 | 6.53 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||
Tumor necrosis factor | Cytokine | IC50 | 7.89 | WOMBAT-PK | |||||
Bromodomain-containing protein 4 | Unclassified | IC50 | 5.29 | CHEMBL | |||||
Cereblon isoform 4 | Unclassified | Ki | 5.51 | CHEMBL |
ID | Source |
---|---|
4025089 | VUID |
N0000175347 | NUI |
D04687 | KEGG_DRUG |
4025089 | VANDF |
C1144149 | UMLSCUI |
CHEBI:63791 | CHEBI |
CHEMBL848 | ChEMBL_ID |
DB00480 | DRUGBANK_ID |
D000077269 | MESH_DESCRIPTOR_UI |
216326 | PUBCHEM_CID |
7331 | IUPHAR_LIGAND_ID |
8505 | INN_ID |
F0P408N6V4 | UNII |
337535 | RXNORM |
20816 | MMSL |
355195 | MMSL |
73707 | MMSL |
d05696 | MMSL |
011171 | NDDF |
421471009 | SNOMEDCT_US |
421737001 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Lenalidomide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0480-1242 | CAPSULE | 5 mg | ORAL | ANDA | 31 sections |
Lenalidomide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0480-1243 | CAPSULE | 10 mg | ORAL | ANDA | 31 sections |
Lenalidomide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0480-1244 | CAPSULE | 15 mg | ORAL | ANDA | 31 sections |
Lenalidomide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0480-1246 | CAPSULE | 25 mg | ORAL | ANDA | 31 sections |
Revlimid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59572-402 | CAPSULE | 2.50 mg | ORAL | NDA | 32 sections |
Revlimid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59572-402 | CAPSULE | 2.50 mg | ORAL | NDA | 32 sections |
Revlimid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59572-405 | CAPSULE | 5 mg | ORAL | NDA | 32 sections |
Revlimid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59572-405 | CAPSULE | 5 mg | ORAL | NDA | 32 sections |
Revlimid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59572-410 | CAPSULE | 10 mg | ORAL | NDA | 32 sections |
Revlimid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59572-410 | CAPSULE | 10 mg | ORAL | NDA | 32 sections |
Revlimid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59572-415 | CAPSULE | 15 mg | ORAL | NDA | 32 sections |
Revlimid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59572-415 | CAPSULE | 15 mg | ORAL | NDA | 32 sections |
Revlimid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59572-420 | CAPSULE | 20 mg | ORAL | NDA | 32 sections |
Revlimid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59572-420 | CAPSULE | 20 mg | ORAL | NDA | 32 sections |
Revlimid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59572-425 | CAPSULE | 25 mg | ORAL | NDA | 32 sections |
Revlimid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59572-425 | CAPSULE | 25 mg | ORAL | NDA | 32 sections |